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UNIVERSITY OF SOUTHAMPTON 
ABSTRACT 
FACULTY OF LAW, ARTS & SOCIAL SCIENCES 
SCHOOL OF SOCIAL SCIENCES 
Doctor of Philosophy 
THREE PAPERS ON SIDE EFFECTS AND MODERN CONTRACEPTIVE 
USE AMONG WOMEN IN GHANA 
By Claire Elizabeth Bailey 
 
This thesis investigates the issue of side effects and how they may act as a barrier 
to the use of modern contraceptive methods among women in Ghana. Three 
papers are presented each addressing the issue using different sources of data 
and  different  methodologies.  The  disparate  nature  of  the  data  sources  and 
techniques used provides each paper with its own perspective on the research 
question and each paper gives a unique insight into the topic.  
 
  The aim of the first paper is to use a qualitative focus group methodology to 
explore  in depth  the  way  individuals  perceive  information  about  family 
planning. The study seeks to better define what is meant by the term fear of side 
effect in this particular social context and to determine on what information and 
from what sources is this fear constructed. Overall the findings of this study 
show  that  fear  of  side  effects  does  act  as  a  significant  barrier  to  the  use  of 
temporary  methods  and  these  fears  result  mainly  from  a  large  amount  of 
negative  information  regarding  side  effects  being  passed  through  the  social 
network. However the events being recounted cannot be dismissed as myth or 
rumour as they are most often based in real experiences. 
 
  The second paper uses monthly data on contraceptive use and the experience of 
side  effects  from  the  calendar  section  of  a  longitudinal  survey  of  women  in 
Southern  Ghana.  Using  life  tables  and  a  multi level  logistic  discrete time 
hazards  model  this  study  analyses  contraceptive  discontinuation  and  how  it 
relates  to  the  concurrent  self reported  experience  of  side  effects. The  results 
show  that  experiencing side  effects  is  associated  with  a  higher  probability  of 
discontinuation  of  the  method  and  that  counselling  from  health  workers  is 
extremely important in minimizing discontinuation rates.  
 
  The third paper uses a sub sample of women who are not current contraceptive 
users  from  the  2003  GDHS.    The  study  uses  multiple  logistic  regression  to 
determine  the  association  between  exposure  to  family  planning  information, 
through  mass  media  and  interpersonal  channels,  and  the  probability  that  a 
respondent will cite fear of side effects as their main reason for not intending to 
use a contraceptive method in the future. The results show that the only family 
planning  communication  variable  which  does  have  a  significant  effect  is 
receiving a message from a health worker which increases the odds of fear of 
side  effects  being  the  main  reason  for  not  intending  to  use  a  method  in  the 
future. Overall the socio economic characteristics of those not intending to use a 
method in the future due to a fear of side effects is more similar to current users 
than to those who are not intending to use in the future for other reasons.  
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Chapter One 
 
Introduction 
 
This document presents a study on the topic of contraceptive use among 
women in Ghana. One of the issues which is consistently raised in studies 
of contraceptive use in sub Saharan Africa is the non use of contraceptive 
methods  due  to  fear  of  side  effects  or  detrimental  health  effects.  The 
specific focus of the study is the fear of side effects as a barrier to the use 
of modern contraceptive methods and the overall research questions are 
as follows:  
•  In  what  way  does  fear  of  side  effects  influence  contraceptive 
behaviour  and  function  as  a  barrier  to  the  use  of  modern  or 
hormonal methods among women in Ghana?  
•  Is the fear of side effects and subsequent contraceptive behaviour 
influenced  by  exposure  to  different  sources  of  family  planning 
information?  
 
The thesis is presented in a three paper format where a variety of data 
and methods are employed to fully explore the topic. This introductory 
chapter  begins  by  explaining  the  rationale  behind  the  study.  It  then 
presents  information  on  the  background  context  in  relation  to  fertility 
and contraceptive use in Ghana. Finally the aims of the study are stated 
and the structure of the thesis outlined.  
   2 
1.1: Rationale for Study 
 
Ghana  was  the  first  country  in  Sub Saharan  Africa  to  implement  an 
official population policy in 1969 in response to the recognition by the 
government  of  high  fertility,  a  high  population  growth  rate  and  their 
potentially  detrimental  consequences  on  social  and  economic 
development.  This  policy  had  only  a  modest  impact  prior  to  the  early 
1990’s due to lack of political commitment and was revised in 1994 to 
integrate population issues in development planning and to  take account 
of  emerging  issues  such  as  the  HIV/AIDS  epidemic  (Ghana  Statistical 
Service et al, 2004). The total fertility rate (TFR) then declined sharply 
from 6.4 in 1988 to 4.6 in 1998, however this decline has subsequently 
stalled and the TFR has remained at 4.4 between 1998 and 2003 (Ghana 
Statistical Service et al, 2004).  
 
A wealth of empirical evidence shows a strong correlation between the 
TFR  and  the  contraceptive  prevalence  rate  (CPR)  at  national  level.  As 
such  family  planning  policy  and  programmes  aimed  at  increasing 
contraceptive use accomplish the concurrent aims of improving mother 
and child health, enabling reproductive freedom of choice and lowering 
the TFR. As part of the Ghana Poverty Reduction Strategy (GPRS) in 1995 
the Vision 2020 Plan of Action was adopted of which the central aims are 
to eradicate poverty, accelerate economic development and enhance the 
quality  of  life  for  all  citizens.  The  ultimate  goal  of  Vision  2020  is  for 
Ghana to become classified as a middle income country by 2020. One aim 
of Vision 2020 is to have a CPR of modern methods of 50% by 2020 
(World  Bank,  2003).  The  strategy  for  achieving  this  aim  is  firstly  to 
decentralize service delivery and expand the availability of contraceptives 
and secondly to implement a national campaign on fertility regulation. 
This  includes  a  comprehensive,  systematic,  and  culturally  sensitive 
information, education and communication (IEC) programme to promote 
the use of family planning (World Bank, 2003).  
   3 
The  Millennium  Development  Goals  (MDGs)  were  developed  by  the 
United Nations (UN) to focus the efforts of the international community 
on  to  key  development  issues  and  to  introduce  measurable  goals  and 
targets.  The  original  declaration  in  2000  introduced  eight  major  goals 
with  associated  targets.  The  year  2007  marked  the  mid way  point 
between the adoption of the framework and the original target date of 
2015.  At  this  mid point  some  progress  had  been  made  but  several 
countries in sub Saharan Africa are not on track to achieve any of the 
goals.  The 2007 report of the Secretary General of the United Nations 
acknowledged with reference to the MDGs that poor access to health care 
and  reproductive  health  services  is  one  of  the  pervasive  challenges  to 
meeting  the  goals  (United  Nations,  2007).  When  the  goal  monitoring 
framework was revised in 2007 by the Inter Agency and Expert Group on 
Millennium Development Goal Indicators greater emphasis was placed on 
reproductive health care and family planning as integral to achieving Goal 
5 to reduce maternal mortality. Achieving universal access to reproductive 
health care by 2015 was added as a new target towards Goal 5 and the 
contraceptive prevalence rate (CPR) and unmet need for family planning 
were introduced as indicators of progress towards this goal. While it can 
be  argued  that  family  planning  underpins  the  attainment  of  all  of  the 
MDGs it has a particular significance in achieving Goal 4 to reduce child 
mortality, and Goal 3 to promote gender equality and empower women. 
As  Cleland  (2001:46)  puts  it  ‘by  releasing  women  from  the  burden  of 
frequent  childbearing  it  paves  the  way  for  a  revolution  in  gender 
relations’.   4 
1.2: Background Context 
 
1.2.1: Fertility Trends in Ghana 
 
The current TFR in Ghana calculated for the three years preceding the 
2003  Ghana  Demographic  Health  Survey  (GDHS)  is  4.4  births  per 
woman. This is relatively low in comparison to other sub Saharan African 
countries many of which have an average of over 6 births per woman, as 
shown in Figure 1.1 below. 
 
Figure 1.1: Total Fertility Rates aged 15 49 of Selected Sub Saharan 
African Countries 
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Source Data: Central Bureau of Statistics [Kenya] et al, 2004; Central Statistical Agency 
[Ethiopia] & ORC Macro, 2006; Central Statistical Office [Zimbabwe] & Macro 
International Inc., 2007;  Ghana Statistical Service et al, 2004; Institut National de la 
Statistique [Cameroon] & ORC Macro, 2004; Institut National de la Statistique et de la 
Démographie [Burkina faso] & ORC Macro, 2004;  Institut National de la Statistique et 
de l’Analyse Économique [Benin] & ORC Macro, 2002; Ministry of Health and Social 
Services [Namibia], 2003; National Statistical Office [Malawi], & ORC Macro, 2005;  
Ouagadjio et al, 2004; Uganda Bureau of Statistics & Macro International Inc., 2007 
 
Table 1.1 shows the change in TFR calculated from GDHS survey data 
from  1988,  1993,  1998  and  most  recently  2003.  There  has  been  a 
dramatic  decline  in  fertility  of  2  births  per  woman  between  1988  and 
1998,  however  the  decline  in  fertility  appears  to  have  stalled  between 
1998 and 2003 and the TFR remains the same between these two surveys.   5 
Trends in this data should be interpreted with some caution as they must 
be viewed within the context of the varying data quality and sample size of 
each of the four different surveys (Ghana Statistical Service, 2004).  
 
Table 1.1: Trends in Total Fertility Rates from GDHS, 1988 2003* 
  GDHS 
1988 
GDHS 
1993 
GDHS 
1998 
GDHS 
2003 
TFR ages 15 49 
years   
6.4  5.2  4.4  4.4 
* Rates are per 1,000 women and refer to the three year period preceding the survey 
Data Source: GDHS, 2003 
 
This stall in fertility decline is evident despite the continued rise in the 
contraceptive  prevalence  rate  (CPR)  measured  between  these  surveys. 
The relationship between the TFR and the CPR over the time of these four 
GDHS surveys is shown in figure 1.2 which shows both the continued rise 
in the CPR and the levelling off of the decline in the TFR.     
 
Figure 1.2: Scatter Graph of Total Fertility Rate and Contraceptive 
Prevalence Rate from GDHS, 1988 2003 
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Data Source: GDHS, 2003  
 
A study by Bongaarts (2005) explores the possible determinates of the 
fertility stall in Ghana along with six other countries where a similar stall 
has  been  identified.  The  study  found  that  in  Ghana  there  were  no 
significant  increases  in  unwanted  fertility  or  the  unmet  need  for   6 
contraception and median age at first marriage rose while family planning 
effort scores improved slightly during the period between the 1998 and 
2003 surveys. The study also looked at the socio economic variables of 
GDP,  child  survival  and  proportion  schooled  and  found  that  although 
changes in these variables had levelled off over the period in question this 
was not a significant factor in the fertility stall. Despite no significant link 
being  found  between  socio economic  development  and  the  stalling 
fertility  the  study  did  conclude  that  improvements  in  socio economic 
development  are  needed  in  Ghana  to  further  reduce  wanted  fertility 
which was 3.7 children per women at the time of the 2003 survey. The 
study  also  concluded  that  although  the  findings  suggested  no  major 
deterioration  in  access  to  contraceptives,  the  level  of  unmet  need  is 
relatively  high  at  34%  and  improvements  in  access  to  family  planning 
methods would therefore be desirable (Bongaarts, 2005).  
 
Another interesting finding from this study is, that at the onset of the 
fertility stall the TFR in Ghana was already low compared to what would 
be expected based on the level of socio economic development. There is 
no clear explanation for this finding but it is in line with a similar finding 
from a study by Blanc & Grey (2000) that the TFR calculated from the 
1998 GDHS is lower than would be expected based on the CPR at that 
time. Based on a regression line, calculated using data from 100 surveys 
in developing countries, the expected TFR predicted for Ghana in 1998 
would be 5.75 while the actual recorded fertility according to the GDHS of 
that year is 4.61 (Blanc & Grey, 2000). The study explored the possible 
reasons for this finding and concluded that there had been a number of 
changes in contraceptive dynamics prior to 1998 that could increase the 
effect of contraceptive prevalence on fertility reduction.  These include a 
marked shift from traditional methods to modern methods, a reallocation 
from  the  use  of  contraception  for  birth  spacing  towards  the  use  of 
contraception for the limitation of births and a substantial reduction in 
                                                 
1 This figure differs from the TFR of 4.4 reported by the GDHS and presented in table 1.1 
because the GDHS calculate the TFR based on births from the 3 years preceding the 
1998 GDHS survey whereas the Blanc & Grey study based their TFR on births from the 5 
years preceding the survey.      7 
“redundant” use (Blanc & Grey, 2000). Another suggestion put forward 
by Agyei Mensah (2005) is that the stall is related to fertility desires and 
that  a  drop  below  four  children  represents  a  significant  psychological 
barrier for couples which will require ‘a more radical transformation of 
the society’ (Agyei Mensah, 2005:16). As evidence of this the study points 
to a stall in the decline of the ideal number of children which coincides 
with the stall in TFR and is shown in table1.2 below.   
 
Table 1.2: Mean Ideal Number of Children (all women aged 15 49 years), 
GDHS 1988 2003  
  GDHS 
1988 
GDHS 
1993 
GDHS 
1998 
GDHS 
2003 
Mean ideal 
number of 
children 
5.3  4.4  4.3  4.4 
Data  source:  Ghana  Statistical  Service  &  Institute  for  Resource  Development/Macro 
Systems, Inc., 1989;  Ghana Statistical Service (GSS) and Macro International Inc., 1994; 
Ghana Statistical Service (GSS) and Macro International Inc. 1999 & Ghana Statistical 
Service et al, 2004) 
 
Overall these studies do not offer an obvious explanation of the fertility 
stall in Ghana or provide a clear prediction of what the future fertility 
trends may be. The suggestion is that the stall is a temporary adjustment 
based on the fact that prior to stalling the TFR was already lower than 
would be expected given other determinants. In essence that fertility has 
stalled while CPR and levels of socio economic development continue to 
rise and in effect ‘catch up’ to the fertility level. If this theory is correct it 
would  follow  that  once  the  ‘catch  up’  is  complete  then  fertility  will 
continue to decline towards replacement level. The idea that fertility in 
Ghana should continue to decline and reach replacement level is based on 
classical  demographic  transition  theory  and  the  past  experience  of 
European  countries.  The  applicability  of  this  theory  to  sub Saharan 
African countries is questionable and the lowest fertility level which will 
be achieved at the end of the transition in Ghana is unknown. 
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1.2.2: Contraceptive Use in Ghana 
 
According  to  the  GDHS  2003  knowledge  of  contraceptive  methods  in 
Ghana is almost universal with 97.7% of all women and 98.9% of all men 
aged  15 49  years  reporting  knowledge  of  at  least  one  method.  Among 
women modern methods are more widely known than traditional.  The 
overall CPR for all women aged 15 49 years in 2003 is 20.7%. As would be 
expected the CPR for married women is higher than for all women and in 
2003 was 25.2% for any method (Ghana Statistical Service et al, 2004). In 
the global context this is relatively low, for example the corresponding 
figure in 2009 in the UK for currently married women is 84% and the 
world  average  is  62%  (Population  Reference  Bureau,  2009).  However 
figure 1.3 shows the CPR of selected countries and regional averages in 
sub Saharan Africa, and shows that within this regional context the CPR 
in Ghana is actually quite high.  
 
Figure 1.3: Contraceptive Prevalence Rates of Selected Sub Saharan 
African Countries and Regions (currently married women aged 15 49 
years) 
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Figure 1.3 shows that Ghana has an all method CPR higher than any other 
country in West Africa and higher than the average for all of sub Saharan 
Africa. The modern methods CPR is the same as the average for all of sub 
Saharan Africa and is only lower than the Eastern Africa regional average. 
Figure 1.4 is based on GDHS data and shows the trends in contraceptive 
use  for  married  women  aged  15 49  by  modern,  traditional  and  any 
method from 1988 to 2003. The graph shows a steady increase in the 
prevalence  of  modern  methods  accompanied  by  a  decline  in  the 
percentage reporting use of a traditional method since 1993. Despite the 
increases  in  the  use  of  modern  methods  shown,  the  CPR  of  modern 
methods remains below 20% in 2003 which makes the previously stated 
goal of the GPRS Vision 2020 to have a modern methods CPR of 50% by 
2020 seem a difficult target to attain.  
 
Figure 1.4: Trends in Contraceptive Use among Currently Married 
Women Aged 15 49 years from 1988 to 2003 (%) 
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Data Source: Ghana Statistical Service et al, 2004 
 
1.2.3: Reasons for Non use of Contraception in Ghana 
 
1.2.3.1: Current Non Use 
 
Many  previous  studies  have  used  DHS  data  to  determine  the  socio 
economic and cultural characteristics which may act as determinants of 
individuals’  contraceptive  behaviour  and  in  doing  so  have  identified   10 
several barriers to contraceptive use. Studies in Ghana have shown that 
rural residence, illiteracy, low levels of education and lack of exposure to 
media  sources  all  act  as  barriers  to  the  use  of  modern  contraceptives 
(Parr, 2001). Many DHS provide data on the non use of contraceptives in 
which respondents are asked the question: ‘You have said that you do not 
want (a/another child soon) (any more children), but you are not using 
any method to avoid pregnancy. Can you tell me why?’ (Ghana Statistical 
Service et al, 2004). Respondents are allowed to answer more than one 
reason and their responses are then field coded in to the 21 categories 
which  appear  in  table  1.3  below.  Table  1.3  shows  the  number  and 
percentage of respondents citing each reason for non use in the GDHS 
2003.  
 
Table 1.3: Reason for Current Non use of Contraception GDHS 2003 
Reason for non use  Frequency N = 2328  Percent 
Not married  332  14.3 
Not having sex  653  28.0 
Infrequent sex  206  8.8 
Menopausal/hysterectomy  98  4.2 
Subfecund/infecund  47  2.0 
Postpartum amenorrheic  124  5.3 
Breastfeeding  302  13.0 
Fatalistic  3  0.1 
Respondent opposed  41  1.8 
Husband/partner opposed  47  2.0 
Religious prohibition  34  1.5 
Knows no method  141  6.1 
Knows no source  106  4.5 
Health concerns  127  5.4 
Fear of side effects  384  16.5 
Lack of access/too far  74  3.2 
Costs too much  133  5.7 
Inconvenient to use  20  0.9 
Interferes with body’s processes  32  1.4 
Other   84  3.6 
Don’t know  59  2.5 
* Percentages do not add up to 100 as respondents are allowed to answer in more than 
one category.  
 
Table 1.3 shows that the most commonly cited reason for non use is not 
having  sex  which  is  mentioned  by  28%  of  respondents,  the  next  most 
frequency cited reason is fear of side effects followed by being unmarried.   11 
Lack of knowledge, lack of access and opposition to family planning in 
general are not frequently cited reasons for non use.   
 
1.2.3.2: Future Intentions for Non Use 
 
Along  with  being  asked  their  reason  for  not  currently  using  a 
contraceptive method respondents in DHS are also asked if they intend to 
use a contraceptive method in the future.  If the answer is ‘no’ then those 
respondents are asked the follow up question: ‘What is the main reason 
that you think you will not use a contraceptive method at any time in the 
future?’ (Ghana Statistical Service et al, 2004). The responses are grouped 
into five main categories and the percentage distribution of respondents 
in each category from the GDHS 2003 is shown in figure 1.5 below.  
 
Figure 1.5: Percentage Distribution of Currently Married Women aged 
15 49 by Main Reason for Not Intending to Use Contraception in the 
Future GDHS, 2003 (N = 1102)  
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Figure 1.5 shows that as would be expected ‘fertility related reasons’ is the 
most commonly cited category of responses with 40.5% of respondents 
citing  one  of  these  as  their  main  reason  for  not  intending  to  use  a 
contraceptive  method  in  the  future.  Fertility  related  reasons  comprise 
those  whose  main  reason  is  ‘subfecund/infecund’  or  ‘wants  as  many 
children as possible’ each of which account for approximately 15% of all   12 
responses.  The  remaining  two  fertility  related  reasons  are 
‘menopausal/had  hysterectomy’  and  ‘infrequent  sex/no  sex’  each  with 
approximately  5%  of  all  responses.  The  category  of  ‘method  related 
reasons’  is  the  second  most  commonly  cited  category  of  reasons  with 
37.3%  of  respondents  citing  one  of these  as  their  main  reason  for  not 
intending  to  use  FP  in  the  future.  The  remaining  categories  are 
‘opposition to use’, ‘lack of knowledge’ and ‘other’ comprising 12.3%, 5.7% 
and 4.2% of responses respectively.2  The category of primary interest to 
this  study  is  ‘method  related  reasons’  and  figure  1.6  below  shows  this 
category broken down into its six individual response categories.  
 
Figure 1.6: Percentage Distribution of Currently Married Women aged 
15 49 by Main Reason for Not Intending to Use Contraception in the 
Future – Method Related Reasons GDHS, 2003 (N = 408) 
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Figure  1.6  shows  that  ‘fear  of  side  effects’  dominates  ‘method  related 
reasons’  with  68%  of  all  responses.  This  translated  to  25.6%  of  all 
respondents citing fear of side effects as their main reason for intention 
not to use family planning which is by far the most often cited reason. 
‘Health concerns’ accounts for a further 20% of method related reasons or 
                                                 
2 These three categories are comprised of the following individual responses: 
Opposition  to  use:  Respondent  opposed,  Husband/partner  opposed,  Religious 
prohibition. 
Lack of knowledge: Knows no method, Knows no source 
Other: Other, Don’t know, Missing 
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7.6% of all reasons, and the four remaining categories each account for a 
small percentage of responses.   
 
1.2.4: Clinical Evidence of Side Effects 
 
As shown above fear of side effects is a frequently cited reason for the 
non use of modern contraceptives.  One of the aims of this study is to 
attempt to gain a better understanding of the term ‘fear of side effects’ 
and  of  what  women  are  actually  experiencing  when  they  refer  to  side 
effects. There is a large body of evidence based on clinical trials which 
details  the  possible  physical  symptoms  and  side  effects  which  may  be 
caused  by  using  a  particular  contraceptive  method  (see  for  example 
Kubba et al., 2000). Table 1.4 shows a summary of the side effects which 
are associated with each different hormonal methods and IUDs, which is 
compiled from the WHO family planning providers’ handbook. Table 1.4 
shows  that  all  methods  are  associated  with  menstrual  changes  and 
hormonal  methods  are  most  often  associated  with  headaches  and 
dizziness. There is also evidence to show that there is a small risk of more 
serious side effects such as deep vein thrombosis, pulmonary embolism or 
stroke, however these are all very rare. Connections have also been made 
between  some  types  of  hormonal  contraceptives  and  increased  risk  of 
certain  cancers  particularly  breast  and  cervical  cancer.  There  are  also 
instances  where  contraceptive  method  use  can  have  a  protective  effect 
against certain types of cancer, as shown in table 1.5. There are obvious 
health  benefits  of  contraceptive  use  in  terms  of  avoiding  unwanted 
pregnancies and the associated risks of child birth or induced abortion, 
however  looking  beyond  this  there  are  other  potential  protective  or 
beneficial  effects  of  methods  which  are  summarized  in  table  1.5.    Of 
particular relevance in the sub Saharan African context  is the possible 
protecting against iron deficiency anaemia provided by many methods.  
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Table 1.4: Possible Side Effects of Modern Methods 
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Possible Side Effects 
Changes in bleeding pattern  ￿  ￿  ￿  ￿  ￿  ￿  ￿ 
Headache  ￿  ￿  ￿  ￿  ￿    ￿ 
Dizziness  ￿  ￿  ￿  ￿  ￿    ￿ 
Nausea  ￿  ￿      ￿    ￿ 
Breast tenderness  ￿  ￿    ￿  ￿    ￿ 
Weight change  ￿    ￿  ￿  ￿    ￿ 
Mood changes  ￿  ￿  ￿    ￿    ￿ 
Acne (Usually improves)  ￿        ￿    ￿ 
Abdominal pain/bloating    ￿  ￿    ￿     
Lower sex drive      ￿         
Cramps  and  pain  during  monthly 
bleeding            ￿   
Other Possible Physical Changes 
Increase in blood pressure  ￿             
Loss of bone density      ￿         
Enlarged ovarian follicles          ￿     
Ovarian cysts              ￿ 
Source: CCP & WHO (2007) 
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Table 1.5:  Health Benefits of Modern Methods 
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Known health benefits: ￿ ￿ ￿ ￿￿ ￿ ￿ ￿ = helps protect against ￿ ￿ ￿ ￿ = may help protect against  
Endometrial cancer  ￿￿    ￿￿      ￿   
Cancer of the ovary  ￿￿             
Symptomatic pelvic inflammatory 
disease  ￿￿    ￿    ￿￿     
Uterine fibroids      ￿￿         
Iron deficiency anaemia  ￿    ￿    ￿    ￿￿ 
Ovarian cysts  ￿             
Pelvic inflammatory disease              ￿ 
Reduces: 
Symptoms of endometriosis  ￿    ￿        ￿ 
Sickle cell crises among women 
with sickle cell anaemia      ￿         
Menstrual cramps/bleeding problems  ￿            ￿ 
Ovulation pain  ￿             
Excess hair on face or body  ￿             
Symptoms of polycystic ovarian 
syndrome   ￿             
Source: CCP & WHO (2007)   16 
1.2.5: Fear of Side Effects in Ghana 
 
Overall  fear  of  side  effects  is  25.6%  of  women’s  main  reason  for  not 
intending to use contraception and is by far the most commonly cited 
single reason why women say they do not intend to use contraception in 
the  future.  Fear  of  side  effects  has  also  increased  in  importance  as  a 
reason for non use between 1998 and 2003, from 18% to 26%. Fear of 
side effects is more likely to be cited as the main reason for not intending 
to use in the future by younger women with  34.2% of those in the age 
range 15 29 years citing this reason compared to 22.5% in the age range 
30 49  years.  Figure  1.7  shows  that  compared  to  other  sub Saharan 
African countries Ghana has a high level of fear of side effects with only 
Uganda being slightly higher at 26%.  
 
Figure 1.7: Percentage of Respondents Citing Fear of Side Effects as 
Main Reason for Not Intending to Use a Contraceptive Method in the 
Future Selected sub Saharan Countries 
0
5
10
15
20
25
30
Chad
Ethiopia
Cameroon
Namibia
Burkina Faso
Benin
Zimbabwe
Kenya
Malawi
Ghana
Uganda
%
 
f
e
a
r
 
o
f
 
s
i
d
e
 
e
f
f
e
c
t
s
 
a
s
 
m
a
i
n
 
r
e
a
s
o
n
 
f
o
r
 
n
o
t
 
i
n
t
e
n
d
i
n
g
 
t
o
 
u
s
e
 
c
o
n
t
r
a
c
e
p
t
i
o
n
 
Source Data: Central Bureau of Statistics [Kenya] et al, 2004; Central Statistical Agency 
[Ethiopia]  &  ORC  Macro,  2006;  Central  Statistical  Office  [Zimbabwe]  &  Macro 
International Inc., 2007;  Ghana Statistical Service et al, 2004; Institut National de la 
Statistique [Cameroon] & ORC Macro, 2004; Institut National de la Statistique et de la 
Démographie [Burkina faso] & ORC Macro, 2004;  Institut National de la Statistique et 
de l’Analyse Économique [Benin] & ORC Macro, 2002; Ministry of Health and Social 
Services  [Namibia],  2003;  National  Statistical  Office  [Malawi],  &  ORC  Macro,  2005;  
Ouagadjio et al, 2004; Uganda Bureau of Statistics & Macro International Inc., 2007 
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Figure 1.8 shows the correlation between the percentage of respondents 
who cite fear of side effects as their main reason for not intending to use a 
method in the future and the CPR of modern methods. The data is taken 
from the most recent DHS survey from each country. The graph shows 
that  there  is  a  positive  correlation  between  the  two  variables  and 
generally the percentage of respondents citing fear of side effects goes up 
as the modern method prevalence goes up. The correlation coefficient for 
the relationship between the two variables is 0.60. Clearly Uganda and 
Ghana  both  have  an  unusually  high  prevalence  of  fear  of  side  effects 
compared  to  their  modern  method  CPR  when  compared  to  the  other 
countries shown in figure 1.8. 
 
Figure 1.8: Plot of Percentage of Respondents Citing Fear of Side Effects 
as Main Reason for Not Intending to Use a Contraceptive Method in the 
Future by CPR modern methods 
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Source  Data:  Central  Statistical  Agency  [Ethiopia]  &  ORC  Macro,  2006;  &  Macro 
International Inc., 2007;  Ghana Statistical Service et al, 2004; Institut National de la 
Statistique [Cameroon] & ORC Macro, 2004; Institut National de la Statistique et de la 
Démographie [Burkina faso] & ORC Macro, 2004;  Institut National de la Statistique et 
de  l’Analyse  Économique  [Benin]  &  ORC  Macro,  2002;  National  Statistical  Office 
[Malawi], & ORC Macro, 2005;  Ouagadjio et al, 2004; Uganda Bureau of Statistics & 
Macro International Inc., 2007 
 
1.2.5.1: Method Mix 
 
Clearly when exploring the issue of side effects some methods are less 
relevant than others due to their lack of related side effects. Traditional 
methods are not a focus in this study as they have few clinical symptoms, 
and are not often associated with other side effects, although there may of   18 
course be socio cultural implications in their use. Due to the differential 
effects  of  each  method  the  overall  experience  of  side  effects  in  a 
population of contraceptive users will depend heavily on the method mix. 
Table 1.6 shows the distribution of current users by specific method in 
Ghana based on data from the GDHS 2003.    
 
Table  1.6:  Distribution  of  Current  Contraceptive  Users  by  Method, 
GDHS 2003 
Method  Frequency  Percent* 
Pill  218  19.0 
IUD  32  2.8 
Injections  226  20.0 
Diaphragm3  3  0.3 
Condom  220  19.0 
Female Sterilization  66  5.8 
Periodic Abstinence  232  20.0 
Withdrawal  42  3.7 
Other4  30  2.6 
Norplant  45  3.9 
Lactational amenorrhea (LAM)  13  1.1 
Female condom  7  0.6 
Foam or jelly  12  1.0 
Total  1146  99.8 
* does not add to 100 due to rounding 
 
Table  1.6  shows  that  the  most  frequently  used  methods  which  are 
associated with potential clinical side effects are injectables and the pill 
with 20% and 19% of current users respectively. These two methods along 
with periodic abstinence with 20% of users and condom with 19% account 
for 78% of all current use. All methods associated with clinical side effects 
combined account for 51.5% of all current use.  
 
 
 
 
                                                 
3 At the time of the 2003 GDHS the diaphragm was no longer available in Ghana 
4 This category consists of users of folkloric methods, an ill defined and context specific 
categorization concerned with methods of unknown efficacy. For the purposes of this 
study these respondents could be considered non users however they cannot be included 
in the sample for analysis as they were not asked the relevant questions asked of non 
users.    19 
1.2.5.2: Experience of Side Effects  
 
In this study a distinction is made between the concept of ‘fear of side 
effects’ and the actual experience of side effects by current or past method 
users.  The  GDHS  collects  information  on  fear  of  side  effects  among 
current non users, which has been presented above, and also asks current 
users of the pill whether or not they have experienced a range of side 
effects during the current episode of use of the method. Table 1.7 presents 
the answers to this question which is asked as a yes/no question for each 
individual side effect listed in the table. Current users of other methods 
besides the pill are not asked questions about their experience of side 
effects. 
 
Table 1.7: Side Effects Experienced by Current Users of the Pill, GDHS 
2003 
Side Effects From Pill N=218*  Frequency  Percent 
Dizziness     
Yes  15  6.9 
No  201  93.1 
Weight gain     
Yes  3  1.4 
No  213  98.6 
Headaches     
Yes  10  4.6 
No  206  95.4 
Excessive bleeding     
Yes  5  2.3 
No  211  97.7 
Irregular cycle     
Yes  18  8.3 
No  198  91.7 
Painful period/cramps     
Yes  3  1.4 
No  213  98.6 
Palpitations     
Yes  12  5.6 
No  204  94.4 
Other     
Yes  6  2.8 
No  210  96.3 
No side effects     
Yes  162  75.0 
No  54  25.0 
* For all variables in this table 2 cases (0.9% of data) are missing   20 
Table 1.7 shows that the majority of pill users (75%) have not experienced 
any side effects at all. The most commonly mentioned side  effects are 
irregular  cycle  and  dizziness  mentioned  by  8.3%  and  6.9%  of  current 
users respectively.   
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1.3: Aims of Study 
 
The aim of this thesis is to shed light on an under researched topic about 
which little detail is currently known. Many studies make mention of the 
issue  of  side  effects  but  invariably  it  is  a  secondary  theme  in  studies 
ultimately focused on another topic. Due to the frequency with which the 
problem of side effects arises research into this area specifically is needed. 
This  thesis  will  explore  the  topics  of  side  effects  from  all  possible 
perspectives and will present three papers each uniquely addressing the 
issue of side effects by using three different sources of data and three 
different  corresponding  methods.  Each  paper  is  addressing  the  same 
topic and within the same theoretical framework however the disparate 
nature of the data sources and techniques used provides each paper with 
its  own  distinctive  perspective  on  the  research  questions.  Each  paper 
stands  alone  as  a  sufficient  body  of  knowledge  and  each  method 
contributes  something  unique  towards  an  understanding  of  the 
phenomena under study (Morgan, 1997). Additionally the combining of 
these very different methods in the thesis as a whole creates the ability to 
make larger connections within the results which according to Bryman 
(1988: 21) is highly desirable.  
 
1.3.1: Research Questions 
 
Each paper has specific research questions associated with it determined 
by the nature of the data and method but the overall research questions 
addressed are: 
 
•  In what way do side effects and the fear of side effects influence 
contraceptive  behaviour  and  function  as  a  barrier  to  the  use  of 
modern or hormonal methods among women in Ghana?  
•  Is the fear of side effects and subsequent contraceptive behaviour 
influenced  by  exposure  to  different  sources  of  family  planning 
information?  
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The first paper is an in depth look at the issues of side effects using a 
qualitative  approach  to  explore  individuals’  perceptions,  attitudes  and 
experiences.  This  paper  goes  beyond  the  limited  range  of  responses 
provided  by  survey  data,  and  looks  at  how  the  individual  women 
concerned understand the issue of side effects and fear of side effects.  
The  particular  method  employed  in  the  data  collection  is  focus  group 
discussions which are used to gather substantive information while also 
providing insight into group dynamics and the nature of informal social 
interaction  (Avogo  &  Debpuur,  2005).  The  study  will  focus  on  the 
communication  of  information  about  family  planning,  in  this  case 
interpersonal communication passed from woman to woman within an 
informal  social  network,  as  the  primary  explanatory  factor  in 
understanding fear of side effects.  
 
The second paper broadens the focus slightly and uses calendar data from 
a longitudinal data set collected in three regions in Southern Ghana. This 
paper uses monthly data on contraceptive use and the experience of side 
effects over a five year period to explore the effect of experiencing side 
effects on contraceptive discontinuation. The methodology employed is a 
multi level  logistic  discrete time  hazards  model  which  allows  for  the 
inclusion  of  socio economic  background  variables  and  time  varying 
covariates. The main explanatory variables in this study are measures of 
communication  about  family  planning  and  whether  users  were 
encouraged or discouraged to use family planning.  
 
The third paper uses the nationally representative 2003 GDHS data and 
logistic regression analysis examine the association between exposure to 
family  planning  information,  through  mass  media  and  interpersonal 
channels,  and  the  probability  that  a  respondent  will  cite  fear  of  side 
effects  as  their  main  reason  for  not  intending  to  use  a  contraceptive 
method in the future. This paper also looks at the socio economic and 
demographic characteristics of those who cite fear of side effects as their 
main  reason  for  not  intending  to  use  contraception  in  the  future.  The 
method  allows  the  determination  of  which  explanatory  variables  are   23 
significant determinants of fear of side effects, along with a quantification 
of the direction and magnitude of any associations, while controlling for 
any possible confounding factors.  
 
1.3.2: Limitations 
 
There are specific limitations associated with each of the three papers in 
this study which occur by virtue of the nature of the data or the methods 
of  analysis.  The  first  paper  uses  a  qualitative  methodology  which 
overcomes  the  lack  of  depth  and  detail  which  limit  quantitative  data 
sources  but  in  common  with  all  qualitative  studies  lacks 
representativeness  and  comparability.  The  second  paper  is  based  on 
longitudinal data which allows for the temporal placing of events but is on 
a relatively small scale and cannot be said to be representative beyond the 
six study communities sampled. The final paper is based on GDHS data 
which is a nationally representative sample but suffers from the fact that 
it is a cross sectional survey and therefore the timing of events cannot be 
ascertained  and  no  causal  connections  can  be  established.    Each  data 
source carries limitations of its own, but also makes up for the limitations 
of another so overall these limitations are not detrimental to the study 
because each angle is explored by a different paper.  
 
Another potential limitation of this study is that it does not consider men 
in any of the analysis. Obviously men have an extremely important and 
influential role in all reproductive and contraceptive behaviour. It was felt 
for a number of reasons however that within the scope of this study it is 
really  women’s  experiences  and  perceptions  which  speak  to  this  issue.   
Side effects are mostly applicable to hormonal or inter uterine methods 
so only women actually experience their use and directly experience their 
consequences (Hardon, 2002). Many of the secondary and social effects 
of  contraceptive  use  feature  men  directly  but  it  is  really  women’s 
perception  of  male  involvement that  is  the  focus  of this  study.   Other 
authors  have  been  questioning  of  program  efforts  and  research  which 
replaces the individual with the marital couple as the decision making   24 
unit. They believe that although men may influence couple reproductive 
decisions, ‘spouses should not be assumed to act together as a decision 
making unit’ (Biddlecom & Fapohunda, 1998: 360).  
 
Studies do show that spousal communication about family planning is an 
important  factor  (Tesfayi  &  Mishra,  2007)  in  predicting  method  use; 
however information on spousal communication can be gained from the 
women only. In this study unmarried women are included in paper one 
and  therefore  husbands  characteristics  could  not  be  included  and  in 
paper two, although only married women are in the data set, for reasons 
of  data  quality  and  availability  husbands  characteristics  were  not 
included. It is not felt that this is a serious limitation given that previous 
studies in Ghana looking at contraceptive use have found that partners’ 
characteristics  are  not  a  significant  predictor  of  contraceptive  use 
(Oheneba & Takyi, 1997; Tawiah, 1997). The limitations specific to each 
paper are further discussed in each of the introduction sections.  
 
1.3.3: Structure of Thesis 
 
This thesis is presented in six chapters which are briefly described here. 
The first chapter of the thesis has introduced the topic and has provided 
the relevant background data and rationale behind the study. Contextual 
information on current contraceptive use and fertility dynamics in Ghana 
and the overall aims of the study have been outlined. The second chapter 
establishes the theoretical framework, of diffusion of innovation theory, 
which  is  common  to  all  three  papers  and  briefly  reviews  some  of  the 
relevant  literature.  Each  of  the  next  three  chapters  presents  the  three 
individual papers in turn. Each is presented in five sections beginning 
with  an  introduction to  the  specific  topic  including  research  questions 
and aims of the paper. This is followed in each case by reviews of relevant 
previous studies  and  then a section on  data and methods. Results are 
then presented and each chapter ends with some discussion of the results 
and conclusions and policy implications which can be drawn. Ultimately 
the thesis is concluded in chapter six by a discussion and conclusion of   25 
the results of the study as a whole, along with policy implications and 
suggestions for further study. A summary of the three papers and their 
associated data and methods is provided in table 1.8 below.  
 
Table 1.8: Summary of Three Papers 
Chapter  3  4  5 
Data  Qualitative data 
from primary 
data collection 
Longitudinal 
survey data 
7 rounds of 
data 1998 2003 
2003 GDHS 
Method  Focus group 
discussions 
Multi level 
logistic 
discrete time 
hazards model 
Logistic regression 
analysis 
Study Area  2 of the previous 
6 locations in 
Southern Ghana 
6 locations in 3 
regions in 
Southern 
Ghana 
Nationally 
representative 
survey 
Population 
of Interest 
All women aged 
15 49 resident in 
one of the two 
study locations 
and who have at 
least some prior 
knowledge of 
family planning 
All women aged 
15 49  
All women aged 15 
49  
Sample  55 convenience 
sampled focus 
group 
participants 
(Plus interviews 
with 10 
purposively 
selected opinion 
leaders and 
service providers) 
732 episodes of 
contraceptive 
use contributed 
by 476 
individuals 
1330 women who 
are current non 
users and who state 
that they do not 
intend to use a 
contraceptive 
method in the 
future  
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Chapter Two 
 
Theoretical Framework 
 
Since  the  1960s  many  developing  countries  have  implemented  family 
planning programmes as a key element in population policies aimed at 
regulating  fertility.  The  impetus  for  these  policies  is  concern  over  the 
effects  of  rapid  population  growth,  which  threatens  to  undermine 
improvement in standards of living and health care which in turn allows 
persistently  high  fertility  levels,  creating  a  negative  feedback  loop 
(Bongaarts et al, 1990). Overall fertility in developing countries has been 
declining since the late 1960s but there has been significant regional and 
country level variation. In Sub Saharan Africa fertility declines have been 
particularly small. Fertility declines are largely attributable to the spread 
of contraception and data collected over several decades shows evidence 
of a strong correlation at national level between contraceptive use and 
fertility (Blanc & Grey, 2000; Bongaarts et al, 1990). There is however 
some  debate  over  the  ability  of  family  planning  programs  to  influence 
fertility preferences (Freedman, 1997) and numerous studies have tried to 
quantify the contribution of family planning programs to fertility decline 
but for various reasons have come to highly varying estimates (Bongaarts 
et al, 1990).  
 
Traditional  theories  of  fertility  decline,  including  Notestein’s  (1945) 
Demographic  Transition  Theory,  Easterlin  (1975)  and  Caldwells  (1982) 
cost benefit  models  of  individual  fertility  decision making,  focus  on 
underlying  socio economic  development  as  the  driving  force  of fertility 
change and contraceptive use as the primary means through which it is 
achieved.  The  demographic  transition  theory  commonly  attributed  to 
Notestein (1945) has proved the most influential theory of fertility change.  
The  theory  postulates  that  in  pre transitional  society’s,  fertility  and 
mortality are high and there is little or no use of contraception to restrict 
fertility.  Over  time  societies  undergo  a  process  of  ‘modernization’  with  
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associated  changes  in  urbanization,  modes  of  production  and 
improvements  in  socio economic  development.  Better  health  care, 
sanitation and nutrition lead to a declining mortality rate, fertility remains 
at a level high enough to permit survival in an earlier period and a period 
of  rapid  population  growth  results  (Notestein,  1945).  Throughout  this 
transition period desired family size begins to decline in response to the 
new  socio economic  conditions  and  fertility  declines  primarily  through 
‘rational control, largely by means of contraceptive practices’ (Notestein, 
1945: 40). At the end of the transition mortality remains low, fertility is at 
or below replacement level and some form of fertility control is practiced 
by the majority.   
 
The  core  of  the  demographic  transition  theory  is  that  macro economic 
change  and  the  development  of  industry  acts  as  the  driving  force  of 
fertility change. However the mechanisms through which this is achieved 
are  not  specified  in  the  theory.  Classic  transition  theory  has  also  been 
criticized for its lack of attention to cultural influences on fertility (Kirk, 
1996). Subsequent theories have attempted, to a greater or lesser degree, 
to  integrate  social,  economic  and  cultural  factors.    Micro economic 
theories apply the theory of consumer behaviour to the analysis of fertility, 
where  children  are  seen  as  a  special  kind  of  consumer  good.  Demand 
theories,      such  as  the  theory  of  ‘household  choice’  or  ‘new  home 
economics’  first  proposed  by  Becker  in  1960,  focus  on  changes  in  the 
economic  costs  and  benefits  of  children  which  reduces  demand  for 
children  and  drives  fertility  change.  Easterlin’s  (1975)  ‘supply  and 
demand’ theory, and a subsequent variation put forward by Bongaarts in 
1993, expands on previous micro economic theories by explicitly taking 
into  account  variables  related  to  the  supply  of  children.  The  ‘supply 
demand’  theory  suggests  that  the  three  central  elements,  supply  of 
children, demand for children, and the cost of fertility regulation, are the 
mechanisms  through  which  socio economic  developments  operate  to 
influence fertility and its proximate determinants (Bongaarts, 1993).  Also, 
in  an  attempt  to  encompass  the  views  of  non economists,  Easterlin’s  
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framework  includes  subjective  variables,  such  as  preferences  and 
attitudes, in the costs of fertility regulation (Easterlin, 1975).  
 
Caldwell’s (1982) ‘wealth flow theory’ of fertility decline focuses on the 
direction  and  magnitude  of  inter generational  flows  of  ‘money,  goods, 
services and guarantees that one person provides to another’ (Caldwell, 
1982:  333).  In  contrast  to  previous  theories  Caldwell  argues  that  high 
fertility in pre transitional societies does represent economically rational 
behaviour and he further points out that the goals of family life may not 
necessarily be to maximize the economic position of the nuclear family. In 
this  theory  all  economic  transitions  are  ultimately  seen  to  serve  social 
ends and so the nature of the goals of the family will depend on their 
particular socio cultural context. In pre transitional societies the flow of 
wealth  is  from  children  to  parents  making  high  fertility  advantageous. 
Over  time  changes  in  the  mode  of  production  and  processes  of 
modernization, particularly mass education, cause families to transit to a 
more nuclear structure and become more egalitarian.  As such the cost of 
children increases and the situation is reversed with wealth flowing from 
parent  to  child  and  high  fertility  is  no  longer  economically  rational. 
Although these theories may attempt to include the influence of cultural 
factors on fertility change they all fundamentally stress changes in socio 
economic variables as the driving force of fertility decline.   
 
Cleland and Wilson (1987) argue that micro economic theories of fertility 
change  are  implausible  and  incomplete  and  structural  change,  while 
undoubtedly playing a role, is not sufficient to explain observed fertility 
trends. The demographic transition theory is both highly generalized and 
Euro centric and for a variety of reasons its applicability to demographic 
change in contemporary developing countries has long been in question. 
For  example,  the  pace  and  source  of  mortality  decline  in  developing 
countries is different from the European experience due to the importing 
of medical technologies which may reduce mortality regardless of the level 
of  development  (Teitelbaum,  1975).  Caldwell  suggests  that  the  fertility 
transition  in  developing  countries  is  not  only  influenced  by  
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‘modernization’ and associated structural changes but also by a process of 
‘westernization’ which has imported Western ideology and concepts of the 
family (Caldwell, 1982).    
 
In addition to this the ability of the demographic transition theory to fully 
explain  the  European  fertility  decline  is  also  questionable.  From  1963 
until 1986 Ansley Coale led the Princeton European Fertility Study which 
was  an  attempt  to  empirically  test  the  demographic  transition  theory 
using provincial level data on European fertility from 1870 to 1960 (Coale 
& Watkins, 1986). One of the key findings of this study was that once 
fertility  in  a  region  of  a  country  had  begun  to  decline,  neighbouring 
regions  with  the  same  language  or  culture  followed  after  short  delays, 
even when they were less developed. The findings suggest that the effects 
of  modernization  are  not  confined  only  to  those  who  adopt  a  new 
behaviour but also alter the social context for those who do not. This and a 
number of other unexplained patterns of reproductive change led to the 
proposal  that  the  diffusion  of  information  about  family  planning  is  an 
important mechanism for fertility change (Bongaarts & Watkins, 1996). In 
settings  in  which  fertility  has  been  high  innovation  takes  the  form  of 
contraceptive adoption and fertility limitation.  
 
Diffusion of innovation theory states that new ideas and behaviours can be 
spread  through  a  network  of  people  by  various  channels  of 
communication and comprises four main elements (Rogers, 1983): 
 
1)  An innovation: an innovation is an idea, practice or object that is 
perceived as new by an individual.   
2)  Communication  through  certain  channels:  Diffusion  is  a 
particular type of communication in which the information that is 
exchanged  is  concerned  with  new  ideas.  In  essence  information 
exchange  by  one  individual  communicates  a  new  idea  to  one  or 
several others. ‘A communication channel is the means by which 
messages  get  from  one  individual  to  another.  The  nature  of  the 
information  exchange  relationship  between  a  pair  of  individuals  
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determines the conditions under which a source will, or will not, 
transmit the innovation to the receiver’ (Rogers, 1983:17). Different 
types  of  communication  channel  allow  different  styles  of 
communication.  For  example  mass  media  enables  one  or  a  few 
individuals  to  reach  a  large  audience  whereas  interpersonal 
channels  involve  a  face to face  exchange  between  two  or  more 
individuals 
3)  Time:  The innovation needs time to diffuse from one individual to 
the  next  and  each  individual’s  resulting  attitude  or  behaviour 
change happens as a process over time. This has implications for 
the kind of data required to capture the diffusion process and ‘the 
inclusion of time as a variable in diffusion research is one of its’ 
strengths’ (Rogers, 1983:20).  
4)  A social system: In order for people to exert social influence over 
each other the diffusion of innovations requires a social system that 
provides structure and norms of behaviour.  
 
In  the  process  of  adopting  a  new  innovation  individuals  embark  on  a 
decision making process in which they weigh up the costs and benefits 
associated  with  adoption  as  well  as  information  or  ignorance  about 
outcomes and alternatives. As more individuals adopt an innovation an 
endogenous  feedback  process  begins  and  as  the  process  advances  the 
uncertainty associated with the innovation is reduced. The outcomes of 
others’ adoption become observable to those in the community who have 
not yet adopted the innovation and their resistance is diminished as their 
information about the potential risks  and benefits  is enriched (Palloni, 
2001). As the innovation becomes more common so the social influence of 
peer groups accelerates the incidence of adoption (Cleland, 2001).  
 
Diffusion  of  innovation  theory  does  not  reject  the  traditional  idea  that 
fertility  and  contraceptive  use  are  a  result  of  socio economic 
determinants; rather it seeks to incorporate diffusion variables into the 
socio economic model.  The central argument is that diffusion dynamics 
are  one  mechanism  through  which  the  fundamental  factors  of  social,  
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cultural  and  economic  situation  operate  on  an  individual’s  decision 
making. ‘Diffusion dynamics condition and mediate the effects of other 
variables either dampening or amplifying the effects’ (Montgomery et al., 
2001:  25).  Therefore  diffusion  attempts  to  explain  how  a  cascading 
mechanism  can  result  in  some  individuals  adopting  a  new  behaviour 
despite the fact that their resources or social position remain the same.  
The  adoption  of  new  behaviour  therefore  ‘occurs  as  a  result  of  the  re 
evaluation of one’s own choices in light of other people’s behaviour, not as 
a  strategic  response  or  accommodation  to  a  realignment  of  resources’ 
(Palloni,  2001:  68).  The  dynamics  of  diffusion  can  take  the  form  of 
cascade, contagion and tipping point phenomena. Based on the work of 
Casterline & Montgomery (1996) and Montgomery, Casterline & Heiland, 
(2001) two theories of the mechanism through which diffusion processes 
operate have been identified, social learning and social influence.  
 
Social  learning  is  the  concept  that  individuals  can  gain  information 
relevant to their own decision making process from others in their social 
network. Where modern contraceptive use is still new social learning may 
help to establish the properties of contraceptive methods themselves, for 
example their efficacy, monetary or social costs or potential side effects. 
Social learning can take place interpersonally through the observation of 
one  actor  by  another  or  by  the  inference  of  attitudes  from  observed 
behaviour or through an individual’s commentary and discussions about 
the  innovation.  Social  learning  can  also  take  place  impersonally  when 
information is gained through mass media. Social learning encompasses 
both the acquisition of information and the filtering of information into 
terms  that  are  meaningful  to  an  individual’s  decision  making.  ‘The 
concept  of  social  learning  is  pertinent  to  environments  that  are 
characterized by flux and uncertainty, in which choice options are coming 
to the fore with associated costs and benefits yet to be fully understood’ 
(Montgomery et al., 2001: 2). Social learning is an important concept in 
the evaluation of family planning programs as there is a spill over effect 
whereby the behaviour of one user can affect the motivations of another 
person  who  does  not  necessarily  have  any  direct  contact  with  the  
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programme. This spill over effect termed ‘informational externality’ can be 
either positive or negative in character and can therefore have either an 
amplifying or a restraining effect on the family planning program efforts.   
 
Social influence refers to the power of pressure towards social conformity 
in groups. Hierarchical and power based influences can be interpreted as 
additional constraints on an individual’s behaviour (Montgomery et al., 
2001:5).  There  is  no  assumption  that  social  influence  must  reinforce 
innovation and particularly where contraceptive use is low it may be seen 
as a significant barrier to adoption. Based on physiological literature it is 
suggested  that  negative  information  is  often  given  disproportionate 
weight  in  the  formation  of  perceptions  and  the  evaluation  of  risks.  As 
Montgomery et al. (2001:6) put it ‘one gets the impression from research 
in developing countries that conversation about modern contraception is 
far more often negative than positive, with stories about extreme health 
repercussions  of  contraceptives  often  dominating  the  discussion.’  The 
same authors also go on to use dynamic situation models which reflect 
differences in network composition and the content  of the information 
passed  to  show  that  these  factors  can  contribute  to  a  convergence  of 
opinion in a population on the costs of contraceptive use. If this is the case 
then over time negative views about contraception can come to dominate 
in the population.  
 
As the use of modern contraceptives remains low in Ghana this study is 
primarily concerned with exploring social learning and how information 
and  ideas  passed  through  a  social  network  can  influence  reproductive 
behaviour.  Of  particular  interest  is  how  communication  about  family 
planning  works  to  enhance  or  allay  the  fear  of  side  effects  and  the 
influence of side effects on contraceptive behaviour. Once an individual is 
exposed  to  information  about  family  planning  through  either 
interpersonal  or  mass  media  channels,  the  way  in  which  his  or  her 
contraceptive behaviour is influenced will depend in part on the content of 
the  information  received.  When  studying  the  influence  of  mass  media 
family planning messages, it is generally assumed that the content of the  
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messages is positive and is encouraging the adoption of contraceptives.  
However in the case of interpersonal communications, discussions of the 
negative  health  consequences  of  family  planning  methods  may 
predominate with the result that contraceptive innovation is frustrated. 
Studies  have  also  shown  that  rumours  and  misconceptions  about 
contraception can increase fear of side effects and frustrate adoption and 
reports from DHS surveys have indicated that this is one of the major 
reasons for non adoption of contraception (Feyisetan, et al. 2003).  
 
The content of messages is an aspect of family planning communication 
that is difficult to measure, particularly in quantitative studies and in the 
past  researchers  have  cited  the  need  to  document  the  content  of 
conversations  about  family  planning  in  order  to  facilitate  meaningful 
analysis of the impact of diffusion on contraceptive change (Feyisetan et 
al.,  2003:50).  Much  of  the  negative  information  being  communicated 
concerns  the  possible  harmful  health  effects  or  side  effects  of 
contraceptive methods. ‘One of the assumptions of a diffusion approach is 
that the innovation offers an indisputable benefit to the adopter’ (Cleland, 
2001:40) this may be true at the aggregate level however the individuals 
concerned may perceive things differently. Fear of side effects is among 
the most commonly cited reasons for non use and side effects or health 
concerns are also the main reasons for the discontinuation of a method.  
 
The  focus  of  this  study  is  on  the  links  between  side  effects  and 
contraceptive use behaviour, rather than the levels of contraceptive use 
per se or the ultimate effect of contraceptive use on fertility. As such the 
aim is not to make any contribution to theories of  fertility decline but 
rather to use the ideas found in diffusion of innovation theory to inform 
the research. As previously discussed diffusion theory, in particular social 
learning is the concept that individuals can gain information relevant to 
their own decision making process from others in their social network. 
This  study  seeks  to  understand  how  the  acquisition  of  information  on 
contraceptive side effects influences individual’s ideas about the costs and 
benefits associated with contraceptive use.   
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There are clear practical and policy implications in understanding how the 
communication of information about side effects influences reproductive 
behaviour. Family planning education can then best utilize networks to 
disseminate  information  or  understand  how  networks  may  work  as  a 
deterrent to individual contraceptive adoption.  As such women can then 
be made fully aware of all the outcomes and alternatives of contraceptive 
use and can make truly informed choices about what is best for them at 
any given point in time.  
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Chapter Three 
Discussions, Perceptions, and Fear of Contraceptive 
Side Effects in Southern Ghana 
 
3.1: Introduction 
 
Previous  quantitative  studies,  especially  those  based  on  DHS  data,  have 
highlighted  fear  of  side  effects  as  a  reason  for  non use  of  modern 
contraceptive  methods.  However  ‘fear  of  side  effects’  still  remains  an  ill 
defined and poorly understood concept. There are multiple interpretations of 
the meaning of fear of side effects as measured by surveys such as the DHS. 
For example, are respondents referring to fear that a contraceptive method 
will make them physically unwell, or fear of social or economic repercussions 
from  contraceptive  use,  or  perhaps  concerns  over  the  effect  of  current 
contraceptive  use  on  future  childbearing.  Each  of  these  definitions  would 
need different policy or programmatic intervention if the fear of side effects 
were  to  be  minimized  as  a  barrier  to  contraceptive  use.  In  addition,  for 
program intervention to be effective, an understanding of the origin or cause 
of the fear of side effects would be beneficial. These fears may be based on 
past  personal  experience  of  using  contraception,  from  the  observed  or 
relayed  effects  on  others  in  the  community  or  may  be  perceived  fears 
stemming solely from misinformation and rumors. In light of these differing 
mechanisms for the creation of fear of side effects a key explanatory element 
in this study is the spread of information about family planning.  
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3.1.1: Aims of study  
 
The aim of this study is to use a qualitative approach to explore the multiple 
interpretations of the meaning and cause of fear of side effects in a particular 
social context. The study location is two villages in Southern Ghana which 
will provide the setting for an in depth exploration of how women in those 
locations perceive and articulate the issue of fear of side effects. This paper 
goes beyond the limited range of information provided by survey data, and 
seeks to better define what is meant by the term fear of side effects in this 
particular social context.  It also aims to determine on what information and 
from what sources this fear is constructed. The particular method employed 
in the data collection is focus group discussions which are used to gather 
substantive  information  while  also  providing  insight  into  group  dynamics 
and the nature of informal social interaction. The research questions that 
this paper aims to answer are: 
 
•  How do women in the study locations interpret the concept of fear of 
side effects and what are the causes and consequences of fear of side 
effects? 
•  To  what  extent  does  information  about  contraceptive  use  received 
through social networks influence attitudes and behaviours towards 
contraceptive use, specifically regarding side effects? 
•  Do women believe fear of side effects is a barrier to the use of modern 
or hormonal methods in their community? 
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3.1.2: Limitations 
 
In common with all qualitative studies one major limitation of this study is 
its specificity. Only two study sites were used and given the small sample size 
and the nature of the sample selection process the sample cannot be said to 
be  representative  of  the  study  population  as  a  whole  (Bryman,  1988). 
Therefore it is not possible to generalize the resulting data to a population 
beyond those individuals involved in the study. This is the expected outcome 
of this study and is not considered problematic. The underlying rationale for 
this study is to address the limitations of the quantitative and representative 
data  currently  available  by  investigating  the  issues  from  a  different 
methodological perspective.  
Another issue inherent to qualitative research is subjectivity which may lead 
to questions about ‘the feasibility of seeing through others’ eyes if observers 
themselves are so heavily implicated in what is found ’ (Bryman, 1988: 77). 
The influence of the researcher both on behaviour in the field and during the 
process  of  analysis  must  be  borne  in  mind  and  to  consider  this  study  as 
totally free from bias would be unrealistic. While some see this subjectivity as 
a weakness others think that qualitative methods are strengthened by ‘the 
ability to acknowledge bias, value it and make its impact on the research 
process as explicit as possible’ (Keenan Forrest & Teijlingen, 2004: 258). In 
line with Seales’ (1999) checklist of criteria for the evaluation of qualitative 
research  the  possibility  of  bias  introduced  into  the  study  through  the 
methodology or data collection process is further disused in section 5.3.   
 
An  element  of  this  study  which  could  be  considered  limiting  is  that,  in 
keeping  with  the  previous  papers  in  this  thesis,  the  study  included  only 
female participants.  It is of course recognized that men play an important 
role in family planning issues and reproductive decision making. The women 
in the study refer to their perception of men’s involvement in the issue of fear 
of side effects but the perception of the men themselves is not sought. It is 
felt  that  in  relation  to  this  specific  issue  it  is  women  who  physically  
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experience the act of contraceptive use.  Barrier or natural methods involving 
both  partners  rarely  feature  in  the  discussion  of  fear  of  side  effects  and 
although social side effects may often involve male partners it is the woman’s 
experience of these with which this study is concerned.  
 
3.1.3: Structure of Study 
 
This  paper  is  presented  in  five  sections,  the  first  of  which  has  already 
outlined the background to the study and its aims and objectives. The second 
section provides a summary of some of the issues related to this topic which 
have been found in previous qualitative studies. Next, section 3.3 details the 
methodology used in the study. This includes sections on the methods used, 
the data collection process and the ethical considerations raised by the study. 
The results are presented in section 3.4, and finally the paper finishes with 
discussion and conclusions arising from the results.  
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3.2: Previous Studies 
 
This section provides a brief discussion of some of the previous qualitative 
studies which have raised the issue of side effects or fear of side effects as 
part of their findings.  The issues which are discussed include what exactly 
the  components  of  fear  of  side  effects  are,  how  these  are  communicated 
between women and the social consequences of side effects, such as in cases 
of  covert  contraceptive  use.  These  then  lead  on  to  a  discussion  of  the 
implications for quality of care such as, content of family planning messages, 
quality of counseling and source of method supply.  
 
Many previous studies, while not setting out to specifically investigate the 
issue of side effects, have determined that family planning and especially the 
potentially  negative  aspects  are  frequent  topics  of  conversation  amongst 
study  participants.  Rutenberg  and  Watkins  (1997)  conducted  a  study  in 
Nyanza  District  Kenya  which  set  out  to  discover  the  content  of  women’s 
informal conversations about contraceptives to determine the effect of these 
interactions  on  contraceptive  practice.  In  the  course  of  their  focus  group 
study they found abundant evidence that side effects is the most common 
topic  of  conversation  regarding  family  planning.  The  study  participants 
identified  two  main  fears  related  to  side  effects,  first  fears  for  their  own 
health, and second fears for their relationships with men. The women in the 
study  were  concerned  about  the  cost  of  treating  ill  health  due  to 
contraceptive use which is a potential source of tension as this responsibility 
will fall mainly on the husband. With regard to fears for their own health the 
study  found  that  women did  discuss  unexpected  and  extreme  side  effects 
which the  authors referred to as ‘myths and rumors’ however they talked 
more often about expected and more benign side effects such as nausea and 
irregular bleeding (Rutenburg & Watkins 1997).  
 
Williamson et al., (2009) conducted a meta ethnography of seven qualitative 
studies  on  modern  contraceptive  use  among  young  women  in  developing  
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countries.  They  found  that  all  the  studies  they  looked  at  showed  that 
concerns  over  experienced  and  perceived  side  effects  of  hormonal 
contraceptive  methods  were  central  to  young  women's  non use  of  these. 
Another study of young people in Mali (Castle 2003) found that rather than 
immediate  health effects it is fear for future fertility which prevents young 
women  from  using  hormonal  contraceptives.  Long  term  sterility  was 
perceived  to  have  severe  social  consequences  such  as  the  husband  taking 
another  wife  or  seeking  a  divorce  and  ostracism  from  the  community  in 
general. A study of side effects in Ghana by the Ghana Ministry of Health 
(1992) found a similar result and consequently many people believed using a 
contraceptive method is only acceptable for women who have had children.  
 
One aspect of side effects particularly related to hormonal methods is the 
issue of menstrual disruption which Williamson et al. (2009) also find is a 
feature  of  the  studies  they  reviewed.  They  conclude  that  methods  which 
interrupt the perceived natural pattern of menstruation are unacceptable to 
many young women (Williamson et al., 2009). Other studies also cite the 
value  women  place  on  regular  menstruation  and  the  low  tolerance  of 
menstrual  disruption  as  a  side  effect  (Snow  et  al,  2002;  Hardon,  2002). 
There may be many reasons for this as several authors point out that levels of 
tolerance  of  side  effects  will  be  dependent  on  the  local  context  (Khanna, 
1999; Henry, not dated; Hardon, 2002). The process of menstruation has 
socio cultural,  religious  and  psychological  significance  which  varies  in 
different cultures. Many women see their pattern of menstruation as a sign of 
their reproductive health and of their health in general and (Khanna, 1999). 
Hardon (2002) finds that amenorrhea can lead women to question whether 
or not they are pregnant which causes considerable anxiety if they are not 
adequately  warned  about  this  effect  of  hormonal  methods.  However  in  a 
study  based  in  the  Philippines,  Henry  (not  dated)  says  that  midwives 
reported that telling women that changes in menstruation are normal is not 
effective in reducing anxiety.  
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When  discussing  this  issue  Castle  (2003)  states  that  rather  than  being 
troubled  by  the  physiological  effects  of  hormonal  methods  it  is  really  the 
social  consequences  of  these  side  effects  that  induce  fear.  As  mentioned 
previously women fear that side effects will cause conflict with their partner 
and this is particularly so if they are using a method covertly. Method users 
who  are  doing  so  without  the  knowledge  of  their  partner  or  other  family 
members face significant concern over method related bleeding disturbances 
related to their need to maintain secrecy (Snow et al, 2002). A population 
based study in the urban Ndola district of Zambia found that 7% of current 
users  were  doing  so  covertly  and  where  the  husband  was  difficult  to 
approach on the subject of family planning the participants were more likely 
to use secretly than not to use a method at all (Biddlecom & Fapohunda, 
1998). Some of these women may face challenges to their right to privacy and 
confidentiality and the authors point to recent efforts to involve men more in 
family planning as a potential threat to privacy (Biddlecom & Fapohunda, 
1998: 369).   
 
Privacy  in  clinic  setting  is  not  only  important  to  those  who  are  using  a 
method secretly. A study of side effects in Ghana by the Ghana Ministry of 
Health (1992) found that in some contexts the use of family planning is still 
associated  with  immorality  and  promiscuity  and  so  lack  of  confidentiality 
and  privacy  at  clinics  is  a  significant  barrier.    The  report  concludes  that 
‘while medical screening procedures are minimal or non existent, privacy is 
highest  at  commercial  sellers,  probably  a  reason  why  the  relative 
contribution of contraceptive distribution at commercial outlets is high in 
Ghana’ (Ghana Ministry of Health, 1992: 15). These sales from commercial 
outlets, which do not involve any trained personnel, are not favored as it is 
believed the concept of family planning is not well understood within the 
population (Ghana Ministry of Health, 1992).   This is a sentiment shared by 
the women themselves who believe that the risk of experiencing side effects 
is lower if a health worker is consulted and who attribute severe side effects 
to the improper use of methods (Rutenburg and Watkins 1997).    
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There  is  evidence  from  other  studies  that  in  fact  when  methods  are 
administered by the user there may be inconsistent or illogical application of 
methods,  sometime  with  unintended  or  even  dangerous  consequences 
(Gready  et  al,  2002;  Hardon,  2002).  A  study  of  women’s  experiences  of 
contraceptive services in South Africa found that this was due to inadequate 
or misunderstood instructions and the women in the study felt they had been 
given  insufficient  information  on  how  methods  work,  side  effects,  and 
information  about  follow up  services  (Gready  et  al,  2002).  Even  where 
personnel  do  undergo  some  training,  as  is  the  case  for  community  based 
distribution workers, there is still evidence to suggest that knowledge and 
counseling on side effects is still lacking. For example, an assessment of the 
community  based  distribution  programs  in  Ghana  found  that  knowledge 
among the CBD agents on side effects of the pill was low and they did not 
provide  adequate  information  on  side  effects  and  ways  to  manage  them 
(Chege et al 2000). ‘Very few agents or supervisors could correctly mention 
symptoms of severe side effects for which a woman should seek assistance. 
The majority of agents and supervisors knew what information to provide to 
a pill client who has forgotten to take the pill for one day but they were less 
knowledgeable when it is two days’ (Chege et al 2000: 15).  
 
The discussion this far has focused on information from health workers or 
CBD agents which is an important channel for the flow of information and 
ideas about contraceptive use. The theoretical framework within which this 
study is situated is diffusion of innovation theory which states that new ideas 
and  behaviours  can  be  spread  through  a  network  of  people  by  individual 
channels  of  communication.  Understanding  the  diffusion  of  reproductive 
behaviours is important to the study of side effects as diffusion effects have 
the potential to accelerate social change and where contraceptive use is still 
relatively  new,  social  learning  may  help  establish  the  properties  of  the 
contraceptive methods themselves (Montgomery & Casterline, 1998). As the 
innovation becomes more common so the social influence of others in the 
community accelerates the incidence of adoption (Cleland, 2001). While it  
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can be assumed that the majority of communication from a health worker to 
an individual is encouraging family planning this may not necessarily be so 
for communication coming from others in the community.  This creates the 
possibility  of  negative  diffusion  effects,  where  ‘rumours  about  health  side 
effects  …  can  serve  as  barriers  to  contraceptive  adoption  by  persons 
otherwise motivated to use’ (Population Council, 2005). When women cite 
fear  of  side  effects  as  a  reason  for  not  using  contraception  it  is  often 
attributed to misinformation and rumours regarding the possible effects of 
modern methods (Bongaarts & Bruce, 1995).  
 
A  study  using  focus  groups  and  in depth  interviews  in  a  village  in  India 
(Kirkconnell Hall,  et  al.  2006)  uncovered  a  social  learning  process  with 
negative effects on the uptake of temporary methods of contraception. The 
study  found  evidence  of  large  doses  of  contraceptive  pills  being  taken 
without the guidance of a physician and subsequent reporting of side effects 
such as abdominal pain, nausea and vomiting (Kirkconnell Hall, et al. 2006). 
These experiences were then related to other women whose perceptions of 
the risks associated with the use of hormonal methods were influenced. The 
authors  concluded  that  ‘women’s  lack  of  correct  knowledge  regarding 
mechanisms and side effects directly affects the risks that they perceive in 
using the temporary methods that are available to them. These perceptions 
are largely formed by the experiences other women relate to them, which in 
turn  are  coloured  by  a  lack  of  understanding  and  confusion  about  the 
mechanisms’(Kirkconnell Hall,  et al. 2006).  Henry  (not  dated)  also  found 
evidence of temporary methods being used contrary to recommendations or 
instructions. The study looked at women’s experiences of side effects as a 
follow  up  to  the  findings  of  the  DHS  and  found  that  women  were  using 
methods based on their bodies’ response but contrary to the instructions they 
had  been  given  by  the  service  provider.  For  example  women  using  Depo 
Provera would cease using the method when they experienced amenorrhea 
and then upon the return of their menstruation would go to their provider 
and request to continue with the method (Henry, not dated).   
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These  practices  may  be  creating  an  effect  where  problems  are  discussed 
within the social network and considered as legitimate side effects when in 
fact they are due to incorrect use. The study by the Ghana Ministry of Health 
found that most of the side effects mentioned by women in the study were 
real, but, there were also lots of unfounded fears which are likely influencing 
people’s decision making. They concluded that there is a ‘high awareness of 
possible  side  effects  contrasting  with  modest  actual  experience’  (Ghana 
Ministry of Health, 1992). When discussing contraceptive decision making 
Rutenburg and Watkins (1997: 297) found that decisions about contraceptive 
use are ‘preceded by a period during which women overhear or participate in 
conversations with others, and then by more strategic conversations when 
women seek out those whom they believe are using contraceptives’. In this 
gathering  of  information  formal  dissemination  of  information  from  the 
health sector is important but ultimately women are more convinced by the 
opinions and attitudes of people they know. The most salient characteristic 
of the person who is trusted to give advice is that they are women who others 
believe have some past personal experience of FP because they have used it 
themselves  (Rutenburg and Watkins 1997).  
 
In Ghana there is a growing motivation to limit fertility and space births, 
young people are expressing doubts about the economic advantages of large 
families  and  birth  spacing  is  seen  as  essential  for  both  mother  and  child 
health.  This combined with traditional methods increasingly being seen as a 
burden  leading  to  quarrels  and  confrontations  indicates  there  can  be 
substantial  motivation  for  some  women  to  use  modern  methods  (Ghana 
Ministry of Health, 1992). Snow et al. (2002) found that this high level of 
motivation  can  be  powerful  enough  that  they  are  tolerating  substantial 
discomfort  in  order  to  contracept,  and  even  long  episodes  of  use  cannot 
necessarily be regarded as a sign of satisfaction with the method.   
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3.3: Methodology 
 
This section begins by outlining the method of data collection used for this 
study and the theoretical arguments behind the decision to use this method. 
Then the process of feildwork and data collection is described including a 
detailed description of the study areas, the research team and the design of 
the study. A description of the data analysis strategy is given and finally there 
is some discussion of the ethical issues considered in this study.  
 
3.3.1: Methods 
 
Focus group discussions are the primary method of data collection and are 
used  to  provide  substantive  information  from  the  perspective,  and  in  the 
words,  of  the  participants,  while  also  providing  an  insight  into  group 
dynamics  and  informal  social  interaction.  The  focus  group  data  is 
supplemented  by  interviews  with  service  providers  and  other  local 
stakeholders.  
 
The  focus  of  this  study  is  on  interpersonal  communication  about  family 
planning and  as such focus groups, as a research method are particularly 
appropriate to this research question. Focus groups can provide  access to 
group  meanings,  processes  and  social  norms  (Bloor  et  al,  2001),  and  by 
extension explore normative behaviour in terms of reproductive activities. 
This is vital to this study as in the words of Bloor et al (2001:21) socially 
constructed ‘norms of behaviour remain the mainsprings of human action’ 
and the situation of the focus group can provide occasion and stimulus to 
articulate  those  normally  unarticulated  normative  assumptions.  Another 
area in which focus groups are useful is the investigation of the gap between 
educational  messages  and  a  community’s  beliefs  and  understanding 
(Litosseliti, 2003). This is particularly relevant in this study where one aim is 
to  determine  the  source  of  ‘myths’  regarding  contraceptive  use  and  how 
messages from health workers are perceived. The nature of the topic is also a  
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consideration in the choice of methodology and in this case the topic should 
be considered somewhat sensitive. Although contraceptive use is relatively 
common in the study locations and this does not need to be considered a 
taboo topic, it certainly is a private and personal subject and needs to be 
handled with some sensitivity. Wilkinson (2004: 180) believes focus groups 
are particularly appropriate to sensitive topics and that the group context 
‘may actually facilitate personal disclosures’. 
 
A particular strength of focus groups in the context of this study is that they 
are a socially oriented event which brings together a group of people in order 
to  explore  views,  attitudes  and  perceptions  that  occur  in  real  life  social 
situations (Litosseliti, 2003). This speaks directly to the aim of this study 
which  is  concerned  with  the  meanings  attached  to  the  everyday  informal 
inter personal communications between individuals. The social orientation 
of  focus  groups  contextualizes  respondent  responses  and  produces 
‘simulations  of  everyday  discourses’  (Flick,  2002:  121)  where  participants 
influence and are influenced by others. However this is not an observational 
study of real life interactions among a naturally constructed group but rather 
a simulation created and staged by the researcher. Morgan (1997) argues that 
the control of a focus group by the researcher limits the naturalism of the 
interaction  and  Litosseliti (2003:23)  notes  that  ‘caution  must  be  taken in 
suggesting that focus groups can replicate how people communicate within 
other group settings.’  
 
This replication of a natural setting has the advantage of allowing for free 
flowing  discussion  where  participants  are  able  to  respond  in  their  own 
language and vernacular, as opposed to choosing from a list of pre defined 
responses (Wilkinson, 2004; Litosseliti, 2003). This results in rich data that 
arise  in  a  natural  or  indigenous  form  with  minimal  imposition  by  the 
researcher and which is illustrative of, and appropriate to, the local context 
(Stewart & Shamdasani, 1990). Focus groups are designed to ‘understand 
how  individuals  conceptualize  and  categorize  phenomena’  (Stewart  &  
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Shamdasani, 1990:41). Using this methodology in a field study avoids pre 
judgment  of  the  nature  of  the  phenomena  and  does  not  require  the 
construction  of  hypothesis  based  on  a  priori  assumptions  (Shaffir  & 
Stebbins,  1991)  rather  the  focus group elicits  information  in a  way  which 
enables the researcher to find out why an issue is salient to the participants 
(Litosseliti, 2003).  
 
Another  relevant  aspect  of  focus  groups  to  this  study  is  the  insight  they 
provide  into  group  dynamics  and  interaction.  As  mentioned  above  inter 
personal communication is thought to play an important role in the adoption 
of  behaviours  and  focus  groups  could  provide  information  on  both  the 
perception of issues and the ways in which people are influenced by others 
(Litosseliti, 2003). Complex networks of inter personal communications can 
be difficult to study but interaction between participants is a key feature of 
focus groups. The interaction between group members produces insights that 
would be less assessable without the group and will typically capture more of 
a  range  of  communicative  processes  than  interviews  (Wilkinson,  2004). 
Participants  respond  to  and  build  upon  views  expressed  by  others  in  the 
group and the data contains both consensus and diversity brought about by 
group interaction (Morgan, 1997).  
 
While  the  previous  paragraphs  highlight  the  strengths  of  focus  groups  in 
relation  to  this  study  there  are  also  limitations  associated  with  the 
methodology. The ways in which messages are interpreted and reproduced, 
focus groups may not be the best method of mapping individuals’ behaviour 
change, as the social context may mean intra group variations are likely to be 
under reported (Bloor et al, 2001). In common with all qualitative methods 
the results are not representative and data is limited to the verbal and self 
reported and relies on the retrospective recall of events and information by 
respondents (Morgan, 1997). The data are subject to potential bias both at 
the  time  of  collection  and  in  the  analysis  where  it  is  subject  to  the 
interpretation  of  the  researcher.  People’s  motivations  are  complex  and  
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participants may rationalize their behaviour or give false information in their 
desire to please the researcher (Litosseliti, 2003). The focus on the group 
also makes it difficult to distinguish between individual views and the group 
view therefore it is possible that the group may present a false consensus.  
 
3.3.2: Data Collection 
 
Data was collected in the Cape Coast area of Southern Ghana during a period 
of fieldwork from July to October of 2007.  
 
3.3.2.1: Study Areas 
 
Two  study  locations  were chosen  in  the  Central  Region  of  Ghana  both  of 
which are approximately 30 kilometers from the town of Cape Coast. These 
two  locations  are  two  of  the  six  study  locations  in  the  Cape  Coast  Social 
Learning, Social Influence and Fertility Control Survey which conducted a 
longitudinal household survey between 1998 and 2003. This data forms the 
basis for chapter 4 in this thesis and so in order to spatially and contextually 
tie  the  studies  together  two  of  the  same  locations  were  used  for  the 
qualitative  data  collection.  The  six  locations  in  the  survey  were  originally 
chosen  to  provide  maximum  heterogeneity  and  each  differs  in  terms  of 
ecological setting, economic activity, ethnicity, or kinship system. The two 
locations for this study were chosen to provide some diversity in terms of 
economic activity and ecological setting but to retain enough homogeneity in 
terms  of  language,  ethnicity  and  religion  so  that  the  results  remain 
comparable. Although the dominant ethnic and language groups of the two 
villages are different both are members of the Akan speaking groups and, as 
the primary lineage type follows from the ethnic composition, both villages 
follow  a  matrilineal  system.  Table  3.1  below  outlines  some  selected 
characteristics of each location.  
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Table 3.1: Characteristics of the Two Study Locations  
Study Area  B  A 
 
Location  Coastal  Inland 
Primary economic activity  Farming, Fishing  Farming 
Primary ethnic/language 
group 
Fante 
 
Twi 
 
Primary religious affiliation  Orthodox 
Christian 
Orthodox 
Christian 
Total Population 2000*   1,294  588 
Total  number  of  households 
2000*  
242  143 
*(Ghana Statistical Service, 2005) 
 
Location  A  is  a  small  village  located  inland  in  the  Twifo  Hemang Lower 
Denkyira district of the central region, and the primary economic activity is 
subsistence farming. The village is located on a main road providing good 
access to public transportation. The village is used to the presence of tourists 
and visitors due to its close proximity to the Kakum Forest Reserve which is a 
major  tourist  attraction  in the area.  Location  B  is  a coastal  village  in  the 
Komenda Edina Eguafo District of the central region. The primary economic 
activity  is  fishing  but  there  is  also  some  income  generated  through  the 
production of salt. The village is situated approximately 5 kilometres from 
the main road and access to the village is by a paved road which dead ends in 
the village. Public transportation is available in the form of shared taxis or 
Tro Tros. The village is host to a tourist class beach resort and as such the 
presence  of  visitors  and  foreigners  in  the  area  is  not  a  novelty,  although 
tourists rarely visit the actual village itself. Both villages are connected to 
mains electricity and water is supplied from covered wells or in a few cases 
piped direct to houses or compounds.  
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3.3.2.2: The Research Team  
 
The decision was taken to hire a local research team for the data collection as 
it  was  felt  this  would  bring  a  number  of  advantages  to  the  study.  Most 
importantly  it  enabled  the  focus  groups  to  be  conducted  in  the  local 
languages, Fante and Twi. Although English is the official language of Ghana 
and  is  widely spoken  it  is  usually  taught in  school  so in  situations  where 
participants may be poorly or uneducated, fluent English is unlikely.  As such 
it was felt necessary to conduct the groups in the local languages to enable all 
participants to contribute equally and not be restricted by language issues, 
while  avoiding  the  complication  and  time  implications  of  simultaneous 
translation.  The  interviews  with  service  providers  were  conducted  by  the 
researcher  herself  in  English.  Another  advantage  of  using  indigenous 
research assistants is their familiarity with life, culture and expected norms 
of  behaviour  in  the  study  locations.  This  knowledge  was  particularly 
invaluable  in  the  initial  stages  of  negotiating  access  and  dealing  with  the 
sometimes complicated hierarchy of village leaders.  
 
Two  female  research  assistants  were  hired;  the  first  was  the  focus  group 
moderator who was a research assistant in the Department of Geography and 
Tourism  at  the  University  of  Cape  Coast  and  the  second  who  acted  as 
assistant  to  the  moderator  and  was  an  MPhil  student  of  the  same 
department. The final member of the field team was the researcher herself 
who was present at all times. Although not familiar with reproductive health 
topics or research the assistants were chosen based on their knowledge and 
experience of conducting focus groups.  Initially a four day skills training 
programme  was  planned  based  on  that  developed  for  relatively  unskilled 
bilingual focus group facilitators by Maynard Tucker (2000). This needed to 
be adapted given the  expertise of the research assistants and the training 
programme was subsequently focused more on the topic of the research than 
the data collection method. Part of the training consisted of a pilot study 
which  is  described  in detail  in  section  3.3.2.3  below. The  selection  of  the  
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research assistants was also influenced by their personalities and personal 
characteristics which were suitable and desirable in relation to the intended 
study design.  The two field research assistants were specifically constrained 
to  be  female  as  research  on  interviewing  regarding  sensitive  topics  has 
suggested that respondents are generally more comfortable with interviewers 
of similar social characteristics including gender (Lee, 1993). The other three 
team  members  consisted  of  two  females  and  one  male,  along  with  the 
researcher who is female.  
 
Subsequent to the data collection the audio recordings were simultaneously 
translated and transcribed by a further three members of the team who were 
also students of the University of Cape Coast and were selected based on 
their language skills. These team members also received 2 days of training in 
the  research  topic  and  transcription  techniques,  and  were  provided  with 
detailed instructions as to exactly what was required by the research in order 
to enhance standardization in translation. All transcriptions were checked 
and verified by both the moderator and assistant moderator. Interviews with 
service providers and key informants were conducted by the researcher in 
English. The researcher and two of the research team are pictured in Figure 
3.1, in village location B in September 2007.  
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Figure 3.1: The Research Team September 2007 
 
 
As Rutenburg and Watkins (1997) point out the imbalance of power and the 
expectation of gains on the part of the participant communities undoubtedly 
has  some  influence  on  the  data,  especially  where  the  economic  distance 
between the parties is perceived to be great. In the case of this study every 
attempt  was  made  by  the  research  team  to  be  clear  with  the  participant 
communities  as  to  the  purpose  of  the  study  and  the  outcomes  for  the 
community. This imbalance of power is one of the reasons the decision was 
taken to hire local research assistants to collaborate with the researcher and 
lead the groups in the local languages. It was hoped that by doing this the 
participants would feel more comfortable and at ease during the groups. It 
must be kept in mind however, that the research assistants while originating 
from the local area, were both currently urban residents and highly educated 
university staff or students. Therefore the study participants may still have 
perceived  a  significant  imbalance  between  themselves  and  the  indigenous 
researchers.  
   
The field study was kept as low key and unobtrusive as possible and attempts 
were made to lessen the perceived differences between the researchers and  
  53 
the study communities. For example whenever possible the research team 
travelled by public transportation and care was taken over style of dress so as 
not  to  appear  too  formal.  Despite  this  the  presence  of  a  white  foreign 
researcher  did  create  some disturbance particularly on the first visits and 
during  screening  when  it  was  necessary  to  announce  the  presence  of  the 
research  team  to  the  whole  village  in  order  to  attract  participants.  The 
repeated presence of the research team in the study locations led to a certain 
level of familiarity and acceptance when the groups were taking place and 
while this effect on the data in acknowledged it is believed to be minimal.   
 
3.3.2.3: Study Design  
 
Each group contained between 4 and 9 participants and in each of the two 
study  locations  groups  were  composed  according  to  two  participant 
characteristics.  The  desired  number  of  participant  in  each  group  was 
between 6 and 8 as it was felt that smaller groups would allow for a more in 
depth  level  of  discussion  without  placing  undue  burden  on  any  single 
participant. This was achieved in all but one of the groups, which only had 
four  participants.  Firstly  participants  were  grouped  according  to age  with 
groups comprising those aged 30 and under or those aged over thirty. This 
distinction was made based on the findings of the GDHS 2003 that women 
aged less than 30 are more likely to cite fear of side effects as a reason for 
non use than women aged over 30 (Ghana Statistical Service et al, 2004). 
The  groups  were  then  also  separated  according  to  their  history  of 
contraceptive  use  into  never  users  and  ever  users  to  provide  some 
homogeneity  in  the  personal  experiences  of  family  planning  within  the 
group.  This  was  done  with  the  dual  aim  of  creating  a  permissive  and 
comfortable environment for the participants and aiding the analysis of the 
data, which is focused at the group rather than the individual level (Bloor et 
al,  2001).  The  groups  were  not  broken  down  further  to  preserve  enough 
diversity to encourage discussion and provide a range of opinions. A diagram  
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showing  the  multiple layer  specification  of  groups  is  shown  in  figure  3.2 
below. 
 
Figure 3.2: Focus Group Specification Diagram  
 
Pilot Study 
 
One pilot focus group was conducted in a third location prior to the start of 
data collection. This enabled refinements to be made by the research team to 
both the screening questionnaire and the focus group schedule.  The location 
of the pilot study was chosen for convenience and based on its proximity to 
the  University  of  Cape  Coast  and  the  prior  acquaintance  of  the  village 
assembly man to the researcher. The screening was relatively chaotic and 
disruptive compared to the actual data collection for a number of reasons. 
Firstly the research team only visited the screening location once, due to the 
arrangements having been previously made with the assembly man off site. 
This  resulted  in  the  research  team  drawing  significant  attention  by  their 
presence and a crowd of onlookers gathering.   Secondly the screening and 
the  focus  group  were  conducted  on  the  same  day  due  to  time  pressures, 
which was a Saturday. This meant that there were more people than usual in 
the  village  including  many  children  who  were  not  at  school  and  whose 
attention  was  also  attracted  as  explained  above.  This  of  course  had  a 
significant impact on the process of conducting the pilot study and especially 
at the screening stage caused somewhat of an ethical dilemma related to the  
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privacy  of  the  participants.  This  was  mitigated  as  far  as  possible  by 
conducting  the  individual  screening  questionnaires  and  the  actual  focus 
group itself as far away from the main screening location as was feasible to 
allow for maximum privacy and minimize the potential for eavesdropping. 
This created some logistical difficulty at the pilot location but was not an 
issue during the actual data collection for the reasons previously mentioned 
in section 3.3.2.2 above and in the sections on data collection sites below.  
 
As a result of the pilot study some small adjustments were made to the focus 
group schedule and one change was made to the eligibility criteria. Prior to 
the  pilot  study  participants  were  asked  if  they  had  ever  discussed  family 
planning with anyone, and were only considered eligible if they responded 
that they had.  This criteria was removed after the pilot as the numbers of 
women responding that they had discussed family planning was very low and 
was restricting the available pool of participants unnecessarily. In addition it 
was felt that this question was potentially interpreted in different ways by 
participants. It was noticed during the pilot screening that a few women who 
reported being ever users of contraceptive also reported that they had not 
discussed family planning. This struck the research team as incongruous and 
so  these  women  were  further  questioned.  In  some  cases  the  women 
responded that they had discussed family planning with a health worker but 
thought  the  question  referred  only  to  discussing  with  their  peers,  yet  in 
others exactly the opposite explanation was given. Rather than attempt to 
reconcile this, the eligibility criteria were changed.  
 
Question Route Design 
 
The question route was designed following the recommendations of Kruger & 
Casey (2000) and a  copy is attached as  appendix 3A.  The local research 
team was given an opportunity to comment on the question route before the 
data collection and also to make any changes following the pilot study. The 
questions  were  not  translated  into  the  local  languages  in  writing  as  the  
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moderator felt this was unnecessary as the local languages  do not have a 
strong written tradition and she was more comfortable working in written 
English.  
 
Participant Selection 
 
The fieldwork process began with negotiation of access to people living in the 
locations  with  the  leaders  of  the  local  communities.  First  the  assembly 
person  was  contacted  and  the  purpose  of  the  study  was  explained.  The 
assembly person then facilitated a meeting with the village chief, or in the 
case of location A where the chief is absent with the queen mother. The chief 
and  queen  mother  were  then  visited  and  brought  the  traditional  gift  of  a 
bottle  of  schnapps,  so  that  a  libation  ceremony  could  be  performed. 
Following  the  granting  of  permission  by  the  chiefs  and  the  deciding  of  a 
suitable date for participant screening the village announcer or gong beater 
was hired to go around the village and invite women aged 18 to 49 to present 
at a designated time and location if they were interested in being screened to 
participate in the study. Once participants had gathered they were given a 
short verbal introduction to the study and then invited to take a screening 
questionnaire which is presented in appendix 3B. Once identified as eligible 
participants and placed into the appropriate group individuals were asked if 
they would like to participate and told where and when their group would 
take place. In cases where a potential participant was unsure of their age a 
visual  judgment  was  made  by  the  researcher  administering  the  screening 
questionnaire.   
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Locations 
 
Previous focus groups discussions conducted in northern Ghana by Adongo 
et  al  (1997)  found  that  interruption  or  casual  participation  by  non 
respondents was a problem. They felt it was paramount to choose a study 
location  that  was  relatively  secluded  from  the  general  public  but  yet  still 
familiar  to  the  participants  so  as  to  put  them  at  ease  and  not  overly 
inconvenience  them.  In  Location  A  the  pre screening  took  place  in  the 
community centre pictured below in figure 3.3, and the groups themselves 
took place in the room to the rear of the community centre pictured in figure 
3.4.  
 
Figure 3.3: Screening Location A 
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This location was relatively private and the ability to close the doors meant 
passers  by  could  not  see  into  the  room.  However  the  location  was  noisy 
particularly due its proximity to the road which is busy and supports very 
heavy traffic such as logging trucks from the nearby forest reserve. 
 
 
Figure 3.4: Focus Group Location A 
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In Location B the screening took place outside in front of the royal palace 
where  there  was  space  for  the  respondents  to  sit  down  at  the  side  of  a 
building. The groups were conducted in the porch space of a nearby house. 
The space was enclosed on three sides and was open to a path on one side. 
The path was not heavily used but when people did walk past they could 
observe  the  group.  It  was  felt  that  this  location  was  acceptable  as  the 
participants could also observe passers by and chose to stop speaking if they 
wished. The location is shown below in figure 3.5. 
 
Figure 3.5: Focus Group Location B 
 
 
3.3.3: Analysis 
 
The  data  resulting  from  the  focus  group  discussions  and  interviews  with 
service  providers  was  analyzed  using  a  process  of  analytical  induction. 
Analytical  induction  is  described  by  Bloor  et  al  (2001:66)  as  ‘a  means  to 
derive explanatory hypothesis which apply to all of the data available on any 
particular phenomena.’ This process uses a progressive stepwise procedure 
of  developing  and  revising  hypothesis  which  are  then  compared  with  all 
available evidence. Deviant cases are included in the analysis and are used to 
force revisions of the hypothesis until the hypothesis fits all the cases.  The  
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analysis considers the substantive content of the data looking at the ideas 
issues  and  themes  in  the  participant’s  comments.  Both  consistency  and 
contradiction  in  attitudes  and  arguments  are  considered  along  with  the 
frequency and extensiveness of an idea. Other aspects of the data are also 
included in  the  analysis such  as  the  context  of  the  comments,  if  they  are 
prompted  by  other  participants,  if  they  are  vague  comments  or  specific 
responses,  and  the  tone  and  intensity  of  comments.  Also  considered  are 
aspects of non verbal communication such as group mood, spontaneity and 
body language recorded in the field notes at the time of the data collection.  
  
The  transcripts  were  analyzed  with  the  aid  of  Nvivo  Version  2.  Each 
transcript was initially coded in a deductive thematic framework based on 
the original focus group schedule.  An inductive and analytical process was 
then carried out to develop a more detail coding schema for further coding 
and analysis. The unit of analysis in this study is the group, comparisons are 
made across groups and individuals within groups are not identified.  The 
results of the study are presented with the use of verbatim quotes to illustrate 
the issues arising in the original words of the participants.   
 
 
3.3.4: Ethical Consideration 
 
Ethical approval for this study was sought prior to the commencement of 
fieldwork  from  the  Ethical  Review  Committee  of  the  School  of  Social 
Sciences,  University  of  Southampton.  The  Ethical  Review  application  is 
reproduced in its entirety in Appendix 3D. Appendix 3E presents a copy of 
the leter of approval recivied from the Ethical Review Committee on 2nd July 
2007.  
 
As  previously  mentioned  the  topic  of  this  study  is  relatively  sensitive  in 
nature and raises some issues which have the potential to cause distress for 
the participants. Issues may be raised such as recalling stressful events such  
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as episodes of poor health due to adverse side effects or family conflict over 
the use of contraception which could cause a participant to become upset at 
the time of the discussion. In this study the research team took collective 
responsibility to ensure the well being of the participants and monitor for 
signs  of  distress.  Oliver  (2003)  also  points  out  that  participants  may  be 
happy  to  get  a  chance  to  talk  about  their  life  and  overall  may  feel  more 
valued and have an enhanced sense of their own self worth. 
 
There is also the issue that the members of each group will likely know each 
other in some respect and will possible have to face each other again in daily 
life.  There are arguments within the literature about the effect of conducting 
focus groups with participants who know each other and there is a possibility 
that participants may be more reluctant to disclose personal information in a 
group of people they know and are likely to see again. However, in village 
settings such as those in this study it is virtually impossible to put together 
groups of participants who do not already know each other to some degree.  
It  is  felt  that  the  topic  of  contraception  and  contraceptive  use  is  not 
sufficiently sensitive as to present a problem in this regard and participants 
will be made aware in the informed consent process that they may refuse to 
answer  specific  questions  or  disclose  certain  personal  information  if  they 
wish. All participants will be asked to keep the contents of the discussion 
confidential during the informed consent process and this will be re iterated 
to them at the end of the discussion.  
 
Anonymity and Confidentiality 
 
The anonymity of the participants is preserved in a number of ways. When 
the focus group tapes were transcribed names of individuals were not used 
and any personal and identifying information disclosed by participants was 
excluded.  Only  the  research  team  was  present  at  the  time  of  the  data 
collection and every effort was made to provide a private location.  
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3.3.4.1: Informed Consent 
 
The process of gaining informed consent is central to the research process 
and  consent  was  gained  from  each  participant  before  each  focus  group 
began.  The  process  of  informed  consent  usually  involves  a  written 
information sheet and a form to be signed by the participant formally giving 
consent. However this process does not take into account the socio cultural 
setting of this study in which a proportion of the potential participants can 
reasonably be expected to have low literacy skill and a limited educational 
background.  According to UNESCO statistics the adult female literacy rate 
in Ghana for 200 04 was 65.9%, which suggests that given a random sample 
one could expect one third of potential participants to be illiterate (UNESCO, 
2005). Van Den Hoonaard (2002) points out that informed consent must be 
tailored  to  the  circumstances  of  the  potential  participants  and  take  into 
account  participant’s  skills  including  level  of  reading  recognition  and 
comprehension. Further to this Oliver (2003) notes that a way should be 
found to explain the basics of the research to the participants in a manner 
which  they  understand  which  may  involve  overcoming  limitations  of 
language  and  limited  education.  In  its  guidelines  for  research  involving 
people  in  developing  countries  the  Wellcome  Trust  (Undated)  state  the 
following: 
 
‘The process [of obtaining consent] is more important than the 
signing of a consent form, which should only be regarded as 
evidence that a consent process has been carried out. Written 
consent  may  not  always  be  the  most  appropriate  form  of 
recording  consent,  for  example  where  participants  are 
visually impaired or illiterate.’ 
 
In  this  study  the  basics  of  the  research  and  the  issues  of  anonymity, 
confidentially, withdrawal from the study, and audio recording were verbally 
explained to participants by the moderator before the discussion began. The  
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moderator gained a verbal response from each participant on a number of 
questions designed to check consent.  The explanation and the check list are 
included as appendix 3C. 
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3.4: Results  
 
3.4.1: Service Provision 
 
Prior to the data collection an audit of the family planning service provision 
in and around both locations was undertaken to establish the relative ease or 
difficulty of accessing services in these locations. It is important to note that 
this audit was not exhaustive so it is possible that other sources of services 
exist  but  have  been  overlooked,  particularly  if  they  are  private  clinics  or 
commercial locations selling pills. Table 3.2 summarizes the service delivery 
points according to proximity to each location.   
 
Table 3.2: Location and Services of Family Planning Providers  
  Type of provider  Distance  from 
village  
Services provided 
Location A 
1  Family planning agent  Resident in village  Distributes  pills,  makes 
referral  appointments,  IEC 
activities  
2  GHS clinic  2km (main road)  all  services  except  IUD  and 
implants  –  refers  to  district 
hospital 
3  GHS clinic  15km (1okm main road 
plus  5  km  off  main 
road) 
all  services  except  IUD  and 
implants  –  refers  to  district 
hospital 
4  GHS clinic  20km (main road)  all  services  except  IUD  and 
implants  –  refers  to  district 
hospital 
Location B 
1  Agent/pharmacy  Resident  in  village  – 
pharmacy  is  in  next 
village ½ km 
Distributes  pills,  makes 
referral  appointments,  IEC 
activities 
2  Private  health  care 
clinic 
5km  (at  junction 
w/main road) 
all  services  except  IUD  and 
implants  
3  Local hospital   20km  (5km  to  main 
road then 15km) 
All services except IUD 
Referral Hospitals 
1  Cape  Coast  District 
hospital  
approx.  30km  from 
both locations  
All services 
2  Cape  Coast  Central 
regional hospital 
approx.  30km  from 
both locations 
All services 
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As  table  3.2  shows  neither  of  the  villages  have  a  clinic  but  both  have  an 
individual who acts as a family planning agent and is resident in the village. 
In location A this is an official agent who is ‘employed’ and trained by the 
Planned Parenthood Association of Ghana (PPAG). In location B there is no 
official agent but the role is taken by a local resident who works as a nurse’s 
assistant in the nearby local hospital and provided IEC activities and assists 
people with obtaining pills from the pharmacy in the next village.  In location 
A there is a GHS clinics with all temporary methods except implants and IUD 
are within walking distance of the village. In location B there is not clinic 
within  walking  distance  and  only  pills  and  condoms  are  available  at  the 
pharmacy. Temporary methods are available from the small local hospital 
which is nearby but not within walking distance. For access to the methods 
not available in the clinics or local hospital women are referred to the larger 
family planning units within either of the hospitals in Cape Coast. Given the 
locations of both villages on or close to main roads and the good availability 
of  transportation  there  are  no  significant  physical  barriers  to  accessing 
services in either of these villages, although in location B the services are 
further away.  
 
3.4.2: Fear of side effects  
 
One of the central aims of this study is to gain some insight into what exactly 
‘fear of side effects’ means to women in this particular context. In every one 
of  the  focus  group  discussions  the  issue  of  side  effects  was  raised 
spontaneously  by  the  participants  in  response  to  general  questions  about 
family planning. There is no doubt that the term ‘side effects’ is well known 
in these communities and by extension the concept of fear of side effects. 
However when asked to describe fear of side effects in more depth many of 
the responses were vague and non specific: 
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 ‘When you do it, it results in some sickness or diseases which 
can worry you’ (Over 30, ever user, location B)  
 
Where reference was made to specific symptoms which were believed to be 
side  effects  of  contraceptive  use,  these  were  most  often  what  would  be 
considered  to  be  ‘expected’  or  common  side  effects  based  on  the  clinical 
literature. The specific side effects participants reported knowing about are 
dizziness,  headaches,  palpitations,  nausea,  weight  change  and  menstrual 
disruption.  More  unexpected,  or  unlikely,  side  effects  were  mentioned 
although  not  frequently  in  comparison  to  the  more  likely  effects  already 
mentioned.  Condition  such  as  high  blood  pressure,  diabetes  and  asthma 
were all discussed in relation to contraceptive use. In a few cases participants 
raised the idea that the side effects of using a contraceptive method could 
ultimately result in death.  The following exchange shows that this opinion 
may not have been shared by all participants some of whom may not have 
considered this to be a serious risk:  
 
Moderator: If one says she’s afraid of the consequences of the 
family planning, what does she really want to tell us?  
 
Participant 1: Death 
 
Participant 2: Oh no please don’t say this [laughter] 
 
Moderator: Please allow her to speak. What did you say? 
 
Participant 1: If one says she’s afraid you may think of death.’  
(30 or under, never user, location A) 
 
As  discussed  in  the  previous  literature  the  fear  of  side  effects  is  often 
dismissed as being a result of wild rumors of very severe, but ultimately very 
unrealistic,  side effects. This study shows that this is not the case in these 
communities where the women are most concerned over the impact on their 
quality of life of expected and common side effects, especially of hormonal 
methods.   
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Another  component  of  fear  of  side  effects  which  was  discussed  is  the 
potential for contraceptive use to impact on future fertility. Specifically these 
fears are of difficulty in getting pregnant or total infertility, requiring surgical 
intervention at future deliveries and  in extreme cases the  death  of babies 
before or during delivery: 
 
‘There  are  others  who  complain  of  complications  during 
pregnancy  or  death  of  their  babies  because  the  family 
planning was for longer period.’  
(30 or under, never user, location A) 
 
Although it is unlikely for complications at future births to be caused by past 
contraceptive use, it is the case that some hormonal methods, notably the 
injectable, which is a popular method in this setting, can cause a delay in 
return  to  fertility  upon  discontinuation.  This  in  itself  is  not  problematic 
provided the user has been adequately counseled and knows what to expect 
prior  to  adopting  the  method.  In  contexts  where  neonatal  and  maternal 
mortality  remain  relatively  high  it  is  not  unreasonable  for  women  to 
rationalize this type of event by placing the blame on the most obvious, and 
perhaps the only, western medical intervention previously experienced.  
 
Besides the fear of physical side effects and potential future fertility issues 
another  area  of  concern  which  was  raised  by  the  groups  is  the  social  or 
physiological  side  effects  of  use.  This  can  be  related  to  experiencing  a 
physical  side  effect,  such  as  menstrual  disruption,  which  while  medically 
innocuous can have significant impact on women’s day to day life and on 
their relationships with others, particularly their husband. 
 
‘There  are  instances  where  instead  of  the  normal  five  days 
menstruation  period  it  takes  about  two  months  and  this 
creates  problems  between  spouses  because  the  man  might 
think you are just pretending in order to keep him away from 
your bed.’ (Over 30, ever user, location A) 
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A second aspect of this issue is related to the perceived social stigma of using 
a  method  at  all  regardless  of  whether  or  not  a  physical  side  effect  is 
experienced. Rather than coming from husbands or other men, this general 
disapproval of contraceptive use seems to come from other women who may 
cast  aspersions  on  the  motivation  of  users.  As  described  by  one  female 
service provider: 
 
 ‘Something like the women here when the other women see 
them  coming  in  for  family  planning,  it’s  like  when  you  do 
family planning it prevents you from getting pregnant okay, 
so if you are a bad women and you want to go behind your 
husband and you want to sleep with a lot of men then you do 
family  planning  so  that  you  don’t  get  pregnant  okay.  So 
people don’t even want their peers to know that they want to 
do family planning, okay they don’t want to talk about family 
planning  because  when  you  talk  about  it  you  want  to  do 
something abominable, do you see? So it’s one of the things 
that  deter  people  from  coming  to  do  family  planning.  This 
happens in the community, in the typical community.’ 
(Family  Planning  Service  Provider,  Cape  Coast  District 
Hospital) 
 
3.4.3: Causes of Side Effects  
 
It is clear that many women in these communities perceive side effects from 
contraceptive use to be extremely common, which leads some to feel that 
side effects are an inevitable consequence of modern method use. One issue 
which  causes  concern  and  confusion  among  some  women  is  the 
unpredictable  nature  of  side  effects  and  the  seeming  randomness  in  who 
suffers side effects and who does not: 
 
 ‘Some people do it and do not experience even headache and 
what baffles me most is that, they say when you are going to 
do it, they first look at the one which will be suitable for you 
before they do it. So why is it that it still poses problems. That 
is  what  I  also  don’t  understand.’  (30  or  under,  never  user, 
location B) 
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This represents a serious problem for service providers who may struggle to 
counsel  women  effectively  on  what  to  expect  given  the  inherent 
unpredictability which they find difficult to come to terms with.   While some 
participants acknowledged the randomness of the occurrence of side effects 
others pointed out that in their experience side effects most often occur when 
there is some flaw in the process of administration of the method, or in some 
cases are  directly caused through actions of the individual user themselves. 
For example the following quote illustrates that the participant believes the 
negative outcome in question would not have happened had the women been 
honest with the service provider: 
 
‘As for the family planning there are instances where the fault 
is from the individuals themselves. I happen to know one lady 
who went for the family planning and was asked if has had 
her period and she answered yes but it was not true and the 
nurse administered the drug. Later this lady was experiencing 
blackout as result of the reaction between the pregnancy and 
the  drug  and  she  had  to  be  taken  to  the  hospital  until  the 
doctor found out she was pregnant and directed her to the lab 
for a test which revealed everything before she was treated 
but she lost the baby all the same. I think some of them do not 
tell the truth when questioned and that is one of the reasons 
for the negative effect.’ (30 or under, never user, location B) 
 
In the case above the individual had consulted a service provider but had 
failed to give correct information, however the service providers themselves 
see a problem with side effects arising in particular from those users who do 
not have any contact with clinic personnel when they obtain and use their 
method:  
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‘Because if one has gone in for lets say Norplant it does not 
mean that you must also go in for Norplant, if one is using 
condom or contraceptive pill, any of the others does not mean 
that you should also go in for the same because you have to be 
screened. Sometimes some of them go to drug stores and buy 
the drugs themselves. Not knowing even how to start using 
them, you see they go to drug stores and begin to buy the, the 
tabs,  the  28  day  type  and  begin  to  use  them,  without 
consulting anybody.’ 
(Female  Service  Provider,  Private  health  care  clinic,  Near 
Location B) 
 
The quality of these drugs is unknown, and they frequently do not come in 
the  original  packaging  or  with  instruction  legible  to  the  women  in  these 
communities.  The success of social marketing of oral contraceptive and their 
widespread availability is a benefit to the many women who are obtaining 
their  contraception  this  way  and  might  otherwise  not  be  able  to  assess  a 
method at all. However the safety of this unregulated access is an issue and 
one consequence of this might be an  increase in side  effects arising from 
incorrect method use or lack of knowledge of what to expect on the part of 
the user. Participants also see consulting with a service provider as a crucial 
element  in  the  avoidance  of  side  effects  in  relation  to  method  choice. 
Participants  expressed  the  idea  that  side  effects  come  as  a  result  of  the 
method  being  unsuitable  for  their  body.    This  is  one  of  the  reasons  why 
providing a wide range of different methods is considered a key element in 
assessing  the  quality  of  family  planning  programmes  and  their  service 
provision. Where side effects are experienced, switching methods may be the 
most appropriate course of action and some trial and error may be involved 
before the right method is found.  Offering the user an informed choice of a 
range of methods is a vital component of providing quality services, however 
many participants expressed the feeling that they did not want to make these 
choices for themselves.   
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‘…whenever I decide to go for a family planning I will see a 
doctor and let him advice me on which of the methods that 
may be suitable for me instead of  making my own choice.’ (30 
or under, never user, location A) 
 
Some women believe they are not capable of choosing their own method but 
rather by visiting a clinic and getting the appropriate ‘lab test’ ‘blood test’ or 
‘examination’  the  most  ‘suitable’  method  for  a  particular  women  can  be 
determined.  It is therefore seen as the fault of an individual user if she either 
does not see a service provider, or she chooses her own method and then 
experiences side effects. This view is extended even further by some who see 
side  effects  as  a  failure  on  the  part  of  the  service  provider  to  correctly 
determine the most suitable method for each individual: 
  
 ‘It [side effects] is also the fault of the family planning officers 
because  it  is  the  responsibility  of  the  officers  to  determine 
which  of  the  methods  or  drugs  will  be  suitable  for  the 
individual since the person has no idea or knowledge about 
the family planning method.’ (30 or under, ever user, location 
A) 
 
Rather than seeing individual choice of methods as a sign of service quality 
the participants believe individuals are not in a position to be able to make 
these choices for themselves and if the choice is placed in their hands this is 
viewed as an indictment of the family planning programme. In the view of 
these women it is up to the service provider to encourage a woman towards a 
particular method which they believe is most suitable for her.  
 
3.4.4: Other Explanations for Side Effects 
 
Besides incorrect method choice, the focus group participants were also in 
agreement that another major cause of the side effects they hear of is not 
actually  side  effects  at  all.  Rather  symptoms  of  another  illnesses  or 
conditions unrelated to contraceptive use are being classified as side effects 
and blamed on the method used:  
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‘Even  if  the  condition  was  there  and  manifested  after  the 
family planning, she is likely to blame the family planning as 
the cause of the problem.’ (30 or under, never user, location A) 
 
Although  the  participants accept  that  this happens  frequently  they  find  it 
difficult to distinguish between the different possible causes of symptoms’, 
especially when the individual concerned believes their symptom to be a side 
effect of contraceptive use. Even in cases where the user herself does not 
believe her symptoms are a side effect she can still face significant pressure 
to stop, from others who are aware of her status (as a contraceptive user) 
should she become ill for any reason. This experience is typified in the quote 
below from a current pill user in location B.  
 
 ‘I remember two years ago I had a terrible stomach ache and 
my mother was putting the blame on the family planning, she 
even warned me to stop the family planning medication but I 
refused because I knew it was not true. We have had many 
such  situations  in  this  town  where  all  sicknesses  are 
unnecessarily  blamed  on  family  planning.’  (Over  30,  Ever 
user, Location B) 
 
In this case the individual was able to stand up to her mother and did not 
stop taking the pill, however this level of autonomy  may not always be the 
case and this could be the cause of contraceptive discontinuation while still 
at risk of an unwanted pregnancy. This is one reason why many current users 
in  these  communities  chose not to  make  their status  known  amongst  the 
community members in general or even members of their own family.  
 
3.4.5: Covert Users 
 
As noted above users can sometimes face significant pressure from others to 
stop using their method, particularly if the user is sick or it is perceived that 
they are experiencing a side effect. They may be subjected to many stories 
about the potential consequences of using family planning which are a source 
of  fear  and  unease  for  the  current  user  who  is  put  in  a  highly  defensive 
position.   A few respondents who were current ‘never users’ stated that if  
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they were to adopt a method they would keep this a secret from their friends 
and family as a way of avoiding such negative interactions. 
 
‘If  you  are  to  listen  to  what  people  say  you  will  never  tell 
anyone you are involved in family planning because you may 
get heart attack from just listening to what people say.’ (Over 
30, ever user, location A) 
 
For this reason it is believed that many users keep their status a secret from 
their peers, family and sometimes their husband. The participants described 
discussing their own use of family planning in terms of ‘making a confession’, 
although it is worth noting that most did not appear to hesitate to discuss 
their own use in the focus group context, despite being reassured  that they 
did not have to reveal personal information if they did not want to.  
 
3.4.6: The Flow of Information and Influence  
 
The  above  discussion  on  covert  use  also  has  implications  for  the  flow  of 
information  regarding  family  planning  through  informal  social  networks. 
Clearly  in  some  cases  knowledge,  and  fear,  of  side  effects  comes  from 
personal  experience  but  in  a  great  majority  of  cases  it  comes  from  the 
transition of knowledge through social networks. The content and accuracy 
of the information being transmitted is influential in the collective level of 
knowledge  and  attitude  to  family  planning  within  the  community.  The 
majority of the respondents agreed that family planning is a frequent topic of 
conversation  and  most  had  at  sometime  discussed  family  planning  with 
someone  in  their  informal  social  network.  Similarly  all  of  the  service 
providers  believed  that  women  in  their  communities  are  commonly 
discussing  family  planning  amongst  themselves.    Although  some  positive 
conversations  were  reported  by  all  groups  overall  the  participants  clearly 
expressed  that  the  overwhelming  majority  of  informal  discussion  about 
family planning center on negative aspects.  
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‘Some talk about the positive effect that it helps you space the 
birth of your child and help the mothers to be ‘free’ but they 
usually emphasize on the negative effect.’ (30 or under, ever 
user, location B)  
 
Comments such as that above were voiced by many participants in all groups 
and there was a clear consensus among group members that the balance of 
the content of discussions was towards the negative. Some of this negative 
discussion  reflects  a  general  opposition  or  ambivalence  towards  family 
planning but mostly it is regarding the specific side effects or health concerns 
associated with using a particular method.  
 
‘People  normally  talk  about  its  side  effect  rather  than  its 
positive parts. Like at times it helps but … the moment you 
mention it, the problems are addressed first.’ (30 or under, 
never user, location B)  
 
Women in these study locations discuss the use of contraceptive methods 
with  others  in  their  community  and  consider  their  peers  as  a  source  of 
information  and  advice.  If  actively  seeking  information  women  are  most 
likely  to  go  to  those  who  they  know  are  current  or  ever  users  of  a 
contraceptive  method.  Although  much  of the information  participants  are 
hearing comes from second hand sources, people known to have first hand 
experience  of  using  a  method  are  considered  the  most  reliable  source  of 
information. These women are also considered to be the most likely to relate 
a positive experience with family planning. 
 
‘Or you will listen to someone who has benefited from it so 
that if you want to do it and you are scared, she can tell you 
that what she did was good for her and so you should do it. I 
think these are some of the people we can talk to, to lessen 
your fear.’ (Over 30, never user, location B) 
 
Information  coming  from  people  believed  never  to  have  used  a  method 
themselves is dismissed as rumors and gossip and in general their advice is 
not sought. This creates something of a dilemma as current and ever users  
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are  potentially  the  most  influential  people  in  the  community  however  as 
previously discussed they often prefer that their status as current users not 
be  widely  known.  Current  users  are  encouraged  by  health  workers  to 
motivate others; however there are potentially real consequences for these 
women if they choose to disclose their status publicly. Additionally where 
past users have had negative experiences, for any of the reasons discussed, 
and are sought out for advice, these single stories can spread through the 
network and become very influential.  
 
3.4.7: The Effect of Counselling  
 
Ultimately  the  most  trustworthy  source  of  information  is  health  care 
providers. None of the participants raised any specific objections or barriers 
to  attending  a  clinic  for  family  planning  services  or  to  discussing  family 
planning with health workers.  
 
‘We have to believe the doctor or nurse because they have the 
knowledge  about  it.  They  know  what  is  good  for  you  or 
otherwise, than someone who do not know anything about it. 
Those  people  you  can’t  trust  them.  So  if  I  should  believe 
anything, it should come from the nurse.’ (Over 30, ever user, 
location B) 
 
However health care workers were not mentioned by participants very often 
in  comparison  to  friends  and  peers,  either  as  a  source  of  advice  or 
information  or  in  terms  of  the  re telling  of  second  hand  information.  So 
although  health  workers  may  be  influential  their  overall  input  into  the 
discussions on family planning may be low. Most family planning outreach 
activities  are  focused  around  ante natal  services  and  weighing  clinics  so 
never users without children are unlikely to come into regular contact with 
health  workers.    As  mentioned  previously  the  task  of  counseling  is 
complicated by the individual and unpredictable nature of most side effects 
however,  where  individuals  are  receiving  some  sort  of  counseling  on  side  
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effects when they adopt a method it can be very effective at reassuring the 
women and preventing discontinuation. As one participant stated:   
 
‘Before  I  went  in  for  the  family  planning  I  was  told  I  was 
going to experience a few side effects at the beginning but I 
was to stay focused and forget about the family planning and 
that it was going to stop. So when I started experiencing these 
effects I did as I was told and after two months the problems 
stopped.’ (30 or under, ever user, location B)  
  77 
3.5: Discussion and Conclusion 
 
Figure 3.6 below shows a diagrammatic summary of the results of this study. 
The diagram shows that there is a cycle operating whereby information flows 
around the network and has the potential to influence individual’s behaviour. 
Fear of  side  effects  is  created  from  a  combination  of  direct  past  personal 
experience  of  side  effects  and/or  information  from  outside  sources  which 
also may be influenced by the experience of side effects, which are generally 
of the expected type and relatively benign from a clinical stand point.  While 
the information flowing through this network may be ‘true’ it may be atypical 
of what a contraceptive user may expect given correct and supervised use of a 
modern  method.    Therefore  this  sort  of  communication  cannot  be  easily 
dismissed as ‘rumor’ because it has a basis in fact, even if the negative effect 
was  due  to  the  misuse  of  a  method.  Rather  than  dismissing  this  sort  of 
information as untrue some way must be found to communicate the relative 
uncommonness  of  these  events  and  that  there  is  not  necessarily  any  link 
between one persons experience and another.  
 
Fear of side effects is a combination of many factors including fear of real 
and immediate health problems and the potential for social, financial and 
relationship  consequence.  Each  of  these  has  a  sound  basis  in  fact  and 
represents legitimate concerns which need to be resolved if the women is to 
adopt a modern method. Another set of factors contributing to fear of side 
effects  is  effects  on  future  fertility  and  potential  neonatal  deaths  or  still 
births. These are not likely consequences of modern method use, however 
they are events which happen frequently in the communities in which these 
women live. Given no other obvious explanations for these events it is not 
unreasonable that they might be linked to a perhaps still unfamiliar western 
medical intervention. Ultimately the results show that the consequences of 
fear  of  side  effects  are  non use  or  discontinuation  of  methods  and  the 
perpetuation of negative information within the social network.  
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Figure 3.6: Diagrammatic Representation of Results  
 
Fear of Side Effects 
Current: sickness, marital conflict, financial implications, social consequences, blame for illness, pressure to stop  
Future: difficulty getting pregnant, difficulty in child birth, caesarean section, neonatal mortality 
Flow of Information 
1) health workers 2) past/current users 3) others 
Experience of Side Effects 
Expected: headache, dizziness, nausea, weight change, menstrual disruption 
Unexpected:  diabetes, high blood pressure, asthma  
Consequences 
 
 
Non use 
Discontinuation 
Discussion of 
negative 
information  
 
 
Reasons for 
Experiencing Side 
Effects/Fear of 
Side Effects 
 
No reason i.e. it is 
unpredictable 
Source of supply 
Not seeing a health 
worker 
Not following 
instructions 
Choosing own 
method 
Overcoming 
Barrier 
Using method 
Tolerating side effects  
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Figure 3.6 does show however that while there is fear and it does act as a 
barrier to the use of modern methods it is by no means insurmountable and 
with  sufficient  motivation  fear  can  be  overcome  and  the  negative  cycle 
broken.  Once  this  happens  relatively  few  users  will  experience  serious 
problems and hopefully be able to contribute positive stories to the flow of 
information.  One  way  to  enhance  this  is  to  include  successful  users  in 
education  and  counseling  activities  which  is  a  strategy  also  suggested  by 
Rutenburg and Watkins (1997).  However the result of this study suggests 
caution must be taken with this approach as publicly disclosing their status 
in this way may involve some significant psycho social costs for the women 
involved.   
 
One factor that may contribute to fears is the often vague and unspecified 
nature  of  the  side  effects  in  the  information  being  circulated  and  the 
uncertainty surrounding exactly what can be expected from each different 
method. Similar to the Ghana Ministry of Health (1992) study, this study 
shows that participants are not always able to link a particular effect to a 
particular method. A positive finding is that the participants in this study 
clearly  identified  a  number  of  reasons  why  individuals  might  have  bad 
experiences which were not related to method use. This backs up what was 
found  by  in  India  Kirkconnell Hall  et  al.  (  2006)  that  women  know  that 
many problems are arising because methods are being used incorrectly. This 
also  related  to  the  problems  of  source  of  supply  of  methods  and  lack  of 
counseling on side effects.  
 
The results of this study indicated that the experience of expected side effects 
may  be  related  to  non clinical  source  of  supply  and  hence  potentially 
incorrect administration of methods. This is a particularly serious issue in 
Ghana  given  that  according  to  the  2003  GDHS  66%  percent  of  pills  are 
obtained from a pharmacy chemist or drug store (Ghana Statistical Service, 
2004).  Additionally  only  30%  of  those  women  are  likely  to  receive  any  
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counseling or information at all on side effects at the time they obtain the 
method compared with over 70% in a public sector health center or clinic.   
 
As well as identifying incorrect use as a source of side effects the participants 
in  this  study  also  clearly  stated  that  symptoms  of  other  illnesses  and 
conditions  are  often  misidentified  as  side  effects.  The  fact  that  the 
participants  are  so  well  able  to  rationalize  the  information  they  hear  and 
differentiate unusual situations from the more normal experience of use is a 
positive step in overcoming their own fear. This does lead to the question of 
why the fear persists if there are so many rational explanations.  The answer 
to this may lie in the unpredictable nature of side effects. Women know that 
even if they do everything right they may still experience a side effect and 
that  no one  can  accurately  predict  this.    This  genuine  uncertainty  may 
amplify other concerns and lead to the persistence of fear of side effects as a 
barrier to use. The best way of overcoming this is through education and 
counseling from health personnel who are perceived to be very influential 
sources of information.  
 
3.5.1: Conclusion and Policy Recommendations   
 
There are clear practical and policy implications in understanding how the 
diffusion  process  influences  reproductive  behaviour.  Family  planning 
education  can  then  best  utilize  networks  to  disseminate  information  or 
understand  how  networks  may  work  as  a  deterrent  to  individual 
contraceptive adoption. Overall the findings of this study show that fear of 
side effects does act as a significant barrier to the use of temporary methods 
and  especially  hormonal  methods.  These  fears  result  mainly  from  a  large 
amount of negative information regarding side effects being passed through 
the  social  network;  but  the  events  being  recounted  cannot  necessarily  be 
dismissed as myth or rumor and are most likely based in real experiences. 
Those experiences however do not reflect the experience of a typical user but 
rather cases of incorrect use or of other illnesses being blamed on method  
  81 
use.   Current users are potentially very influential in overcoming fear of side 
effects and they should be encouraged to participate in education campaigns. 
This  should  be  done  with  care  to  protect  each  individual  and  increased 
education to promote the general acceptability of modern method use will 
facilitate the use of current users as peer educators.  
 
The study shows that counseling and information is important in overcoming 
fear of side effects and proper training for health workers and CBDs in this 
area  is vital.  In  addition  a  very  important  but  neglected  and  unregulated 
source of contraceptives is pharmacies. Widespread availability of methods 
undoubtedly increases the CPR; however an unintended effect of this is an 
increase in fear of side effects due to a lack of adequate counseling. More 
attention to the training of pharmacists to provide counseling on side effects 
may help to decrease misuse and hence the negative flow of information.   
 
This  study  shows  that  with  sufficient  motivation  to  avoid  pregnancy  and 
adequate counseling the fear of side effects can be overcome and the actual 
experience of side effects can be tolerated.  
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Chapter Four 
  
Contraceptive Discontinuation and Side Effects: 
Longitudinal Evidence from Southern Ghana  
 
4.1: Introduction 
 
When considering the issue of low levels of contraceptive prevalence many 
studies focus on the socio economic, cultural and physical barriers women 
have to overcome in order to adopt a method of contraception. Somewhat 
less attention is given to what happens after a woman has overcome these 
barriers  and  adopted  a  method.  The  contraceptive  dynamics  of 
discontinuation,  switching  and  failure  among  users  all  contribute 
significantly to the overall contraceptive prevalence rate (CPR) at any given 
point in time. In many sub Saharan countries where the CPR has historically 
been very low and has only recently begun to rise, encouraging contraceptive 
continuation has been less of a priority than encouraging new adopters.  
 
However  the  influence  of  contraceptive  discontinuation  on  fertility  will 
increase as the CPR increases and fertility falls. The effect of discontinuation 
and failure is even greater on unwanted fertility. In a study of 15 developing 
countries based on Demographic and Health Survey data Blanc et al. (2002: 
132) find that in 14 of those countries ‘more than half of recent unwanted 
fertility was as a result of births that were preceded either by a contraceptive 
failure or by discontinuation of a method [for reasons other than a desire to 
get pregnant]’. The study concludes that family planning programs need to 
pay  more  attention  to  improving  continuation  rates  and  preventing 
contraceptive failure as fertility in a given area declines (Blanc et al., 2002).    
 
So while encouraging new adopters of contraceptive methods is undoubtedly 
important, equally important is continuity of use among current users and  
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studies  are needed  to  determine  the  factors  associated with  contraceptive 
discontinuation (Parr, 2003). One obvious set of reasons given by women for 
contraceptive  discontinuation  is  fertility  related  reasons,  principally  the 
desire to get pregnant. Other reasons for discontinuing may include a women 
reaching menopause or no longer being exposed to the risk of pregnancy for 
example  through  a  union  dissolution  or  the  husband  living  away.  This 
category of reasons indicates the use of temporary contraceptive methods in 
their intended way, and does not reflect any areas of concern or necessary 
area of intervention for family planning service providers. A second category 
of  reasons  for  discontinuation  are  method  related  reasons  which  include 
supply side issues such as stock outs or prohibitive costs, method failure and 
side effects or health concerns. Previous literature has identified side effects 
or the fear of side effects as an important factor in the discontinuation of 
methods, particularly modern hormonal methods, (Ali & Cleland, 1995; Ali & 
Cleland,  1999;  Curtis  &  Blanc,  1997)  and  side  effects  may  also  work  to 
shorten  the  duration  of  use  of  methods  or  influence  method  choice  away 
from  the  high  efficacy  modern  methods.  Additionally  past  negative 
experiences with a method may influence the future contraceptive behaviour 
of users. It is this issue of the link between side effects and contraceptive 
behaviour which is the focus of this study.  
 
This study is situated in Ghana, West Africa and uses data from the Cape 
Coast Social Learning, Social Influence and Fertility Control Survey (CCFCS) 
to explore the issue of contraceptive discontinuation and side effects. Fear of 
side effects has been shown to be a particular barrier to adoption of a method 
in  Ghana  and  according  to  the  2003  Demographic  and  Health  Survey 
(GDHS),  was  the  most  commonly  cited  reason  for  non use  of  modern 
contraceptives among women who are not currently using contraception and 
say they do not intend to do so in the future. In total, fear of side effects is 
25.6% of women’s main reason for not intending to use contraception. The 
overall contraceptive prevalence rate (CPR) remains relatively low at 18.7% 
for modern method use among currently married women aged 15 49 in 2003  
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(Ghana  Statistical  Service,  2004).  Women  who  used  contraception  in  the 
past but are not currently doing so are becoming an increasingly important 
component of contraceptive nonusers in Ghana and lack of continuity of use 
is a significant explanatory factor for the still only modest CPR (Parr, 2003). 
There  is  also  evidence  of  high  levels  of  unmet  need  for  contraception  in 
Ghana. Using data from the 2003 Ghana Demographic and Health Survey 
(GDHS) Khan et al. (2007) showed that 22% of currently married women 
who want to delay further childbearing for two years or more and 12% who 
want to stop further childbearing were not using a method of contraception 
at the time  of the  survey.  The  same  study also  provides  evidence  of  high 
discontinuation  rates  in  Ghana.    The  study  calculated  the  lifetime 
discontinuation rate for 18 sub Saharan African countries and found that the 
percentage  of  currently  married  women  who  had  used  a  method  of 
contraception in the past but were not using a method at the time of the 
2003 GDHS survey was 54%. This was the 9th highest discontinuation rate 
out of the 18 sub Saharan African countries included in the study (Khan et 
al., 2007).  
 
Another study, based on 1998 GDHS data, found that 43% of users of any 
contraceptive method have discontinued the method within 12 months (Parr, 
2003).  Clinical  evidence  shows  that  physical  side  effects  are  mainly 
associated with modern hormonal methods, particularly the pill, injectable, 
implant, and hormone releasing IUD (WHO & CCP, 2007). The classification 
of side effects in this study is slightly broader than physical side effects only 
and also allows for psycho social effects such as loss of sexual pleasure and 
marital disruption. However, these side effects are relatively rarely reported 
and as such this study will primarily focus on modern hormonal methods. 
Within this the focus will be mainly on pill and injectable use given the small 
number of users of other modern hormonal methods in Ghana.  
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4.1.2: Data and Methods 
 
This study has used both the calendar and panel portions of the CCFCS to 
identify  episodes  of  contraceptive  use  and  attach  relevant  covariates  for 
study. The CCFCS is a longitudinal household survey conducted in Southern 
Ghana  between  1998  and  2003.  The  survey  was  conducted  in  six  study 
communities, two in each of the Central, Western and Greater Accra regions 
of Southern Ghana. The target population for the survey was all women aged 
18 to 50 at the time of the round one interview along with the male partners 
of those women who are in formal unions. Respondents were followed from 
one round to the next and the majority of respondents were observed for 
between 56 and 60 months (Aglobitse & Casterline, 2005). A total of 1409 
women were interviewed at round one along with 908 male partners. 1032 of 
those respondents were interviewed over seven rounds of the survey. The 
sample for the analysis of contraceptive use is restricted to women currently 
in union which restricts the round one sample to roughly 900 individuals.  
 
This  study  does  not  use  the  individual  as  the  unit  of  analysis  but  rather 
episodes of contraceptive use are extracted from the calendar data and these 
form  the  basic  unit  of  analysis.    In  addition  discrete  time  event  history 
analysis is conducted which treats the person period, in this case women 
month  of method  use,  as  the basic  unit  of analysis.    Each  episode of  use 
which is captured in full within the study period is classified as ending in 
either  a  discontinuation  or  switch.  The  remaining  episodes  are  those  in 
which the method was still being used at the end of the study period and 
these  episodes  are  considered  to  be  right  censored.  Full  details  of  the 
structure of the data set constructed are given in section 4.3.2. The resulting 
data  set  is  analyzed  first  using  single  decrement  life  tables  to  study 
discontinuation  rates  and  duration  of  episodes,  and  secondly  using 
multilevel multiple logistic regression to determine the significant predictors 
of  discontinuation.  A  multilevel  model  is  used  to  control  for  correlation  
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between episodes caused by the fact that a woman can contribute more than 
one episode to the dataset. 
 
4.1.3: Aims of study 
 
The overall aim of this study is to examine the pattern, timing and frequency 
of contraceptive discontinuation and switching and how these relate to the 
concurrent  self reported  experience  of  side  effects.  Using  the  methods 
described above this study aims to explore the data in three key areas: 
1)  The experience of side effects 
Monthly information is collected on whether or not side effects were 
experienced in a given month and if so what those side effects were. 
The calendar allows for the concurrent reporting of up to 3 different 
side effects. This data is used to investigate the proportion of episodes 
of use in which side effects are experienced, and the type, duration 
and  intensity  of  those  side  effects  by  method.  Background 
characteristics  from  the  panel  interviews  are  also  explored  to 
determine if there are any differences between those who experience a 
side effect and those who do not.  
2)  The effect of side effects on episode length  
The average length of episode by method is calculated and the effect of 
experiencing side effects on the length of episodes determined. It is 
hypothesized  that  where  side  effects  are  experienced  the  average 
episode length will be shorter than where they are not. The effect of 
different types of side effect on episode length is also investigated.   
3)  The response to side effects and the predictors of discontinuation 
The conceptual framework of this study highlights three outcomes of 
an episode of contraceptive use, either the method is discontinued, the 
user switches to another method or the episode continues beyond the 
end of the study period. This study aims to establish if the experience 
of  side  effects  is  a  significant  predictor  of  discontinuation  or  
  87 
switching.  The  study  will  also  control  for  socio economic, 
motivational and experiential variables.  
 
4.1.4: Conceptual framework 
 
Figure 4.1 is a diagrammatic representation of the conceptual framework of 
contraceptive use dynamics and side effects on which this study is based. The 
figure shows the process of and episode of contraceptive use as it happens 
through time, which is divided into three stages. First, at time 1 an individual 
makes the decision to use a particular contraceptive method and an episode 
of use begins. This decision, including the choice of method, is influenced by 
a  number  of  factors  both  external  to  the  individual  such  as  supply 
environment, and individual characteristics such as the motivation to avoid 
pregnancy, stage of the life cycle and past experience with contraceptives. 
Once the episode has begun the user either does or does not experience any 
side  effects  of  their  method.  Time  2  represents  the  length  of  the  episode 
which, in the case of this study, can be anywhere from 2 to 60 months long. 
The line between time 2 and time 3 represents the decision of the user to 
either discontinue their method or to switch to a different method. Again 
numerous  factors  may  influence  this  decision  and  the  central  aim  of  this 
study  is  to  determine  if  the  experience  of  side  effects  is  a  significant 
determinate.  
 
Time  three  represents  the  ultimate  state  of  the  user  once  the  episode  of 
contraception  is  over,  in  the  case  of  this  study  this  may  mean  that  the 
episode did not finish within the study period and the episode has ended by 
being  right  censored.  For  those  individuals  who  switch  methods  they  are 
immediately returned to time 1 and the cycle begins again. For those who 
discontinue then at any time after time 3 they may either decide to begin a 
new  episode  of  use  and return  to  the beginning of  the  cycle  or  they  may 
remain a non user. Each individual may complete this cycle of periods of use 
and non use multiple times and may take similar or contrasting pathways  
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each time.  As mentioned in the introduction the unit of analysis in this study 
is the individual episode, so only one cycle at a time through this pathway is 
considered  in  this  study  and  periods  of  non use  between  cycles  are  not 
included. 
   
4.1.5 Structure of Study  
 
This chapter is presented in 5 sections; the introduction has established the 
background and aims of the study and considered the theoretical framework 
within  which  it  is  situated.  Section  2  gives  an  overview  of  some  of  the 
relevant  literature  and  highlights  the  key  issues  related  to  contraceptive 
discontinuation and side effects. Section 3 gives details about the data and 
methods, beginning with a description of the collection and design of the 
original data set. The process of creating the dataset used for this analysis is 
then described along with the methodology used and the limitations of the 
study. Results are presented in 3 sub sections, first descriptive results, then 
results of the life table analysis and finally results of the multilevel logistic 
regression.  The  chapter  is  concluded  by  discussion  and  conclusions, 
including policy implications.  
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Figure 4.1: Conceptual Framework of Contraceptive Use Dynamics  
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4.2: Previous Studies  
 
There are many studies on contraceptive dynamics which have identified side 
effects as an important reason for discontinuation. For example a study by 
Cleland and Ali (1995) looked at discontinuation in six developing countries 
with  relatively  high  CPR.  This  study  was  based  on  analysis  of  DHS 
contraceptive history calendar data and found that of all episodes of use one 
third had ended within the first 12 months and half within 24 months. The 
reasons  given  for  discontinuation  varied  by  method,  with  episodes  of 
hormonal contraceptive and IUD use most often ending due to side effects 
while traditional methods most often ended in method failure and accidental 
pregnancy. Overall “health concerns, including side effects, were the most 
common cause of discontinuation. For all methods combined about 10% of 
episodes were terminated within the first year for this reason and about 20% 
were ended within two years” (Ali & Cleland, 1995: 96).  
 
In another study that used DHS calendar data for cross country comparisons 
Blanc, Curtis and Croft (2002) studied calendar data from 15 countries and 
concluded that health concerns and side effects account for the majority of 
all  method  discontinuations  in  most  countries.  This  study  found  that 
discontinuations reportedly due to side effects were most prevalent among 
injections  users  where  discontinuations  before  12  months  of  use  for  this 
reason amount to greater than 50% of discontinuations in all but 2 of the 15 
countries. For pill users the numbers are more variable across countries with 
between 34% and 64% of discontinuations before 12 months being side effect 
related.  
 
Similar  results  were  found  in  a  study  which  also  looked  at  contraceptive 
dynamics in 6 countries using DHS calendar data5 (Blanc & Curtis, 1997). In 
                                                 
5 Cleland & Ali’s 1995 study included Ecuador, Egypt, Indonesia, Morocco, Thailand and 
Tunisia. Blanc and Curtis 1997 studied Bangladesh, Colombia, Egypt, Indonesia, Peru, and 
Zimbabwe. Therefore two countries (Egypt and Indonesia) were common to both studies.  
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this study discontinuing due to side effects or health concerns was classified, 
along with other reasons for discontinuation,6 as abandoning a method while 
still in need of contraception. The study found that overall almost half of 
users in Egypt, Indonesia and Zimbabwe had discontinued by 24 months and 
this  rose  to  approximately  two  thirds  in  Bangladesh,  Colombia  and  Peru. 
Much  of  this  discontinuation  reflected  failure,  switching  or  abandonment 
due to reduced need, however abandonment while still in need was found to 
be relatively common.  Method choice was found to be strongly associated 
with the risk of abandonment while still in need and this risk was shown to 
be significantly higher for users of modern methods compared to users of 
traditional methods.  
 
More  recently  Bradley  et  al.  (2009)  conducted  a  comprehensive  study  of 
eight countries in which two consecutive DHS have collected contraceptive 
calendar data7. This study was similar to that by Blanc and Curtis in the way 
in  which  it  specified  the  different  types  of  discontinuation,  with 
discontinuation  due  to  side  effects  being  classified  as  ‘in need 
discontinuation’. When examining the reasons for discontinuation this study 
found that the percentage of discontinuations due to side effects ranged from 
2% in Armenia to 37% in Egypt. This disparity is explained by the specific 
method  mix  in  each  country  with  Armenians  relying  predominantly  on 
withdrawal which, although it has a high failure rate, has very low incidence 
of reported side effects.  Using the two consecutive DHS the study was able 
to look at the reasons for discontinuation over time and found that in all 
countries  except  Kenya  discontinuations  due  to  side  effects  had  either 
decreased  or  remained  roughly  the  same.  In  Kenya  the  proportions  of 
discontinuations due to side effects in 1998 was 21% and this increased to 
29%  in  2003  (Bradley  et  al.,  2009:  29).  This  rise  has  lead  to  an  overall 
                                                 
6  Husband’s  disapproval,  health  concerns,  access/availability,  desire  for  a  more  effective 
method, inconvenience of use, a fatalistic attitude, cost, other unspecified reasons, and ‘don’t 
know’. 
7  Countries  studied  are  Kenya,  Zimbabwe,  Armenia,  Egypt,  Bangladesh,  Indonesia, 
Colombia and the Dominican Republic.  
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increase of the ‘in need’ discontinuation rate in Kenya from 17% to 26% of 
users of all methods. Looking at 12 month discontinuation rates by method 
the  study  found  that  over  15%  of  pill  users  (in  every  country  except 
Zimbabwe and Indonesia) discontinued due to side effects within one year. 
In Egypt, Bangladesh, Colombia, and the Dominican Republic between 23% 
and 37% of injectable users discontinue due to health concerns or side effects 
in the first 12 months. In Kenya injectable discontinuation due to side effects 
also increased between surveys from 12% to 20%. When controlling for other 
factors  in  a  multivariate  model  the  study  found  that  the  probability  of 
abandoning  pills  while  ‘in  need’  was  higher  than  for  any  other  reason  in 
Kenya, Egypt, and the Dominican Republic. The same was true of injectable 
use  in  Kenya,  Zimbabwe,  Egypt,  and  the  Dominican  Republic.  The  study 
concluded  that  abandonment  of  pill  or  injectable  while  in  need  is  more 
common than either failure or switching and the primary reason both types 
of user discontinue while in need is health concerns or side effects (Bradley 
et al., 2009).  
 
Along with the multiple country DHS based studies already discussed there 
are also many similar studies published which use DHS data to focus on the 
contraceptive  dynamics  of  a  single  country.  Blanc  and  Curtis  (1997:  2) 
provide a useful review of the 12 month discontinuation rates by reason for 
discontinuation found by 10 different studies each based on a single country 
DHS. As new DHS continue to be conducted so new studies are undertaken 
to take advantage of the up to date data (see for example Fathonah, 2000; 
Leite & Gupta, 2007 & Laguna et al., 2000; Sambisa, 1996 & Mitra & Al 
Sabir, 1996). These studies all identify side effects as a significant cause, to 
one degree or another, of method discontinuation and as an issue which is 
particularly pertinent to pill and injection users.  
 
All of the studies discussed so far use the calendar portion of the DHS as the 
basis  for  analysis  but  this  data  does  present  some  limitations.  The  DHS 
calendar  collects  monthly  information  on  contraceptive  use  or  non use,  
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pregnancy, and pregnancy outcomes retrospectively for five years prior to the 
date of survey. The calendar also records the respondents stated reason for 
discontinuation in any month in which they end a period of continuous use 
of  a  particular  method  of  contraception.  The  extended  calendar  which 
collected  reason  for  discontinuation  was  part  of  the  model  A  core 
questionnaire from phase II beginning in 1988 through phase IV ending in 
2003. The reasons for discontinuation recorded by the calendar are shown in 
Figure 4.2.  
 
Figure 4.2: Reasons for Discontinuation from DHS Contraceptive Calendar 
 
 
 
Source: (ORC Macro, 2001: 101)  
 
The  major  limitation  of  this  data  source  is  that  it  is  only  available  for 
countries  implementing  the  model  A  core  questionnaire  which  are 
considered high contraceptive prevalence countries. Therefore calendar data 
for countries in sub Saharan Africa is generally limited, and Ghana which is 
the  focus  of  this  study  has  not  collected  extended  contraceptive  calendar 
data. Additionally the calendar suffers problems of recall bias, due to the 
long recall period, and consequently can display serious heaping of data onto 
6 or 12 month intervals (Bradley et al., 2009; Blanc & Curtis, 1997). A study  
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of two overlapping DHS surveys in Morocco compared the reported current 
contraceptive use from one survey with the reported use in the same month 
gained from calendar data collected three years later (Strickler et al. 1997). 
The results show that there are some discrepancies in the reporting at the 
individual level but at the aggregate level generally the data was reasonably 
matched.  It  was  also  determined  that  individual  reporting  errors  were 
randomly distributed. Interestingly the study also found that the indicator 
that was least reliable was the reason for discontinuing.  This may reflect 
other author’s observations that a further limitation of the DHS calendar is 
that it only allows for the recording of one reason for discontinuation when 
in fact this is likely to be either a complex and multidimensional decision to 
stop using or a passive (non)decision not to obtain further supplies (Ali & 
Cleland, 1995).  
 
As mentioned GDHS has not collected contraceptive calendar data but it has 
been possible to calculate discontinuation rates by method using questions 
asked  to ever  users  about  their  last  episode  of  use.  Parr  (2003) used  the 
GDHS 1998 to determine episode duration and explore current reasons for 
non use  amongst  former  contraceptive  users.  The  study  determined  that 
median episode duration for all methods was 12.6 months, 12.2 months for 
episodes  of  pill  use  rising  to  19.6  months  for  injectable  episodes.  The  12 
month discontinuation rate was 43% overall or 47% for pill users and 29% 
for  injectable  users.  As  reason  for  discontinuation  of  episode  was  not 
collected in this survey the study looked at the reason for current non use 
among former users. Across former users of all methods 14.4% stated they 
were not currently using due to health related fears but this was significantly 
more at 20.7% and 26.2% for former pill and injectable users respectively. 
This is the largest percentage reporting any single reason for non use among 
former injectable users and the second largest for former pill users with the 
only the percentage citing a recent pregnancy as reason for non use being 
higher. It was also found that when comparing reasons for non use between 
former users and never users, former users were somewhat more likely to  
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state heath fears.  This result raises the possibility that former users have 
experienced difficulties with methods which have contributed to an increase 
in their concerns over side effects.  
 
Along with the life table type estimates of discontinuation rates and duration 
of use  many studies  have  also employed  multivariate  analysis  in  order to 
determine the socio economic or demography predictors of discontinuation. 
As is suggested by the results previously discussed type of method used is the 
most  significant  and  consistent  predictor  of  discontinuation,  with  women 
being more likely on average to abandon modern methods than traditional 
ones (Bradley et al., 2009: 29). When examining duration of use it seems 
that  highly  effective  hormonal  methods  are  used  for  no  longer  than 
traditional methods because the ‘high rates of method failure for the latter 
are offset by high rates of discontinuation of hormonal methods because of 
side effects and health concerns’ (Ali & Cleland, 1999: 351). Age is another 
characteristic  frequently  found  to  be  significantly  associated  with  the 
probability of discontinuation. In general younger women are found to be 
more likely to discontinue than older women, however the strength of this 
association  can  vary  according  to  method  (Bradley  et  al.,  2009;  Leite  & 
Gupta, 2007; Ali & Cleland, 1999).  
 
The  picture  is  less  clear  with  other  socio economic  characteristics  where 
there  are  not  always  clear  associations  and  results  often  vary  between 
studies.  Education  level  is  one  variable  which  has  been  found  by  some 
studies not to be a significant predictor of discontinuation or duration of use, 
despite  the  strength  of  the  relationship between education  and  the  initial 
adoption of methods.  Similarly residence in urban as opposed to rural areas 
is  a  strong  predictor  of  current  use  but  is  found  not  to  predict 
discontinuation in many studies (Ali & Cleland,1995; Leite & Gupta, 2007), 
while in others it is found that  urban women are more likely to discontinue 
than rural women (Porter, 1984). This is unexpected given that supply issues 
are assumed to be responsible for at least some discontinuation and supplies  
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issues are most sever in rural areas. Cotton et al. (1992: 147) summed up this 
subject by stating that their ambiguous results ‘might indicate that service 
providers  cannot  use  social  or  demographic  characteristics  to  predict 
whether clients are at higher risk for discontinuation’.   
 
Motivational  factors  and  fertility  intentions  have  been  shown  to  be 
associated  with  discontinuation.  Ali  and  Cleland  found  that  couples  who 
want  no  more  children  (i.e.  who  are  using  a  contraceptive  method  for 
limiting) are less likely to discontinue than those who have not reached their 
desired family size and are using a method to space their births. They suggest 
that with sufficient motivation to avoid pregnancy ‘the inclination to cease 
use  because  of  side effects  or  health  concerns’  can  be  overcome  (Ali  & 
Cleland, 1999: 360). Tolley et al (2005) find the same result and suggest that 
fertility  intentions  influence  tolerance  for  menstrual  side  effects.  An  area 
which warrants  further investigation  is  the  effect  of  prior  experience  of a 
method  on  the  likelihood  of  discontinuation  of  a  current  episode.  Ali  & 
Cleland  (1999)  hypothesize  that  prior  experience  may  lead  to  prolonged 
duration of current use given that some methods demand a certain degree of 
skill  from  the  user.  Their  findings  show  that  prior  use  is  a  predictor  of 
discontinuation for condoms and pills but less so for injectables and not at 
all for traditional methods, which could be considered the most demanding 
of the user.  This is an area to be explored in this study with the proposal that 
rather  than  skill  per  se,  what  prior  use  is  contributing  is  knowledge  of 
potential side effects and their likely effect on each particular individual. 
 
Another  area  of  particular  interest  in  this  study  is  discussion  and 
communication about family planning and its effects on episodes of use. It 
has been well established in many studies that communication about family 
planning  encourages  method adoption  (Bawah,  2002;  Hornik&  McAnany, 
2001; Westoff & Bankole, 1997). For example a study using longitudinal data 
in Northern Ghana found that women who have been encouraged by their 
peers are almost three times as likely to subsequently adopt a method as  
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those who have not been encouraged, and this rises to four times as likely 
when  the  encouragement  comes  from  a  health  worker  (Feyisetan,  et  al. 
2003).  The  findings  suggest  that  the  majority  of  communication  between 
spouses  or  friends  in  a  close  network  was  favourable  and  ‘unfavourable 
communication  may  travel  through  less  close  networks’  (Feyisetan,  et  al. 
2003:  24).  This  is  especially  interesting  given  that  in  a  study  of 
discontinuation Porter (1984) found that discontinuation was significantly 
influenced by unfavourable communication from trusted sources or sources 
with  expertise  (past  or  current  users).  Communication  of  any  type  from 
unidentified sources (i.e. rumours) was found not to be a significant factor in 
discontinuation.  This  suggests  that  unfavourable  communication  within 
close  networks  is  less  common  but  significantly  more  influential  than 
encouragement  or  discouragement  from  less  close  networks.  There  are 
currently  no  studies  investigating  the  effect  of  this  encouragement  or 
discouragement to continue a method in the face of the experience of side 
effects.   
 
The studies of contraceptive discontinuation discussed so far provide useful 
information  on  discontinuation  rates,  duration  of  episodes  and  stated 
reasons  for  discontinuation.  However  the  major  weakness  of  this  type  of 
study  is  that  although  a  woman  may  give  side  effects  as  her  reason  for 
discontinuation  the  data  does  not  reveal  any information  at  all  about  the 
actual  experience  of  side  effects  which  caused  her  to  discontinue. 
Additionally nothing is known about individuals who experience side effects 
but  continue  to  persist  with  the  method.  There  have  been  a  number  of 
smaller scale studies which employ calendar techniques to shed light on the 
actual experience of contraceptive users.  It is worth noting at this stage that 
there  is  an  extremely  extensive  body  of  clinical  trial  literature  relating  to 
contraceptive methods and their side effects which is not being discussed in 
this study. Clinical trial data may deal with the purely physical experience of 
side  effects  but  it  does  not  tell  us  anything  about  the  perception  of  the 
individual,  the  social  context  of  the  situation  or  the  behaviour  of  the  
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individual  in  relation  to  the  side  effect.      Additionally,  as  pointed  out  by 
Tolley et al. (2005), clinical trials only focus on one method at a time making 
it difficult to compare different experiences with different methods. For these 
reasons the clinical literature is not reviewed here.  
 
Two clinic based prospective studies of new users in The Gambia and Niger 
followed  clients  for  between  6  and  8  months  from  the  time  of  adoption. 
Methods  used  were  pill,  injection,  IUD  and  barrier  methods  and,  after 
adjustment for loss to follow up, between 67% and 68% of respondents were 
still using at the end of the study, including 10% who had switched methods. 
Side  effects  or  fear  of  side  effects  was  the  most  common  reason  for 
discontinuation in both countries, and was the only reason spontaneously 
mentioned by the respondents (Cotton et al, 1992).  Respondents were asked 
to report whether they had experienced any adverse health effects such as 
excessive  bleeding,  abdominal  pain,  nausea  or  headache  in  the  previous 
month. Overall most respondents had not experienced any adverse health 
effects. In Niger 50% of IUD users reported pelvic pain and 20% of injectable 
users experienced headaches, while in The Gambia 14% of IUD users and12% 
of pill users experienced abdominal pain. Additionally 15% of IUD users and 
8% of injectable users experienced dizziness (Cotton et al., 1992).   
 
One type of side effects which does not receive much attention in the clinical 
literature is menstrual disruption. This is considered to be a clinically benign 
side  effect  and  therefore  can  often  be  minimized  or  dismissed  by  health 
personal (Tolley et al., 2005). However the effect on the individual user can 
be  serious  and  studies  show  that  many  women  have  a  low  tolerance  for 
menstrual changes and this is a major reason for discontinuation (Datey et 
al., 1995).  The methods which are most likely to cause menstrual disruption 
are, hormonal methods, in particular injectables and implants which both 
cause  unpredictable  changes,  and  IUD  which  causes  on  average  slightly 
longer bleeding. Many women will experience a decrease in bleeding as a 
result of hormonal method use and medical findings suggest that overall less  
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bleeding  has  a  positive  effect  on women’s  health.  However  these  sorts  of 
findings  do  not  always  “resonate  with  users”  and  this  kind  of  menstrual 
disruption can still be a cause for discontinuation (Tolley et al., 2005: 21).  
 
One of the difficulties in dealing with this particular side effect is that the 
effects themselves, along with the level of tolerance for those effects, will vary 
from women to women (Tolley et al., 2005). In a study of IUD, implant and 
injectable  users  in  Egypt,  Tolley  et  al.  (2005)  found  that  72%  of  users 
reported noticing menstrual changes in the first two months of use but only 
26% were worried about it. However after 18 months follow up of new users 
40% of discontinuers were found to have cited heavy or long bleeding as the 
main  reason  for  discontinuation  and  bleeding  length  was  a  significant 
predictor  of  discontinuation  of  all  methods  in  a  multivariate  model.  The 
study came to the conclusion that it is women’s perception of their menstrual 
cycle  which  influences  tolerance  of  menstrual  changes  rather  than  actual 
changes in menstruation (Tolley et al., 2005). A study in India found similar 
results using 90 day menstrual diaries which showed that only 20 30% of 
implant users, 30 35% of injectable users and 37% of hormonal IUD users 
experienced what they considered to be normal menstruation (Datey et al., 
1995). These results suggest that while the reporting of side effects is shown 
by  some  studies  to  be  relatively  uncommon  the  occurrence  of  menstrual 
disruption  is  in  fact  very  frequent.  However,  each  individual  will  have  a 
varying  perception  and  tolerance  of  this  side  effect  and  many  may  not 
consider it to be worrying and hence not report it as a side effect.  
 
Besides  the  important  relationship  between  side  effects  and  method 
discontinuation for the overall CPR, the response to side effects can also be 
seen as an indicator of quality of a family planning program and its service 
provision  (Blanc  et  al.,  2002).  Ali  and  Cleland  point  out  that  “although 
willingness  to  persevere  with  a  method  does  not  necessarily  imply 
satisfaction, high discontinuation rates are usually a sign of discontent with 
the method or the service” (Ali & Cleland, 1995: 92).  Tolley et al. (2005)  
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found that as a main effect counselling, or lack of counselling, did not predict 
discontinuation,  which  they  felt  raised  questions  about  the  content  and 
quality of counselling on side effects.  As mentioned above some side effects, 
particularly  menstrual  changes,  are  unpredictable  and  vary  considerably 
from women to women. This uncertainty makes counselling on side effects a 
complicated task and more information on the potential for different side 
effects is not necessarily better. Tolley et al. (2005) found for instance that 
when being counselled regarding side effects users who were told they might 
not bleed became anxious when they did and vice versa. Cotton et al, (1992) 
also  raised  doubts  about  the  quality  of  counselling  and  concluded  that 
discontinuation  was  greatest  among  people  who  said  they  had  not  been 
adequately counselled on side effects and better staff training could increase 
client satisfaction. 
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4.3: Data and Research Methods 
 
This chapter begins by describing the CCFCS study including a brief overview 
of the sample design, study location and response rates. Then the chapter 
describes  the  creation  of  the  dataset  used  for  this  analysis  by  extracting 
information  from  the  calendar  data  file  and  merging  it  with  covariate 
information  extracted  from  the  panel  surveys.  The  issues  of  episode 
censoring,  and  data  quality  are  also addressed.  Each variable  used  in  the 
multivariate modelling and its’ derivation is then described and finally the 
statistical methods used in the analysis and the limitations of the study are 
explained.  
 
4.3.1: Cape Coast Social Learning, Social Influence and Fertility Control 
Survey 
 
This  paper  analyses  data  from  the  Cape  Coast  Social  Learning,  Social 
Influence and Fertility Control Survey (CCFCS). This is a longitudinal survey 
of  women  aged  18  to  50  at  the  time  of  the  first  interview  which  was 
conducted in six locations in Southern Ghana.  The study consisted of eight 
rounds of data collection between October 1998 and November 2003. A total 
of 1409 women were interviewed at round 1 along with 908 male partners. 
Questions regarding contraceptive use were only asked to women currently 
in union so that restricted the sample available for this study to roughly 900. 
Respondents were followed from one round to the next and the majority of 
respondents  were  observed  for  between  56  and  60  months  (Aglobitse  & 
Casterline, 2005). At each round of the panel interview, beginning at round 
2, women were asked to provide monthly calendar data going back from the 
current  month  of  interview  to  the  month  of  the  previous  interview.  The 
calendar collected monthly information on: 
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•  Marital status 
•  If husband is present in home 
•  Pregnancy status (and pregnancy outcome) 
•  Breastfeed status 
•  Abstinence status 
•  Contraceptive method (up to four methods simultaneously) 
•  Experience  of  side  effects  (up  to  four  different  side  effects 
simultaneously) 
•  Advice  given  from  a  health  worker  (up  to  four  answers 
simultaneously) 
The core questionnaire deployed at each round also contains information on 
social interaction specific to family planning and standard socio economic 
and demographic background variables.  
 
4.3.1.1: Study Communities 
 
The  CCFCS  was  conducted  in  six  study  communities,  two  in  each  of  the 
Central,  Western  and  Greater  Accra  regions  of  Southern  Ghana.  The  six 
communities are isolated from each other and were purposively selected to 
provide  maximum  heterogeneity  in  terms  of  ecological  setting,  economic 
activity,  ethnicity,  and  kinship  system  (Casterline,  2007).  Information  on 
some of these factors for each community is summarized in Table 4.1.  
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Table 4.1: Summary of Information on the Six Study Communities of the 
CCFCS 
Study 
areas 
Location  Region  Primary 
economic 
activity 
Primary 
ethnic/language 
group 
Primary 
religious 
affiliation 
1 
 
Coastal 
 
Western  Fishing 
 
Fante 
 
Pentecostal 
 
2 
 
Inland 
 
Western  Farming 
 
Fante 
 
Pentecostal 
 
3 
 
Inland  Greater 
Accra 
Trading 
 
Ga Adangbe 
 
Pentecostal 
 
4 
 
Inland  Greater 
Accra 
Farming 
 
Ga Adangbe 
 
Muslim 
5 
 
Coastal  Central  Farming, 
Fishing 
Fante 
 
Christian 
6 
 
Inland  Central  Farming  Denkyira/Twi 
 
Christian 
 
Table  4.1  conceals  further  variation  between  communities,  for  example 
communities  2  and  6  are  both  primarily  devoted  to  subsistence  farming 
whereas communities 4 and 5 engage in farming for cash crops. There is also 
considerable  variation  in  wealth  status  which,  using  mean  number  of 
household possessions as a proxy, varies from 2.7 in community 6 to 5.0 in 
community 3. Roughly the same percentage of households is electrified in 
each of the six communities, ranging from 71% to 88%. About half of the 
sample are Fante, which is as expected, since that is the dominant ethnic 
group  in  this  part  of  Ghana.  Also  represented  are  Denkyira,  Ga,  and 
Adangbe,  with  Ewe  and Ahanta  also  distinguishable.  The  primary  lineage 
type  follows  from  the  ethnic  composition,  with  the  four  communities 
dominated by Akan speaking groups (Fante and Denkyira) being matrilineal 
and the other two communities being patrilineal (Casterline, 2007). All of the 
communities are in rural locations with the exception of community 3 which 
can be considered peri urban.  
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4.3.1.2: Sample Design  
 
The  initial  sample  was  drawn  based  on  a  household  census  which 
enumerated every household and all eligible women within each household. 
The sample selection varied across communities based on population size 
and geographic dispersion. In the 4 smaller communities all eligible women 
were selected and in the two larger communities participants were selected 
by simple random sampling from the household census data.  
 
The panel survey sample was monitored via an Access data base that was 
developed at the Population Council in New York and maintained by project 
staff at the University of Cape Coast. This data base contains an entry for 
each person eligible for interview at any time during the multiple rounds of 
the panel survey, with further indication of his/her round by round status 
(successfully interviewed, etc.). Each respondent has a unique identification 
code that is maintained throughout the study. 
 
4.3.1.3: Response Rates and Attrition 
 
Response rates range from a low of 84% in community 3 in round one to 
highs of 99% in some areas for some rounds. The overall average response 
rate was 95%. At each round every effort was made to interview all eligible 
respondents  and  as  a  general  rule  three  attempts  were  made  to  locate, 
schedule and/or conduct an interview. This process was aided by the fact 
that most of the interviewers lived in the study communities. Overall sample 
retention was excellent with about 85 percent of women remaining in the 
sample from Round 1 to Round 8. This is particularly exceptional in the West 
African  setting  where  rates  of  residential  and  circular  mobility  are  high 
(Casterline, 2007).  
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In order to maintain the sample, persons who were eligible in the previous 
round but were  not interviewed were  involved in  a ‘re capture  interview’. 
Respondents  were  administered  a  questionnaire,  labelled  a  “hybrid” 
questionnaire,  that  blended  items  from  the  previous  and  current  rounds’ 
questionnaires.  In  round  2  an  additional  209  women  were  added  to  the 
sample who were either non response at round 1 or were women who had 
moved to the study community since round 1 and were deemed eligible for 
the study. These respondents were administered the full questionnaires for 
both rounds 1 and 2. No women were added to the sample after round 2. 
Women missed in two consecutive rounds were deemed too difficult to trace 
and were dropped. 
 
4.3.2:  Creation of Study Dataset 
 
The dataset used for this study was created out of the CCFCS by combining 
elements of both the calendar and panel portions of the data. The calendar 
portion of the data contains information on 1364 individuals and amounts to 
more than 78,000 woman months of observation. The dataset used for this 
analysis was created by extracting episodes of contraceptive use, which form 
the units of analysis for this study, from the calendar data. The calendar is a 
person month  file  containing  observations  for  every  individual  for  every 
month that they were observed.  
 
This study uses a discrete time event history approach to modelling partly 
due to the fact that the data was collected in the discrete time interval of 
months.  Use of month as the temporal unit has one major weakness, in that 
it is assumed a women can only experience one state per month, implying 
that only one event can be experienced per time period.  So for example if a 
couple  used  a  condom  and  then  began  taking  the  injection  in  the  same 
month  then  it  is  not  always  clear  which  code  has  been  inputted  in  the 
corresponding  month  of  the  calendar.  This  can  result  in  the  duration  of 
episode being biased in favour of particular methods (Steel et al, 1996). The  
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CCFCS tries to overcome this by recording pregnancy status, breastfeeding 
status and contraceptive use in different columns. In addition there are four 
columns  for  contraceptive  use  status  to  be  recorded  so  up  to  four 
simultaneous methods could be captured. This is a clear improvement on the 
DHS style calendar, which allows for only one record per month; however for 
the purposes of analysis this detailed data has to be collapsed back into one 
method per month. The obvious advantage of this is that rather than being 
based  on  the  discretion  of  the  field  worker  the  choice  regarding  which 
method is recorded as the primary method is entirely in the control of the 
researcher.  
 
The  basic  approach  is  to  follow  a  hierarchy  of  method  effectiveness  and 
where more than one method is recorded the method considered to have the 
greatest  efficacy  is  chosen.  Hamil  et  al.  (1990)  conducted  a  study  that 
concluded  that  this  approach  did  not  result  in  significant  bias  as  the 
combined  efficacy  of  multiple  methods  approximates  that  of  the  most 
effective one. A full explanation of this process is included in Appendix 4A. 
This  does  have  implications  for  the  results  of  this  study  in  terms  of  the 
prevalence of side effects, as the most effective methods are the hormonal 
methods which are also the most likely to have side effects. When the side 
effects were originally recorded in the calendar the side effect for each month 
was  not  linked  in  any  way  to  the  method  for  that  month  so  after  the 
collapsing  of  the  methods  data  the  side  effect  will  then  be  attributed  to 
whichever method was the most effective, even if it was actually caused by 
another less effective concurrent method. This will not affect estimates of the 
overall  incidence  of  side  effects;  however  it  may  affect  somewhat  the 
proportion of side effects which is attributed to each method. It is not felt 
that this is a serious problem given that the two most effective methods, pill 
and injectable, are also the most likely to cause side effects and are unlikely 
to be taken together.  
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An episode of contraceptive use is defined as the continuous use of the same 
method reported for a period of 2 consecutive months or more. Discrete time 
hazard models estimate the probability of an event during time t given that 
the event did not happen in a previous time period. Therefore if an adoption 
and  discontinuation  both  happened  in  month  1  it  would  not  have  been 
possible for any event to have occurred in the previous time interval. The 
first step in creating the dataset for analysis was to remove individuals who 
were either not married or non users in every month throughout the entire 
observation period. In addition months representing months of use of female 
sterilization8 were removed. Event history modelling estimates the time to 
event on the basis of the length of time ‘at risk’. Users of sterilization are not 
at risk of contraceptive discontinuation (although there may be a very small 
chance  of  a  contraceptive  failure)  therefore  they  are  excluded  from  the 
dataset. Finally each episode of use was identified and two new data files 
created.  One  file  is  in  episode  format  where  one  case  represents  each 
episode, in which case the time varying calendar information is simplified 
into one data point. The other file is in person period format with each case 
representing  one  woman month  of  use,  and  the  calendar  data  intact. 
Examples of each type of data structure are shown in Appendix 4B.  
 
4.3.2.1: Censoring  
 
Where  calendar  data  is  collected  retrospectively  each  episode  of  use 
identified in the data may not be captured in its entirety within the period of 
observation.  Figure  4.3  below  is  a  schematic  representation  of  the  four 
possible  scenarios  into  which  each  identified  episode  may  fall.  The  four 
scenarios are: 
 
 
                                                 
8 There were no recorded episodes of male sterilization in the calendar data.   
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A = an episode of use beginning at an unknown period before the start of the 
observation  period  and  ending  at  an  unknown  time  after  the  end  of  the 
observation period. This type of episode is excluded from the dataset due to 
the left censoring. 
B = an episode of use beginning at an unknown period before the start of the 
observation  period  and  ending  at  a  known  time  within  the  observation 
period.  This  type  of  episode  is  excluded  from  the  dataset  due  to  the  left 
censoring. 
C  =  an  episode  both  beginning  and  ending  at  known  times  within  the 
observation period. This type of episode is included in the dataset and the 
ending is classified as either a switch or a discontinuation. 
D = an episode beginning at a known time during the observation period but 
ending at an unknown time after the end of the observation period. This type 
of  episode  is  included  in  the  dataset.  The  episode  is  considered  to  have 
continued and is coded as ending in right censoring at the time the study 
period ended. 
 
Episodes which fall under scenarios A and B are considered left censored (or 
left truncated). These observations cannot be included in the dataset given 
that the duration of the episode is unknown due to the unknown start date. 
Additionally inclusion of episodes that started prior to the period covered by 
the data may introduce a selection bias against long episodes (Ali & Cleland, 
1999). The duration of episodes of type D, right censored episodes, is also 
unknown however these observations can be used. What is known is that the 
episode lasted at least a certain duration of time up until the point that the 
observation period ended. So whilst no event is observed this episode can 
still  be  included  in  the  denominator  and  contribute  information  to  the 
models.  
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Figure 4.3: Schematic Representation of Episode Censoring 
 
 
4.3.2.2:  Inclusion of Covariate Information 
 
One major limitation of the DHS calendar is that it suffers from a lack of 
covariate  information  given  that  the  calendar  is  collected  retrospectively 
from the date of interview. This means that a lot of the information in the 
interview itself cannot be related back to episodes in the calendar as those 
characteristics refer to a period earlier in time. The Cape Coast data solves 
this by collecting the calendar data retrospectively from the date of interview 
but  beginning  in  the  second  wave.  Therefore  each  episode  of  use  can  be 
matched to a panel which was collected prior to the onset of the episode. 
Covariate information was extracted from the panel data by matching the 
time at the start of each episode with the closest prior interview time. Some 
questions were only asked in the first interview so where this is the case the 
information  for  all  episodes  comes  from  the  round  1  panel.  Where 
individuals joined the panel at round 2 the round 2 hybrid file is used. Those 
women joining for the first time at round 2 answered both round 1 and round 
2  questionnaires  at  that  time  i.e.  answers  were  given  retrospectively  for  
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round 1. Where individuals do not appear in the round 1 or round 2 panels 
the  corresponding  hybrid  round  1  and  round  2  files  are  used.  Where  an 
individual  is  missing  in  rounds  3   7  for the  required  round  to  match  the 
episode then the panel data for the prior round to the missing one is used. 
Characteristics captured by the panel data will have been collected at a time 
point between 1 and a maximum of 16 months prior to the first month of the 
episode in question. Socio economic variables, such as age and education, 
were included along with factors directly affecting an individual’s motivation 
to avoid pregnancy and variables measuring past experience of contraceptive 
use.  
 
Some episodes were excluded from the data set on the basis of missing values 
for the covariate information. In total 20 episodes had missing data on key 
demographic or socio economic characteristics. These cases amount to only 
2.6% of all episodes and it was decided that the most appropriate action was 
to remove these cases from the dataset.   
 
It is worth noting here that the original intention was to include some of the 
husband’s  demographic  and  socio economic  data  as  covariates  in  the 
regression.  However  this  was  not  possible  due  to  the  high  proportion  of 
missing data for husband’s characteristics, in some instances reaching 50% 
of  data  missing.  It  would  have  been  possible  to  obtain  husbands 
characteristics from the separate husband’s dataset and match the cases back 
to  the  partner.  However  in  this  scenario  the  level  of  missing  data  in  the 
husbands  file  would  still  have  presented  a  problem.  It  was  decided  that, 
given  previous  studies  have  found  husbands  characteristics  not  to  be  a 
consistent  predictor  of  discontinuation  behaviour,  they  would  not  be 
included in this study (Ali & Cleland, 1995).  
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4.3.3: Data Quality 
 
One  persistent  problem  with  the  collection  of  retrospective  demographic 
data is the rounding of the timing of events by the respondents resulting in 
the  heaping  of  events  on  convenient  intervals  of  time.  One  of  the  major 
benefits  of  calendar  style  data  collection  is  that  when  compared  to  other 
methods  of  retrospective  data  it  has  been  shown  to  significantly  reduce 
heaping (Becker & Diop Sidibe, 2003). This is because respondents are able 
to place reproductive or contraceptive events in time, relative to other events. 
Problems  with  heaping  are  often  associated  with  the  length  of  the  recall 
period so given its short recall period the CCFCS should be superior to the 
DHS calendars in this regard. Figure 4.4 shows a plot of the percentage of all 
episodes lasting a given duration.  
 
Figure 4.4 shows peaks at 3 and 6 months but this is to be expected in this 
data given the high proportion of episodes which are of injectable use (28% 
of  all  episodes  are  of  injectable  use  and  the  most  commonly  available 
injectable,  brand  name  Depo  Provera,  is  a  3  monthly  dosage  formula). 
Therefore it is only possible for episodes of injectable use to discontinue at a 
duration  which  is  a  multiple  of  3.  Those  experiencing  problems  with 
injectables early in an episode are therefore likely to discontinue at 3 or 6 
months. Figure 4.4 does not show the peaks in the frequency of episodes of 
duration  at  12  or  24  months  which  might  be  expected  if  heaping  were  a 
problem.  
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Figure 4.4: Percent of Episodes by Episode Length in Months (including 
episodes of duration >36 months)  
 
 
4.3.4: Description of the Dataset 
 
The final dataset contains 8937 women months of method use representing 
732 episodes of use which are between 2 and 60 months duration. The data 
represents 476 individuals who each have between 1 and 6 episodes included 
in the dataset. Table 4.2 below shows the  number of individuals who are 
contributing multiple episodes to the data.   
 
Table 4.2: Number of Episodes Contributed by each Woman 
Number of Episodes  Frequency (of individuals)  Percent 
1  476  65 
2  181  24.7 
3  51  7.0 
4  17  2.3 
5  5  0.7 
6  2  0.3 
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Overall 62% (295) of individuals contribute a single episode to the dataset 
while the remainder 181 (38%) contribute multiple episodes. Although the 
longest episode in the data set is 60 months duration the number of events 
(discontinuations  or  switches)  occurring  after  36  months  is  very  small, 
leading any results for episodes of durations longer than 36 months to be 
unstable.  In  this  case  a  total  of  13  events  occur  after  36  months  which 
represents  2.73%  of  all  episodes  or  2.76%  of  all  events.  Therefore  any 
episodes in the data longer than 36 months are considered censored and are 
treated, along with all other censored cases, as episodes which did not end in 
a discontinuation or switch within the observation period. This is in line with 
similar studies which have also censored events after 36 months (Bradley et 
al 2009). Taking this into account table 4.3 shows the number of episodes 
which end in either a discontinuation or a switch to another method or are 
right censored. Close to 63% of episodes in the data have an observed event 
while the remaining episodes are censored. 
 
Table 4.3:  Outcome of Episodes  
 
Outcome  Frequency (of episodes)  Percent 
Discontinuation  365  49.8 
Switch  93  12.7 
Censored  274  37.5 
 
4.3.5: Study variables  
 
The following is a description of the variables used in this study and how 
they have been defined. A list of the variables and their coding is presented in 
Appendix 4C.  
 
Outcome Variable  
 
The outcome variable in this study is a binary variable which marks whether 
or  not  the  episode  of  use  has  ended  in  an  event  or  if  it  has  been  right 
censored.  A  discontinuation  (an  event)  is  coded  1  while  no  event  (or  a  
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censored  observation)  is  coded  0. In  the  episode based  file  this  takes  the 
form  of  either  an  event  or  non event  being  ascribed  to  each  completed 
episode, while in the person period file each month is coded according to 
whether an event has taken place that particular month. A discontinuation in 
this  case  can  be  either  a  stopping  of  use  altogether  or  switch  to  another 
method.  As  previously  described  events  taking  place  after  36  months 
duration are considered to be censored and coded as 0.  
 
Experience of side effects 
 
The main explanatory variable of interest in this study is the experience of 
side effects. This is collected in the contraceptive calendar and takes the form 
of monthly data which can be coded 0 14 to represent either no side effects 
or the different types of side effect as shown in table 4.4 below. 
 
Table 4.4: Coding of Monthly Side Effects Variable 
Side effect  Code 
None  0 
Dizziness  1 
Weight gain  2 
Weight loss  3 
Headaches  4 
Excessive bleeding  5 
Irregular cycle  6 
Painful period  7 
Stomach pains/cramps  8 
Irregular heart beat  9 
Marital problems  10 
Loss of pleasure  11 
Loss of sexual function  12 
Loss of strength or ill health  13 
Other  14 
 
Each month can have up to four different side effects coded simultaneously 
and  the  full  original  data  was  combined  and  used  for  the  purpose  of 
describing the experience of side effects. In the person period file descriptive 
analysis is done on the original calendar data which is month varying and 
coded 0 14. For the regression analysis this variable remains month varying  
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but is coded as a binary variable where 1 represents any type of side effects in 
that month and 0 means no side effect in that month.  In the episode based 
file used in the life table analysis two binary variables were created from the 
original calendar data: 
 
1)  Side effect experienced in any month of the episode   Yes/no 
2)  Side effect experienced in last month of episode   Yes/no 
 
The first variable gives a general measure of the extent of the experience of 
side  effects. As this study does  not have direct information on reason for 
discontinuation the second of these variables may be considered as a proxy 
for  discontinuation  due  to  side  effects.  Other  variables  were  also  created 
from the calendar data to act as proxies for other prominent possible reasons 
for discontinuation. Whether or not the husband was away in the last month 
of  episode  or  first  month  after  a  discontinuation  and  whether  or  not  the 
respondent was abstaining in the last month of episode or first month after a 
discontinuation may represent discontinuation due to a lack of exposure to 
the risk of pregnancy. If the respondent was pregnant within 9 months9 after 
a discontinuation may represent a discontinuation with the intent of getting 
pregnant or a method failure.  
 
Background explanatory variables 
 
A range of other explanatory variables ere included in the logistic regression 
modelling  representing  three  main  areas,  firstly  socio economic  and 
demographic characteristics of the women; secondly variables representing 
                                                 
9 It was not possible to find any studies estimating the time to pregnancy for a planned 
pregnancy following a contraceptive discontinuation in an Africa setting.  A study based on 
data  from  5  European  countries  found  that  on  average  just  over  70%  of  women  were 
pregnant within 6 months of being at risk (Juul et al, 1999). It was felt that setting the time 
limit in this case to 9 months was a suitable time period for pregnancy to occur for it to be 
linked back to the intent of the contraceptive discontinuation. This may underestimate the 
pregnancies of those women discontinuing episodes of injectable use who can take some 
months to regain their fertility after discontinuing.   
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contraceptive  use  past  and  present  and  communication  regarding  family 
planning  related  to  the  episode;  and  finally  variables  which  reflect  the 
motivation of the women to avoid a pregnancy. None of these variables is 
allowed to vary over time at the episode level; therefore the values of these 
variables may be different for the same women at different episodes but are 
constant within episodes. Each of the variables and how they were derived is 
outlined below. 
 
Socio economic and demographic variables:  
•  Age – respondent age in completed years at the first month of the 
episode.  Derived by  finding  the  age  in  completed years  at  round  1 
interview and adding the number of real time months passed between 
the  round  one  interview  and  the  first  month  of  the  episode  in 
question.  
•  Community – A categorical variable with a dummy representing each 
of the 6 study communities.  
•  Ethnicity – ethnicity of respondent measured at the round 1 interview. 
Recoded  into  three  categories,  Fante,  Ga     Adangbe  and  Denkyira/ 
Ahanta/ Ewe/Other. 
•  Education – a derived variable created from combining the answers to 
2 questions from round 1 interview – Have you ever attended school? 
and What is the highest grade of schooling you have ever completed?  
Respondents answering no to the initial question were coded as ‘none’ 
in  the  final  variable  and  the  original  29  categories  of  the  second 
variable were collapsed to create a further three categories or Primary, 
middle/junior and secondary/higher. 
•  Religion – Religion of respondent at round 1 interview, recoded from 
the original 9 categories to 5 categories to avoid small numbers in any 
single  category.  The  categories  included  are  Catholic,  Protestant, 
Moslem, Pentecostal, Other/none/traditional/syncretic.   
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•  Children ever born – A derived variable created from a combination of 
panel and calendar data. The number of live births captured in the 
calendar from the first month of observation until the first month of 
the episode of contraceptive use in question was added to the number 
of  children  ever  born  reported  by  the  respondent  at  the  round  1 
interview. This continuous variable with minimum value of zero and 
maximum value of 11 was then recoded into a categorical variable with 
categories, None, 1 or 2, 3 or 4, 5 or more10. 
 
Contraceptive Use and Communication:  
•  Method of use for the episode – for descriptive purposes the method 
used  is  coded  into  13  categories  (see  appendix  4C)  but  for  the 
purposes  of  life  table  estimations  and  modelling  a  four  category 
variable was used with categories being pill, injection, condom and 
other.  This  variable  was  also  used  to  select  cases  in  order  to  fit 
separate models for pill and injection users.   
•  Respondent has discussed Family Planning with husband – Yes/no. 
This variable is the answer to the question ‘since the last interview 
have you discussed family planning with your husband?’ This is an 
episode  based  variable  created  by  obtaining  data  from  the  closest 
panel interview prior to the first month of the episode. For data taken 
from  the  round  1  panel  the  question  answered  was  ‘have  you  ever 
discussed family planning with your husband?’ 
•  Encouragement given by a health worker in any one or more months 
of the episode   Yes/No. This variable is derived from the calendar 
data in which each month of an episode is coded according to advice 
received from a health worker that month. The variable is coded 1 if 
encouragement to continue was received in any month of the episode 
                                                 
10 This variable may be an underestimate of the actual number of children ever born due to 
the fact that multiple births are not identified in the calendar and will have been treated in 
the creation of this variable as if they were single births.  
  
  118 
and  0  if  either  no  advice  was  received  or  advice  other  than 
encouragement was received.  
•  Respondent has ever talked to anyone who encouraged/discouraged 
family planning   Yes/no. This is two variables representing whether 
or not the respondent has ever been either encouraged or discouraged 
by anyone (other than a health worker) to use family planning. The 
variable is derived from the panel data in the same way as discussing 
family planning with husband.  
•  Respondent  has  ever  used  pill/injection  (in  the  time  before  the 
observation  period)  current  pill/injection  episodes  only     Yes/no. 
These  two  variables  are  derived  from  a  combination  of  panel  and 
calendar data. For current episodes of pill use it is determined if the 
respondent used the pill prior to round 1 from the round 1 interview 
and  this  is  combined  with  data  from  the  calendar  showing  if  the 
respondent used the pill in another episode of use which for reasons 
of  censoring  was  not  included  in  the  dataset.  The  final  variable 
determines whether or not there has been any prior use of the pill 
before the current pill episode. The same procedure is followed for 
episodes of injection use. This specifics not only prior experience of 
contraception but prior experience of the same method as the method 
used in the episode in question.  
 
Motivation to Avoid Pregnancy: 
•  Respondents’  reproductive  intentions  –  reproductive  intentions  are 
measured from the closed panel data prior to the start of the episode 
and are based on intentions to have children with the current husband 
or partner at that time. Respondents are categorized as, want (more) 
children, want no (more) children, can’t get pregnant, undecided and 
don’t know.  Due to small numbers in the last of these three categories 
they were combined.   
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•  Ideal number of children – Questions about ideal number of children 
were only asked at round 1 so this variable was taken from the round 1 
panel  only.  Originally  a  continuous  variable  it  was  recoded  as  a 
categorical variable with categories, none 1 or 2, 3 or 4, 5 or more and 
non numerical response.11  
•  Ease  of  becoming  pregnant  –  As  a  measure  of  respondents  own 
perception of their fecundity they were asked at round 1 how easily 
they became pregnant if they wanted to. Categories are quickly, takes 
a  long  time,  can  no  longer  get  pregnant  and  don’t  know.  As  with 
previous variables the last two of these categories were combined due 
to small numbers.  
 
4.3.6: Methods 
 
Two different discrete time event history techniques are used to analyze the 
data for this study. The first is single decrement life tables which are used to 
provide descriptive statistics such as median episode length and to estimate 
the percentage of users discontinuing an episode within a given time, in this 
case 12 and 24 months. Logistic regression is used to determine the effect of 
side effects on the propensity to discontinue a method while controlling for 
covariate factors. A multi level model is used to control for the fact that each 
individual can contribute more than one episode to the dataset.  
 
As previously mentioned left censored observations cannot be included in 
the analysis but also excluding right censored observations would introduce 
bias and drastically reduce the sample size. In event history analysis, right 
censored  observations  are  included  on  the  basis  that  they  are  non 
informative (i.e. independent of censoring mechanism) (Steele, 2005).  In 
this instance, this assumption should hold for the majority of cases, but it is 
worth  noting  that  due  to  the  longitudinal  nature  of  the  data  collection 
                                                 
11 Non numerical responses include up to God, all eggs in body, don’t know, or other.   
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individuals  can  be  right  censored  by  other  causes  than  the  end  of  the 
observation  period.  There  could be  attrition bias  if  individuals  missing in 
follow up rounds were lost for reasons related to their contraceptive use.  
 
Single decrement life tables are used to analyze the duration of episodes by 
modelling the hazard rates of discontinuation. The hazard function h (t) is 
the probability of an event occurring during interval t, given that the event 
did not occur before time t, which can be defined as: H (t) = Pr (T = t | T ≥ t) 
where T is the event time. Also of interest is the survivor function S (t) which 
can be obtained from the hazard rate and is the probability that an event has 
not occurred before time t. S (t) = Pr (T ≥ t) (Yamaguchi, 1991). The data 
used for the life tables is the episode based file where tj = time to event for 
episode j and δj = a dummy variable indicating if the observation is censored, 
coded 1 if censored 0 otherwise. The life table analysis is broken down by 
method, concentrating on pill and injectable use, and by the experience of 
side effects as outlined previously.   
 
For  the  multivariate  modelling,  although  the  underlying  process  of 
discontinuation can theoretically occur at any time on a continuous scale, it 
is natural to use a discrete time approach, given that the data was collected in 
discrete time intervals.  The discrete time approach also solves the problem 
that in continuous time models it is assumed that only one event can occur at 
a time and there can be problems with ties in the data where multiple events 
occur in the same time period (Jenkins, 2004). The data used is the person 
period  format,  where  each  case  represents  one  month  of  use  within  an 
episode. The model used is a logistic discrete time hazards model where the 
log odds of an event versus no event in any given month are modelled as a 
function of duration of episode and covariates. The parameter estimates are 
the  log  odds  ratios  of  a  discontinuation  for  any  given  set  of  covariate 
characteristics and the exponential of the coefficients is the odds ratio, which 
is equal to one where X and Y are independent. The logit model is specified 
as:   
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Where the covariates Xit can be fixed or time varying and α(t) is the baseline 
logit hazard which is a  function of t. The shape of the baseline hazard can be 
checked by plotting the hazard estimated from the life table analysis against 
time  without  controlling  for  any  other  variables.  Figure  4.5  shows  the 
baseline  hazard  to  36  months  treating  both  switching  and  stopping  as 
discontinuation. Given the shape of the baseline hazard, a step function is 
used to specify α(t) in this analysis.  This is the most flexible form of α(t) and 
is achieved by treating t as a categorical variable and defining each category 
with a dummy variable. In this case dummies were created representing 0 6, 
7 12, 13 24 and more than 24 months episode duration. This results in a 
piecewise constant  hazards  model  where  the  hazard  is  assumed  constant 
within each of the categories of time and the baseline logit hazard takes the 
form: α (t) = α + α 2D2 + α 3D3 + α 4D4 where α is the overall intercept and D2 
4 are the duration dummies minus a baseline category.  
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Figure 4.5: Baseline Hazard of Discontinuation to 36 Months   
 
A model was fitted with only duration effects included to assess the fit of the 
piecewise constant  function  of  time  to  the  data  and  it  was  found  to be  a 
suitable specification. Non proportional effects of method, the experience of 
side  effects and receiving advice from a health worker on discontinuation 
rates  were  tested  by  including  interactions  between  these  explanatory 
variables and duration.  
 
A  main effects  model  was  selected  using  forward  selection  based  on  the 
principle of a nested hierarchy of models where the reduced model (L0) is a 
smaller and simpler model, which is compared to a full model (L1) that is 
more  complex.    The  statistical  significance  of  adding  a  parameter  to  the 
model was tested using the likelihood ratio test to determine the deviance in 
the L2 statistic between the full and reduced models by testing that the extra 
parameters in the full model equal 0. The formula for the likelihood ratio 
statistic is: 
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H0 is that there is no difference between models and L0 represents the model 
where H0 is true with df equal to the number of additional parameters in L1.   
 
Once the fixed effects are selected the model is further extended into a multi 
level  model  or  frailty  model.  Each  episode  of  use  in  this  data  set  is  a 
repeatable event  and  it  is  possible for  each  individual  to  contribute  more 
than  one  event,  as  explained  in  chapter  4.3.3.  Therefore  there  may  be 
unobservable individual specific factors which lead to correlation between 
the durations of episodes from the same individual. For example one would 
expect women who have difficultly with the use of a method to have shorter 
episodes and contribute multiple short episodes to the data whereas women 
with no  difficulties  may have  longer  continuous  episodes of  use  and  may 
contribute only one episode (Steele et al., 1996). Similarly individuals who 
are more sensitive to side effects (less tolerant) are more likely to report side 
effects and also more likely to discontinue, but this sensitivity is not usually 
observable. Failure to account for this unobserved heterogeneity will lead to 
biased  estimates  and  underestimated  standard  errors  resulting  in 
overestimation of the significance of variables (Snijders & Bosker, 1999). A 
two level model is used to allow for the hierarchical structure arising from 
having repeated episodes nested within individuals. Level one is represented 
by each case in the person period data and level two refers to each individual 
woman. The multi level model is a simple extension of model 4.1 including 
an extra term to represent variation at the woman level.  
 
j ijt ijt u x t h + + = β α ) ( ] [ logit         (4.3) 
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Where  uj  is  a  random  effect  for  individual  j  which  follows  a  normal 
distribution with mean 0 and variance
2
u σ . The random effect is interpreted 
as residual variance between individuals due to unobserved time invariant 
characteristics.  The  random  effects  model  is  fitted  following  the  same 
principles of selection as the fixed effects model by creating nested models. 
However,  for  a  multi level  logistic  model  estimated  using  the  quasi 
likelihood approximation the likelihood ratio test is unreliable (Snijders & 
Bosker,  1999).  The Wald  test  is  used  instead  to  test whether  the  random 
intercept parameters introduced to the model are significant. 
 
Results  are  interpreted  by  calculating  predicted  probabilities  of 
discontinuation in each time period for a given set of episode characteristics 
using the formula in 4.4.  
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The descriptive and main effects modelling were conducted in SPSS v. 16.0 
and the random effects were added using MLwiN V. 2.02.  
   
4.3.7: Limitations 
 
The  main  limitation  of  this  study  is  the  limited  representativeness  of  the 
CCFCS. A random probability sample (or complete census) was conducted 
within  each  of  the  six  study  communities  so  the  data  can  be  said  to  be 
representative of those six communities but extreme caution must be draw in 
making inferences to any wider population beyond this.   The socio economic 
context of Northern Ghana is sufficiently different to that represented by this 
data that the results cannot be said to be relevant to Ghana as a whole. The 
compensation for the limited generalizability of the data is its longitudinal  
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design  which  allowed  for  the  calendar  data  to  be  collected  with  minimal 
recall periods. Although this is a significant improvement on other surveys 
collecting data of this type it should be noted that there is still some detailed 
recall involved in this data collection and as such there is the potential for 
some  recall  bias.  This  is  especially  the  case  given  the  complexity  of  the 
calendar data collected which placed a high respondent burden for recalling 
multiple  simultaneous  events.  Another  possible  source  of  bias  associated 
with longitudinal surveys is attrition bias. However, given the generally high 
retention rate in the women’s survey it is not felt that this is a significant 
problem in this study. A final limitation related to the data is that the sample 
size  is  insufficient to allow for analysis to be conducted specialty on sub 
groups, for example according to method.  
 
A further limitation of this study relates to the chosen methodology in which 
left censored episodes are not able to be included in any analysis. This causes 
the  loss  of  a  significant  amount  of  data  and  potentially  leads  to  over 
estimates  of  discontinuation  rates  because  long  time  users  who  use 
consistently throughout the entire observation period are excluded due to 
left censoring. Finally a major limitation of the data in relation to this study 
is the lack of information on reason for discontinuation. The highly detailed 
and  comprehensive  calendar  makes  up  for  this  in  part,  by  allowing  the 
inference of the reason for discontinuation based on the behaviour observed 
at  the  time  the  episode  ended.  However  this  is  making  very  large 
assumptions  about  the  unknown  motivations  and  perceptions  of  the 
individuals involved at the time. 
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4.4: Results 
 
4.4.1: Descriptive statistics  
 
4.4.1.1: Respondent Characteristics  
 
Table 4.5 shows the percentage distribution within the factors of the study 
variables according to both episode and individual. As shown previously in 
chapter 4.3.3 51.4% of episodes end in a discontinuation and 13% in a switch 
to another method. For the purposes of this analysis switches are treated as 
discontinuations as they are the stopping of that particular method episode. 
Around 20% of respondents are from communities 2, 4 and 6 with slightly 
less  from  the  remaining  three  communities  and  the  proportion  of 
respondents  per  community  is  roughly  analogous  to  the  proportion  of 
episodes  of  use  contributed  by  each  community.      The  majority  of 
respondents are aged between 25 and 34, are of Fante ethnicity and have 
completed  middle  or  junior  secondary  school.  There  is  a  relatively  even 
distribution  of  respondents  among  religious  groups  with  slightly  more 
Pentecostals  and  less  Protestants.  Very  few  individuals  (8.2%)  have  no 
children at the start of their first episode, while over 30% have 5 or more.   
 
Injectables are the most commonly used method and account for 28% of all 
episodes, followed by the pill accounting for 23%. The next most commonly 
used modern method is condoms which contribute 13% of episodes. Given 
that traditional methods are not commonly associated with side effects, and 
the  small  number  of  episodes  associated  with  the  remaining  modern 
methods, these will be grouped together to form an ‘other’ category for the 
rest of the analysis.   
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Table 4.5: Background Characteristics of Sample: Episodes and Individuals 
Individuals*  Episodes  Variable  Category 
Frequency 
(%) n = 476 
Frequency 
(%) n = 732 
Event  Discontinuation     365 (51.4) 
  Switch     93 (13.0) 
  Censoring     274 (35.6) 
Socio economic/demographic 
1  73 (15.3)  116 (15.8) 
2  99 (20.8)  168 (23) 
3  66 (13.9)  100 (13.7) 
4  98 (20.6)  130 (17.8) 
5  48 (10.1)  62 (8.5) 
Community 
6  92 (19.3)  21.3 (21.3) 
16 24  146 (30.7)  216 (29.5) 
25 34  211 (44.3)  343 (46.9) 
Age 
35+  119 (25)  173 (23.6) 
Fante  198 (41.6)  296 (40.4) 
Ga   Adangbe  127 (26.7)  218 (29.8) 
Ethnicity 
Other/Denkyira/ Ahanta/ Ewe  151 (31.47)  218 (29.8) 
None  131 (27.5)  191 (26.1) 
Primary  128 (26.9)  212 (29) 
Middle/Junior  194 (40.8)  294 (40.2) 
Education 
Secondary/Higher  23 (4.8)  35 (4.8) 
Catholic  88 (18.5)  129 (17.6) 
Protestant  84 (17.6)  121 (16.5) 
Moslem  112 (23.5)  185 (25.3) 
Pentecostal  132 (27.7)  214 (29.2) 
Religion 
Other/none/traditional/Syncretic  60 (12.6)  83 (11.3) 
None  39 (8.2)  53 (7.2) 
1 2  147 (30.9)  235 (32.1) 
3 4  135 (28.4)  212 (29) 
Children  ever 
born 
5+  155 (32.5)  232 (31.7) 
Contraceptive Use and Communication 
Pill  106 (22.3)  167 (22.8) 
Injectable  121 (25.4)  205 (28) 
Foam/diaphragm/jelly  13 (2.7)  19 (2.6) 
Condom  70 (14.7)  95 (13) 
IUD  11 (2.3)  14 (1.9) 
Rhythm  99 (20.8)  141 (19.3) 
Withdrawal  19 (4.0)   35 (4.8) 
Herbs  32 (6.7)  48 (6.6) 
Norplant  4 (0.8)  7 (1) 
Method 
Other  1 (0.2)  1 (0.1) 
No  108 (22.7)  141 (19.3) 
Yes  349 (73.3)  567 (77.5) 
Respondent 
has  discussed 
Family 
Planning  with 
husband 
Don’t know  19 (4)  24 (3.3)  
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Table 4.5 continued: Background Characteristics of Sample: Episodes and 
Individuals 
Individuals*  Episodes  Variable  Category 
Frequency 
(%) n = 476 
Frequency 
(%)  n  = 
732 
No     433 (59.2)  Encouragement  given  by  a 
health  worker  in  any  one  or 
more months of the episode  
Yes     299 (40.8) 
No  147 (30.9)  209 (28.6)  Respondent has ever talked to 
anyone who encouraged family 
planning 
Yes  329 (69.1)  523 (71.4) 
No  329 (69.1)  502 (68.6)  Respondent has ever talked to 
anyone  who  discouraged 
family planning 
Yes  147 (30.9)  230 (31.4) 
No     86 (51.5)  Respondent has ever used pill 
(in  the  time  before  the 
observation  period)  current 
pill episodes only  
n = 167 
 
Yes     81 (48.5) 
No     125 (61)  Respondent  has  ever  used 
injection  (in  the  time  before 
the  observation  period) 
current injection episodes only 
n = 205 
Yes     80 (39) 
Motivation to Avoid Pregnancy 
Wants  a  (another) 
child 
266 (55.9)  408 (55.7) 
Wants  no  more 
(none) 
177 (37.2)  272 (37.2) 
Respondents  reproductive 
intentions 
 
Cannot  get 
pregnant/ 
Undecided/Don’t 
Know 
33 (6.9)  52 (7.1) 
None, 1 or 2  48 (10.1)  86 (11.7) 
3 or 4  278 (58.4)  437 (59.7) 
5+  110 (23.1)  148 (20.2) 
Ideal number of children 
Non numerical 
response/don’t 
know 
40 (8.4)  61 (8.3) 
Quickly  229 (48.1)  348 (47.5) 
Takes a long time  161 (33.8)  255 (34.8) 
Ease of becoming pregnant  
Can  no  longer 
become  pregnant/ 
Don’t Know 
86 (18.1)  129 (17.6) 
*Individual  data  calculated  using  the  first  episode  of  use  within  the  dataset  for  each 
individual 
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It  would  be  expected  that  most  individuals  would  have  discussed  family 
planning with their husbands given that all are current users of a method. 
The 23% of women who report they have not discussed with their husband 
may  be  engaged  in  the  secret  use  of  a  method  without  their  husband’s 
knowledge.  Encouragement  by  a  health  worker  at  some  point  during  the 
episode is reported in over 40% of episodes, 70% of all individuals report 
ever being encouraged by someone to use family planning while only 31% 
report being discouraged. In around half of the episodes of pill use the user 
reports having used the pill before but this is only true for 40% of injectable 
episodes. In terms of motivation to avoid pregnancy table 4.5 shows that the 
majority  of  respondents  want  another  child  and  feel  that  they  can  get 
pregnant quickly if they want to. The ideal number of children is 3 or 4 for 
almost 60% of respondents.  
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4.4.1.2: The Experience of Side Effects 
 
As previously described the monthly calendar data allowed each respondent 
to mention up to three different side effects simultaneously per month. In 
total  605  months  of  side  effects  were  experienced  during  the  total  8937 
months  of  use.  Of  these  605  months  there  were  59  months  where  two 
different side effects were reported in the same month (thus contributing 118 
months of side effects to the total) and 1 month where 3 different side effects 
were reported (thus contributing 3 months to the overall total). Table 4.6 
shows the number of months in which side effects were reported by type of 
side effect.  Table 4.6 shows that the most frequently experienced side effect 
is irregular cycle which accounts for almost 23% of all months of side effects 
experienced.  This  is  followed  by  headache,  cramp,  irregular  heartbeat, 
dizziness and other which all contribute more than 10%. 
 
Table 4.6:  Number of  Months  Side  Effects Experienced by  Type  of  Side 
Effect 
Type of side effect   Number  of  months 
reported  
%  of  reported  side 
effects  
Dizziness  61  10.1 
Weight gain  13  2.1 
Weight loss  8  1.3 
Headaches  89  14.7 
Excessive bleeding  21  3.5 
Irregular cycle  138  22.9 
Painful period  4  0.7 
Stomach pains/cramps  61  10.2 
Irregular heart beat  84  13.8 
Marital problems  5  0.8 
Loss of pleasure  24  4.0 
Loss  of  strength  or  ill 
health 
20  3.3 
Other  77  12.6 
Total  605  100 
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Table 4.7 shows the number of months of use of pill, injectable and condom 
use, with all other methods grouped into the ‘other’ category as previously. 
This  table  also  shows  the  number  of  months  in  which  a  side  effect  was 
experienced for each of the methods. Measured as a percentage of episodes 
injectable  use  accounts  for  around  25%  of  all  use  however  measured  as 
months  of  use  this  rises  to  37%  due  to  the  longer  episodes  of  use  of 
injectables. The percentage of months of ‘other’ method use is also high at 
36% and this reflects the long episodes of IUD and implant users who are in 
this category.  Of all the months of side effects experienced 55% are caused 
by injectables and 33% caused by pill use. However as a percentage of the 
total number of months of use for that method pill and injectable are roughly 
the  same  with  11.5%  and  10.1%  of  months  with  side  effects  reported 
respectively. As expected condoms and other methods have a considerably 
lower proportion of months of side effects reported.  
 
Table  4.7:  Months  of  Use  of  Method  and  months  of  Side  Effects 
Experienced by Method 
  Pill  Injection  Condom  Else 
  Number 
of 
months 
%  Number 
of 
months 
%  Number 
of 
months 
%  Number 
of 
months 
% 
Total 
months  of 
use  
1716  19.0  3324  37.0  729  8.0  3229  36.0 
Months 
with  no 
side effects  
1518  18.1  2989  35.6  705  8.4  3181  3.9 
Months 
with  side 
effects* 
198  32.6  335  55.4  24  4.0  48  8.0 
%  of 
months  of 
side  effects 
within 
method  
   11.5     10.1     3.3     1.5 
* Total is more than total months of use minus months with no side effects due to the effect 
of months where two or three side effects are reported simultaneously.   
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Table 4.8 shows the number of months reported for each method by specific 
type of side effect. Around one third of the reported months of side effects 
associated with injectable use were of irregular cycle. This is to be expected 
given the established clinical effects of this method; however there is still 
some uncertainty over the reporting of this type of side effect. It is possible 
that  where  individuals  are  expecting  this  effect  and/or  do  not  perceive 
menstrual disruption to be disturbed they will not report this as a side effect 
when  questioned.  Therefore  the  level  of  menstrual  disruption  may  be 
underestimated in surveys not specifically measuring menstrual changes.  
 
Table 4.8: Months of Side Effects Experienced by Method and Type of Side 
Effect 
Number of months reported    Type  of  side 
effect   Pill  Injection  Condom  Else 
Dizziness  11  41  0  9 
Weight gain  2  8  0  3 
Weight loss   3  0  5  0 
Headaches  45  43  0  1 
Excessive 
bleeding  6  15  0  0 
Irregular cycle  30  105  0  3 
Painful period  1  3  0  0 
Stomach 
pains/cramps  34  26  0  1 
Irregular  heart 
beat  24  51  0  9 
Marital problems  0  0  0  5 
Loss of pleasure  0  0  17  7 
Loss  of  strength 
or ill health   9  5  0  6 
Other  33  38  2  4 
Total  198  335  24  48 
 
Table  4.8  shows  that  irregular  heart  beat,  headaches  and  dizziness  each 
contribute between 12  15% of months of side effects for injectable users. For 
months  of  use  of  the  pill  the  most  commonly  reported  side  effect  is 
headaches which accounts for 23% of all months. This is followed by stomach 
cramps, irregular heart beat, irregular cycle and other which each contribute 
between 17% and 12% of months of reported side effects. As expected, side  
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effects are relatively infrequently reported for condom use and use of ‘other’ 
methods. Some 17 months of the side effect of loss of pleasure are reported 
for condom use which is as expected and the ‘other’ category also contains 
some reported loss of pleasure which can most likely be attributed to the use 
of withdrawal. The finding that weight loss is reported  as a side effect of 
condom use is anomalous and cannot be explained. It is possible that this 
simply reflects an error in data entry or coding, it is also possible that this 
has arisen due to the process of combining multiple simulations methods 
and selecting the most effective, outlined in section 4.3.2. This would mean 
that the side effect was actually caused by a less effective method that was 
being used simultaneously with the condom. In this case the second method 
was either IUD, foam/jelly/Diaphragm or a traditional method, so it is still 
improbable that these would cause the side effect of weight loss.  
 
4.4.1.3: Reasons for Discontinuation 
 
As previously mentioned almost 63% of episodes end in a discontinuation 
(counting  switches  as  discontinuations  as  previously  mentioned)  the 
remainder  being  right  censored.    The  reason  for  discontinuation  is  not 
collected by  the survey however it is possible  to  use  the  calendar  data to 
extract  some  information  which  can  be  used  to  infer  the  reason  for 
discontinuation. Table 4.9 shows these assumed reasons for discontinuation. 
Although  the  classifications  in  table  4.9  are  relying  on  some  large 
assumptions  it  is  potentially  informative  to  model  the  data  without  the 
episodes which can be said to be discontinued due to reasons other than side 
effects. Altogether, 318 episodes end either with desire to get pregnant (or 
pregnancy)  or  low  risk  of  exposure  to  pregnancy,  which  implies  that  29 
episodes end in both reasons which is of course somewhat of a contradiction.   
The bivariate and multivariate model results show the effect of the removal 
of these cases on the relationship between the experience of side effects and 
discontinuation.  
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Table 4.9: Assumed Reasons for Discontinuation of Episode*  
Assumed  reason 
for discontinuation  
Measure    Number  Percent  0f 
all 
episodes  
Side effects   Side  effects  in  last  month  of 
episode 
86  11.7 
Wants to get pregnant  Birth  within  9  months  of 
discontinuation* 
159   21.7 
Not  at  risk  of 
pregnancy  
Abstaining  in  month  before 
discontinuation  and/or 
Husband away in month before 
discontinuation 
188  25.7 
* It is possible for each episode to fall into more than one of these categories 
‡ Includes pregnancy in the first month after use which would be considered a contraceptive 
failure  
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4.4.2: Life Table Analysis  
 
4.4.2.1: Duration of Episodes and Discontinuation Rates by Method 
 
Table  4.10  presents  results  from  life  tables  calculated  separately  for  each 
method, methods grouped into modern and traditional, and method grouped 
into four categories. In each case the table shows the proportion of episodes 
which are continuing at 12 and 24 months and the median survival time in 
months.  The results show that as would be expected IUD and Norplant have 
the longest average episode length, although these figures may be unreliable 
due to the small number of cases. Focusing on the pill and injection, which 
are the hormonal methods most commonly associated with side effects, the 
survival time for injection users is more than double that for pill users. Three 
quarters of pill users have discontinued by 24 months compared to just over 
half of injection users. Episodes of condom use are generally shorter than 
any other method with a median duration of 7.67 months and less than 10% 
of episodes continue beyond 24 months.  
 
Table  4.10:  Median  Episode  Duration  and  Proportion  of  Episodes 
Continuing at 12 and 24 Months by Method 
Variable  Category  Median 
episode 
duration 
Proportion 
of  episodes 
continuing 
at 12 
Proportion 
of  episodes 
continuing 
at 24 
Pill  8.67  0.37  0.23 
Injection  21.16  0.68  0.42 
Foam/jelly/diaphragm*  4.77  0.28  0.07 
Condom  7.67  0.28  0.09 
IUD*  36.00  0.77  0.66 
Norplant*  33.94  1.00  0.80 
Traditional methods  9.86  0.41  0.24 
Else12  10.50  0.43  0.26 
Method 
All modern methods  12.54  0.50  0.30 
*  Figures  should  be  interpreted  with  caution  due  to  the  small  number  of  users  of  these 
methods 
 
                                                 
12 Else = combination of Foam/jelly/diaphragm, IUD, Norplant and Traditional methods 
catagories.   
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Figure  4.6  is  a  plot  of  the  cumulative  survival  probability  of  an  episode 
lasting  to  36  months  by  method.  The  plot  shows  that  the  probability  of 
continuation of pill, condom and other users drops quite sharply in the first 
12 months and then begins to level off. Episodes of injectable use do not see 
such sharp declines and level off at a higher rate of continuation than the 
other methods.  
 
Figure 4.6: Plot of Cumulative Survival Function by Method 
 
 
4.4.2.2: Duration of Episodes and Discontinuation Rates According 
to Side Effects Experienced 
 
Table 4.11 shows the proportion of episodes which are continuing at 12 and 
24 months and the median survival time in months according to whether or 
not  a  side  effect  was  experienced  during  the  episode.    Both  variables 
representing side effect, in any month of the episode and in the last month of 
the episode are used. The results show that in both cases the experience of 
side effects increases the median duration of the episode. In addition, the  
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proportion surviving to 12 and 24 months is greater for those experiencing 
side effects in any month. This is not surprising given that the longer the 
duration of the episode the more chance there is of a side effects occurring 
and being reported, although generally side effects occur more frequently in 
the beginning of an episode.  
 
Table  4.11:  Median  Episode  Duration  and  Proportion  of  Episodes 
Continuing at 12 and 24 Months by Experience of Side Effects  
Variable  Category  Median 
episode 
duration 
Proportion 
of  episodes 
continuing at 
12 
Proportion 
of  episodes 
continuing at 
24 
No  10.85  0.45  0.27  Side  effect 
experienced  in 
any month 
Yes  14.08  0.54  0.31 
No  11.44  0.47  0.32  Side  effect 
experienced  in 
last  month  of 
episode 
Yes  11.29  0.47  0.16 
 
In  order  to  further  investigate  this  issue  life  tables  were  constructed 
separately by pill and injection use for episodes with and without side effects. 
The results are shown in table 4.12.  These results show that the relationship 
between side effects and median episode duration is different for episodes of 
pill  or  injectable  use.  For pill use the  median  episode  duration  is  slightly 
longer when side effects are experienced but for injectable it is the opposite 
with  episodes  being  noticeably  longer  if  side  effects  are  not  experienced. 
Where side effects are experienced in the final month of an episode only 20% 
of episodes survive beyond 24 months compared to 50% when side effects 
are not experienced. It appears from these results that the experience of side 
effects  does  shorten  the  duration  of  the  episode  on  average  but  only  for 
episodes of injectable use.  
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Table  4.12:  Median  Episode  Duration  and  Proportion  of  Episodes 
Continuing at 12 and 24 Months by Experience of Side Effects in Episodes of 
Pill or Injection use 
Variable  Category  Median 
episode 
duration 
Proportion 
of  episodes 
continuing at 
12 
Proportion 
of  episodes 
continuing at 
24 
Pill 
No  7.88  0.33  0.21  Side  effect 
experienced  in 
any month 
Yes  10.63  0.46  0.32 
No  8.37  0.37  0.26  Side  effect 
experienced  in 
last  month  of 
episode 
Yes  9.53  0.38  0.16 
Injection 
No  23.58  0.69  0.49  Side  effect 
experienced  in 
any month 
Yes  17.64  0.66  0.33 
No  26.12  0.68  0.50  Side  effect 
experienced  in 
last  month  of 
episode 
Yes  15.78  0.67  0.20 
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Figure  4.7  shows  the  cumulative  survival  function  according  to  the 
experience of side effects in the last month of the episode plotted up to 36 
months  for  pill  episodes  only.  The  plot  shows  that  pill  episodes  have 
approximately the same probability of survival (or continuation), which is 
falling sharply over time, until around 12 months. At this time the probability 
of continuation continues to decrease at a faster rate when side effects are 
experienced in the last month than when they are not.    
 
Figure 4.7: Plot of Cumulative Survival Function by Experience of Side 
Effect in Last Month for Episodes of Pill Use 
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Figure 4.8 shows the equivalent plot for episodes of injectable use only and 
shows  a  similar  overall  trend  to  figure  4.7.  However,  for  episodes  of 
injectable use the probability of survival falls much less rapidly over time, 
especially for those episodes not experiencing side effects. The result is that 
the probability of continuation between the two groups is more divergent for 
injectable episodes than for pill episodes.  
 
Figure 4.8: Plot of Cumulative Survival Function by Experience of Side 
Effect in last month for Episodes of Injection Use 
 
4.4.2.3:  Duration  of  Episodes  and  Discontinuation  Rates  by 
Background Variables 
 
Table 4.13 shows life table results for all background variables to determine 
the  effect  if  any,  of  the  Socio economic  and  motivational  characteristics 
attached  to  each  episode  on  the  duration  of  the  episode.    Episodes  last 
longest and have the highest probability of survival to 12 and 24 months in 
community 4, among those in the Other/Denkyira/ Ahanta/ Ewe ethnicity 
category and Catholics. The median duration of episodes rises with age and 
with number of children ever born. Median episode duration also rises with  
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education level, although those with no education do not fit this pattern with 
longer median episode duration and a higher probability of surviving to 12 
months than those with middle/junior education. Episodes are on average 
longer when the respondent has received advice from a health worker, talked 
about family planning with their husband or been encouraged to use family 
planning  by  someone  else.  However  being  discouraged  from  using  family 
planning, and reproductive intentions seem to have almost no effect. There is 
no clear pattern to be seen in the ideal number of children and the ease of 
getting pregnant categories.   
 
Table  4.13:  Median  Episode  Duration  and  Proportion  of  Episodes 
Continuing at 12 and 24 Months by Background Explanatory Variables 
Variable  Category  Median 
episode 
duration 
Proportion of 
episodes 
continuing  at 
12 months 
Proportion of 
episodes 
continuing  at 
24 months 
1  8.50  0.36  0.25 
2  12.68  0.50  0.24 
3  9.40  0.41  0.23 
4  20.64  0.58  0.46 
5  12.26  0.47  0.30 
Community 
6  10.91  0.45  0.22 
16 24  7.85  0.37  0.18 
25 34  13.21  0.51  0.31 
Age  
35+  13.69  0.52  0.35 
Fante  9.54  0.41  0.26 
Ga   Adangbe  11.61  0.47  0.20 
Ethnicity 
Other/Denkyira/  
Ahanta/ Ewe 
15.52  0.54  0.37 
None  13.19  0.51  0.27 
Primary  8.56  0.36  0.25 
Middle/Junior  13.15  0.50  0.31 
Education 
Secondary/Higher  16.61  0.56  0.29 
Catholic  15.94  0.53  0.36 
Protestant  13.02  0.50  0.25 
Moslem  11.84  0.47  0.26 
Pentecostal  10.49  0.44  0.27 
Religion 
Other/none 
/traditional/Sync. 
7.89  0.40  0.29 
None  5.16  0.21  0.18 
1 2  9.77  0.44  0.20 
3 4  13.03  0.50  0.30 
Children 
ever born 
5+  13.68  0.52  0.37 
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Table  4.13  continued:  Median  Episode  Duration  and  Proportion  of 
Episodes  Continuing  at  12  and  24  Months  by  Background  Explanatory 
Variables 
Variable  Category  Median 
episode 
duration 
Proportion 
of  episodes 
continuing 
at  12 
months 
Proportion 
of  episodes 
continuing 
at  24 
months 
No  10.55  0.41  0.26  Respondent  has 
discussed  Family 
Planning  with 
husband 
Yes  12.17  0.49  0.29 
No  10.26  0.43  0.24  Encouragement 
given by a health 
worker  in  any 
one  or  more 
months  of  the 
episode  
Yes  13.90  0.52  0.34 
No  9.52  0.44  0.23  Respondent  has 
ever  talked  to 
anyone  who 
encouraged 
family planning 
Yes  12.13  0.48  0.30 
No  11.41  0.47  0.28  Respondent  has 
ever  talked  to 
anyone  who 
discouraged 
family planning 
Yes  11.36  0.47  0.27 
Wants a (another) 
child 
11.26  0.46  0.26 
Wants  no  more 
(none) 
11.90  0.48  0.31 
Respondents 
reproductive 
intentions 
 
Cannot  get 
pregnant/ 
Undecided/Don’t 
Know 
8.53  0.47  0.31 
None, 1 or 2  9.45  0.42  0.21 
3 or 4  10.80  0.46  0.26 
5+  13.44  0.51  0.35 
Ideal  number  of 
children 
Non numerical 
response/don’t 
know 
13.01  0.50  0.34 
Quickly  12.82  0.50  0.29 
Takes a long time  10.84  0.46  0.31 
Ease of becoming 
pregnant  
Can  no  longer 
become 
pregnant/  Don’t 
Know 
7.88  0.38  0.20 
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4.4.2.4:  Duration  of  Episodes  and  Discontinuation  Rates  with 
Reason for Discontinuation Assumed 
 
As  discussed  in  section  4.4.1.3  a  number  of  possible  reasons  for 
discontinuation can be assumed from the calendar data.  The previous life 
table analysis has been rerun to see the effect of removal from the dataset of 
episodes  of  use  which  can  be  assumed  to  have  ended  due  to  wanting  a 
pregnancy (or becoming pregnant) and being at low risk of pregnancy due to 
lack of exposure. Table 4.14 presents the results and shows that with respect 
to method type the pattern stays the same while the median method length 
increases in all cases.  This makes substantive sense given that those who 
discontinued  within  36  months  to  get  pregnant  could  reasonably  be 
considered spacers which would mean that after these episodes are removed, 
the balance of the remaining episodes will be towards limiters who would 
naturally  have  longer  episode  durations.  The  proportions  of  episodes 
surviving to 12 and 24 months also increase with 57% of injectable episodes 
and  34%  of  pill  episodes  continuing  beyond  24  months.  Median  episode 
length also goes up overall for the life tables results split by the experience of 
side  effects  and  the  unexpected  result  seen  previously  is  no  longer  in 
evidence. For episodes where side effects are experienced in any month of 
the  episode  the  median  duration  is  20  months  and  for  side  effects 
experienced in the last month of the episode it is 14 months. In both cases 
this  is  considerably  shorter  that  the  approximately  24  month  median 
duration when no side effects are experienced.  When this is further broken 
down by method it can be seen that this pattern persists with pill episodes 
being  in  general  shorter  than  injectable  episodes  and  episodes  with  side 
effects in general shorter than those without.  
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Table  4.14:  Median  Episode  Duration  and  Proportion  of  Episodes 
Continuing at 12 and 24 Months by Method and Experience of Side Effects 
with Reason for Discontinuation Assumed 
Variable  Category  Median 
episode 
duration 
Proportion  of 
episodes 
continuing  at 
12 months 
Proportion  of 
episodes 
continuing  at 
24 months 
Pill  13.61  0.51  0.34 
Injectable  35.50  0.76  0.57 
Condom  10.97  0.45  0.26 
Method 
Else  14.82  0.55  0.43 
No  23.17  0.60  0.47  Side  effect 
experienced  in 
any month 
Yes  19.99  0.64  0.39 
No  24.60  0.61  0.50  Side  effect 
experienced  in 
last  month  of 
episode 
Yes  14.05  0.57  0.16 
Pill 
No  11.46  0.49  0.36  Side  effect 
experienced  in 
any month 
Yes  17.36  0.57  0.33 
No  14.48  0.53  0.42  Side  effect 
experienced  in 
last  month  of 
episode 
Yes  11.03  0.44  0.10 
Injection 
No  36.00  0.78  0.67  Side  effect 
experienced  in 
any month 
Yes  22.51  0.72  0.41 
No  36.00  0.76  0.67  Side  effect 
experienced  in 
last  month  of 
episode 
Yes  18.21  0.74  0.23 
 
Table 4.14 shows that for episodes of injectable use without side effects the 
median episode length is 36 months meaning that less than half of episodes 
have  discontinued  by  this  time.  Removing  the  episodes  which  were 
discontinued  due  to  other  assumed  reasons  intensifies  the  impact  of  side 
effects on median episode length and probability of discontinuing. Figures 
4.9 and 4.10 illustrate this by showing the increased divergence, compared to 
figures 4.7 and 4.8, in the cumulative survival curves between those with and 
without side effects in the last month of the episode for pill and injectable 
episodes respectively. This means that the effect of experiencing side effects 
on the probability of discontinuing is greater among those who do not have  
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another overriding reason to discontinue, such as wanting to get pregnant. 
This  result  suggests  that  the  assumptions  made  concerning  reason  for 
discontinuation are valid.  
 
Figure 4.9: Plot of Cumulative Survival Function by Experience of Side 
Effects for Episodes of Pill Use with Reason for Discontinuation Assumed 
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Figure 4.10: Plot of Cumulative Survival Function by Experience of Side 
Effects for Episodes of Injection Use with Reason for Discontinuation 
Assumed 
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4.4.3: Multiple Multilevel Logistic Regression Results  
 
The life table results presented in the previous chapter show that there is an 
association between the experience of side effects and median duration of 
episodes,  and  that  this  relationship  may  differ  according  to  method.  To 
further explore this relationship and to quantify the predictive power of the 
experience of side effect on episode discontinuation a logistic discrete time 
hazards  model  was  fitted.  The  first  stage  in  the  model  selection  was  to 
examine the relationship between the probability of discontinuation in any 
given month and the experience of side effects. Duration of episode is also 
included in the model to allow the baseline hazard to vary with time. The 
results  of  this  model  are  presented  in  table  4.15  below.  The  side  effects 
variable used is the original calendar variable recoded so that it equals 1 if a 
side effect did occur in a given month and 0 if not, as such the experience of 
side effects is allowed to vary across the episode.   
 
Table  4.15:  Results  of  Logistic  Discrete time  Hazards  Model  with  Side 
Effects as Sole Explanatory Variable 
Variable  Category  β  SE(β)  Sig.   Exp(β) 
0 6  0      1.00 
7 12   .279    .118  .018  .757 
13 24   .588    .127  .000  .556 
Duration 
24+   1.467    .222  .000  .231 
No  0      1.00  Side effect experienced 
Yes  1.095  .137  .000  2.990 
Constant     2.674    .073  .000  .069 
Cox & Snell R Square = .072           
 
Table 4.15 shows that as expected the odds of a discontinuation in any given 
month decrease significantly as the duration of the episode increases. The 
results also show that side effects are a significant predictor and the odds of a 
discontinuation is almost three times higher if a side effect is experienced 
than if it isn’t. The next stage of the model selection is to control for other 
covariates  and  determine  which  are  to  be  included  as  main  effects.  The 
model  selection  was  carried  out  using  forward  selection  based  on  the  
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likelihood ratio test as described in the methods section. The model at this 
stage  contains  main  effects  for,  duration,  side  effects,  method,  being 
encouraged  by  a  health  worker  and  number  of  children  ever  born.  The 
remaining  covariates  were  not  significant  at  the  5%  level  and  were  not 
included. The coefficients for the main effects model are shown in table 4.16.  
 
Table 4.16: Results of Logistic Discrete time Hazards Model Main Effects  
Variable  Category  β  SE(β)  Sig.   Exp(β) 
0 6  0      1.00 
7 12   .153    .120  .202  .859 
13 24   .320    .130  .014  .726 
Episode Duration 
24+   1.014    .227  .000  .363 
Pill  0      1.00 
Injection   .623  .145  .000  .536 
Condom  .282  .170  .097  1.326 
Method 
Other   .083  .132  .529  .920 
None  0      1.00 
1 or 2   .165    .204  .421  .848 
3 or 4   .542    .208  .009  .581 
Children ever born 
5+   .608    .211  .004  .545 
No  0      1.00  Side effect experienced  
Yes  1.250  .146  .000  3.490 
No  0      1.00  Encouragement  given  by  a 
health worker in any one or 
more months of the episode 
Yes   .853    .114  .000  .426 
Constant     1.913    .216  .000  .148 
Cox & Snell R Square = .030           
 
Table 4.16 shows that once the other variables are in the model the effect of 
duration on the odds of discontinuing is significantly attenuated and there is 
no longer a significant difference between episodes of 7 12 months duration 
and the baseline of 0 6 months. There is a significant difference between pill 
and  injectable  episodes  with  injectable  users  having  lower  odds  of 
discontinuing than pill users which is in line with the life table findings. The 
odds of discontinuation decrease as number of children ever born increases, 
however the difference between 1 or 2 children and none is not significant.  
Those episodes in which encouragement was received from a health worker 
during the episode are almost 6 times less likely to end in a discontinuation  
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than  where  no  encouragement  was  given.  Finally  the  odds  ratio  of 
discontinuation with side effects compared to without side effects remains 
significant and is slightly increased.  
 
The final stage in the fixed effects model is to include interaction terms to 
allow  for  differing  relationships  between  the  explanatory  and  outcome 
variables over time.  Two interactions proved to be significant, duration of 
episode and side effects and duration of episode and encouragement from a 
health worker. A third interaction between duration of episode and number 
of children ever born also significantly improved the overall fit of the model 
however none of the individual parameters was significantly different from 
the  baseline  category.  As  the  interpretation  of  this  interaction  is  not 
intuitively  strong  and  in  the  interest  of  parsimony  this  interaction  is  not 
included. The final fixed effects model results are shown in table 4.17. The 
only major change in the model after the inclusion of the interaction terms is 
that the main effect for the experience of side effects is no longer significant. 
This coefficient does not retain any interpretation as a main effect so this 
variable will be interpreted through calculating predicted probabilities which 
include  the  interaction  terms.  The  final  step  in  the  model  selection  is  to 
include a random intercept term to the model to control for any unobserved 
correlation caused by the multiple episodes per women in the dataset.  
 
Table 4.18 shows the model coefficients after the intercept has been allowed 
to vary randomly across women level. Although some of the coefficients vary 
slightly in magnitude there are no significant differences in the model after 
the random effect has been added. The random parameter itself is significant 
at the 5% level according to the rough Wald test value which is 2.33. This 
means that there is significant unexplained variation in the outcome at the 
individual level.  
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Table 4.17: Results of Logistic Discrete time Hazards Model Main Effects 
and Interactions 
Variable  Category  β  SE(β)  Sig.   Exp(β) 
0 6  0      1.00 
7 12   .433    .149  .004  .648 
13 24   .584    .168  .001  .558 
Episode duration 
24+   1.859    .392  .000  .156 
Pill  0      1.00 
Injection   .610  .146  .000  .543 
Condom  .284  .171  .096  1.328 
Method 
Other   .042  .133  .749  .958 
None  0      1.00 
1 or 2   .154    .205  .454  .858 
3 or 4   .501    .208  .016  .606 
Children ever born 
5+   .586    .211  .006  .557 
No  0      1.00  Side effect experienced 
Yes  .807  .235  .001  2.242 
No  0      1.00  Encouragement  given  by  a 
health  worker  in  any  one  or 
more months of the episode 
Yes   1.381    .206  .000  .251 
0 6 * yes  0      1.00 
7 12 * yes  .547  .354  .123  1.728 
13 24  * 
yes 
.737  .354  .037  2.089 
Episode duration * Side effect 
experienced 
24+* yes  2.409  .557  .000  11.123 
0 6 * yes  0      1.00 
7 12 * yes  .895  .285  .002  2.446 
13 24  * 
yes 
.686  .300  .022  1.986 
Episode  duration  * 
Encouragement  given  by  a 
health  worker  in  any  one  or 
more months of the episode 
24+* yes  1.248  .504  .013  3.484 
Constant     1.804    .217  .000  .165 
Cox & Snell R Square = .034           
 
Residual  plots  were  created  to  check  the  assumption  of  normality  and 
constant variance among the level two residuals and are shown in appendix 
4D.   
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Table 4.18: Results of Logistic Discrete time Hazards Model Fixed Effects 
with Random Intercept  
Variable  Category  β  SE(β)  t value  Exp(β) 
0 6  0      1.00 
7 12   0.326  0.154   2.12  0.72 
13 24   0.401  0.177   2.27  0.67 
Episode Duration 
24+   1.576  0.409   3.85  0.21 
Pill  0      1.00 
Injection   0.665  0.160   4.16  0.51 
Condom  0.285  0.188  1.52  1.33 
Method 
Other   0.060  0.147   0.41  0.94 
None  0      1.00 
1 or 2   0.198  0.232   0.85  0.82 
3 or 4   0.564  0.236   2.39  0.57 
Children ever born 
5+   0.655  0.240   2.73  0.52 
No  0      1.00  Side effect experienced  
Yes  0.829  0.248  3.34  2.29 
No  0      1.00  Encouragement  given  by  a 
health worker in any one or 
more months of the episode 
Yes 
 1.428  0.218   6.55  0.24 
0 6 * yes  0      1.00 
7 12 * yes  0.587  0.367  1.60  1.80 
13 24 * yes  0.807  0.372  2.17  2.24 
Episode  Duration  *  Side 
effect experienced  
24+* yes  2.467  0.585  4.22  11.79 
0 6 * yes  0      1.00 
7 12 * yes  0.822  0.297  2.77  2.28 
13 24 * yes  0.605  0.314  1.93  1.83 
Episode  duration  * 
Encouragement  given  by  a 
health worker in any one or 
more months of the episode  24+* yes  1.138  0.528  2.16  3.12 
Constant     1.815  0.243   7.47  0.16 
           
Random intercept     0.191  0.082  2.33  1.21 
 
The effect of method on the likelihood of discontinuation can be interpreted 
as  a  main  effect  and  shows  that  injection  users  are  50%  less  likely  to 
discontinue the episode within 36 months than pill users. The coefficients 
estimated for condom and other methods are not significantly different from 
the baseline category of pill use.  
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Figure 4.11 shows the predicted probability of discontinuation by duration of 
episode for pill and injectable episodes. The graph shows that for both pill 
and  injection  the  probability  of  discontinuation  declines  steadily  as  the 
duration of the episode increases.  
 
Figure 4.11: Probability of Discontinuation by Method and Duration of 
Episode (all other variables held at baseline category) 
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0 6  7 12 13 24 >24
Duration of Episode in months
P
r
o
b
a
b
i
l
i
t
y
 
o
f
 
D
i
s
c
o
n
t
i
n
u
a
t
i
o
n
Pill
Injection
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  153 
Figure 4.12 shows that as the number of children ever born increases the 
probability  of  discontinuation  decreases  but  the  difference  becomes  very 
small  in  episodes  lasting  longer  than  24  months.  This  is  what  would  be 
expected  under  the  assumption  that  limiters  will  on  average  have  longer 
episodes of use than spacers. Although the ‘1 or 2’ category has a slightly 
higher probability of discontinuation than the ‘none’ category in episodes of 
duration longer than 12 months the difference between these two categories 
is not statistically significant.   
 
Figure 4.12: Probability of Discontinuation by Number of Children Ever 
Born and Duration of Episode (all other variables held at baseline category) 
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Figure  4.13  shows  the  interpretation  of  the  interaction  between  the 
experience  of  side  effects  and  the  duration  of  the  episode.  It  shows  that 
where  side  effects  are  experienced  the  probability  of  discontinuation 
increases as the episode duration increases, while where side effects are not 
experienced the probability of discontinuation decreases as the episode gets 
longer.  
 
Figure 4.13: Probability of Discontinuation by Experience of Side Effects 
and Duration of Episode (all other variables held at baseline category) 
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Figure 4.14 shows the same effect for both pill and injectable episodes and 
shows that the pattern is the same for both methods however the disparity 
between  the  probabilities  of  discontinuing  with  or  without  side  effects  is 
greater  for  pill  users.  It  is  also  worth  noting  that  the  probability  of 
discontinuing  injection  methods  with  side  effects  is  still  less  than  the 
probability of discontinuing pill episodes without side effects until 12 months 
duration. The final variable in the model is being encouraged by a health 
worker at some point during the episode.  
 
 
Figure 4.14: Probability of Discontinuation by Method and Experience of 
Side effects over Duration of Episode (not encouraged by a health worker, 1 
or 2 children ever born) 
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The interaction between being encouraged by a health worker at some point 
during the episode and episode duration is shown in figure 4.15. This graph 
shows that in all cases the probability of discontinuation is less for those who 
do receive encouragement from a health worker than for those who do not. 
However the magnitude of this effect diminishes with time. For those who do 
receive encouragement the probability of discontinuing goes up slightly for 
between 7 and 12 months duration but then decreases with time.  
 
Figure 4.15: Probability of Discontinuation by Encouragement from a 
Health Worker and Duration of Episode (all other variables held at baseline 
category) 
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Finally figure 4.16 shows the effect of the random variance at level 2 of the 
model  which  is  the  individual  woman.  The  graph  shows  the  predicted 
probability of discontinuation for an average woman, labelled ‘mean’ and for 
women one standard deviation above and below average. This shows that the 
probability of discontinuation varies by 15% between women with different 
predispositions to discontinuing.  
 
Figure 4.16: Probability of Discontinuation by Random Intercept Variance 
for minus 1 standard deviation, average and plus 1 Standard deviation. (All 
other variables held at baseline category) 
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4.5: Discussion and Conclusions 
 
The results of this study concur with previous studies on the topic and have 
shown that there is indeed a significant relationship between the experience 
of side effects and the discontinuation of hormonal contraceptive methods. 
The importance of this relationship is reinforced by the finding of this study 
that side effects are relatively rarely reported in association with methods 
other than the pill and injectable, which together account for over 50% of all 
methods used in this population. Side effects are most commonly associated 
with episodes of injectable use which contribute 55% of all months of side 
effects compared to only 33% associated with pill episodes. This is due to the 
large  contribution  of  months  of  the  injectable  episodes  to  the  dataset  by 
virtue of their longer duration.  When looked at as a percentage of the total 
number of months of use for that method pill and injectable are roughly the 
same  in  respect  to  the  reporting  of  side  effects  with  11.5%  and  10.1%  of 
months with side effects reported respectively. 
 
Also  in  concurrence  with  previous  studies  by  far  the  most  frequently 
reported side effect was menstrual disruption, which accounted for 23% of all 
the months of side effects experienced. This finding reinforces the opinion of 
Tolley et al. (2005) that menstrual disruption is a side effect which can have 
important implication for continuation and should not be dismissed. Other 
commonly reported side effects were headache, cramp, irregular heartbeat, 
and dizziness which each contribute more than 10%.  As would be expected 
menstrual  disruption  was  most  frequently  associated  with  injectable  use 
while headaches are the most common side effect for pill users.  
 
In  terms  of  the  average  length  of  episodes  injection  episodes  last  almost 
double the length of pill episodes, with three quarters of pill users having 
discontinued by 24 months compared to just over half of injection users. The 
impact of side effects on the length of episodes is due in part to the fact that 
in  longer  episodes  there  is  more  chance  for  a  side  effect  to  occur  and  it  
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appears that the experience of side effects either has no real effect on episode 
length or increases the median duration of the episode. When this result is 
considered more closely it is shown that side effects have a differential effect 
on length of episode according to method. The length of episodes of pill use 
is not affected much by side effects and is slightly longer where side effects 
are  experienced.  However,  the  opposite  is  true  for  injectables  where  the 
length of episodes is significantly shorter when side effects are experienced 
than  when  they  are  not.    The  result  for  all  methods  is  most  likely  being 
skewed by methods in the ‘other’ category such as Norplant and IUD which 
are associated with both, some potential for side effects, and with very long 
average duration.  Where a few users of these methods are experiencing side 
effects and persisting with use over very long periods this will influence the 
overall  median  episode  duration.  This  result  highlights  the  importance  of 
method choice in the issue of side effects and shows that injectable users are 
more at risk of shortened episodes due to side effects than pill users. This is 
an  important  finding  given  that  failure  rates  are  generally  lower  for 
injectables than other methods and so it is an important method for overall 
continuity (Blanc et al., 2002).  
 
One  of  the  limitations  of  this  study  previously  mentioned  is  the  lack  of 
information on reason for discontinuation. Where possible the calendar data 
has been used to make assumptions about the reason for the discontinuation 
of  episodes  based  on  reported  behaviour  at  that  time.  Overall  12%  of 
episodes ended following a month when a side effect was reported, 22% were 
followed  by  a  pregnancy  within  9  months  and  26%  were  at  low  risk  of 
pregnancy  when  the  episode  ended.  This  leaves  40%  of  discontinuations 
unclassified. The effect on the length of episodes of removing the cases where 
discontinuation was due to desire to get pregnant or low risk of exposure to 
pregnancy, was to lengthen them in all cases. This makes substantive sense 
given that those who discontinued within 36 months to get pregnant could 
reasonably  be  considered  spacers  which  would  mean  that  after  these 
episodes are removed, the balance of the remaining episodes will be towards  
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limiters who would naturally have longer episode durations. The proportions 
of  episodes  surviving  to  12  and  24  months  also  increase  with  57%  of 
injectable episodes and 34% of pill episodes continuing beyond 24 months. 
The effect of this on the relationship between episode length and side effects 
was that the differences between median episode length for those with and 
without  side  effects  became  more  pronounced.  This  suggests  that  those 
without other reasons for discontinuing are more susceptible to the episode 
shortening  effects  of  side  effects.  Although  this  result  is  based  on  big 
assumptions and must be treated with caution it does suggest that there is 
some  potential  value  in  inferring  reason  for  discontinuation  from 
contemporary behaviour at the time the method was stopped.  
 
In the logistic discrete time hazards model the experience of side effects was 
shown to be a significant predictor of discontinuation but the relationship 
between  the  two  varies  with  the  duration  of  the  episode.  In  general  the 
probability of discontinuation decreases steadily with time, however where 
side effects are experienced the probability of discontinuation first declines 
after 6 months and then increases again after 12 months. At all times the 
probability  of  discontinuation  is  significantly  greater  if  side  effects  are 
experienced  after  controlling  for  all  other  variables  in  the  model  and 
unobserved factors at the woman level. The strength of motivation to use a 
method  will    vary  considerably  in  episodes  of  short  duration  and  it  is 
accepted that side  effects  are  more  likely  to occur  in  the beginning of  an 
episode  and  that  this  leads  to  high  rates  of  discontinuation  in  the  first  6 
months.  Once  episodes have  survived  to  reach a  certain length  there is  a 
selection  effects whereby  only  highly  motivated  individuals  are  still  using 
while the less highly motivated have already discontinued.  The effect of side 
effects  on  discontinuation  becomes  increasingly  significant  as  episode 
duration increases because those individuals still using after a long duration 
are  highly  motivated  to  use  and  do  not  have  as  many  other  reasons 
remaining to discontinue.  
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It was also investigated whether or not this may be reflecting some sort of 
cumulative effect whereby multiple months of side effects are experienced 
throughout a long episode and eventually a limit to the tolerance is reached. 
This was investigated by including in the model a cumulative measure of how 
many  of  the  months  in  a  given  episode  side  effects  were  reported.    This 
variable proved not to add anything significant to the model as there was no 
statistical difference between any of the coefficients except between having 
no side effects and having one month of side effects.   
 
Although side effects proved to be very significant as a predictor of episode 
duration  and  discontinuation  other  hypothesized  predictors  were  not  all 
significant. The regression showed that the odds of discontinuing decrease 
steadily  with  the  number  of  children  ever  born  but  other  measures  of 
motivation  to  avoid  pregnancy  such  as  fertility  intentions  were  not 
significant. Similarly all of the socio economic variables were insignificant as 
predictors of discontinuation.  This supports the statement by Tolley et al. 
(2005) that it is not possible to identify high risk groups for discontinuation 
on the basis of socio economic characteristics. Among the communication 
variables  only  one  proved  to  be  significant  and  that  is  receiving 
encouragement  from  a  health  worker.  In  contrast  to  what  was  found  by 
Porter (1984) being discouraged from using a method seems to have no effect 
on  discontinuation  in  this  study.  Receiving  encouragement  from  a  health 
worker overall significantly decreases the odds of discontinuing but as with 
side effects this effect differs across time. The influence of encouragement by 
health workers on the probability of discontinuation is particularly great in 
the first six months and then declines proportionally over time.  
 
Method  choice  does  play  a  significant  role  in  the  probability  of 
discontinuation and at all points throughout an episode the probability of 
discontinuing is lower for injectable users than for pill users. This reflects 
attributes  of  the  method  itself  which  may  influence  the  likelihood  of 
discontinuation. The pill is administered in a way in which is totally under  
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the  control  of  the  user  and  which  requires  a  conscious  daily  decision  to 
continue. For this reason it is easy for users to discontinue the pill, either 
because they have a specific reason, or through ambivalence and inaction. In 
either  scenario  the  user  has  the  ability  to  discontinue  immediately.  The 
injectable on the other hand (and to an even greater extend, the IUD and 
implants) are not under the daily control of the user. This can be a benefit as 
the user does not have to make daily decisions regarding their contraceptive, 
however it also ‘disempowers’ women and places some of the control in the 
hands  of  the  service  provider.  This  leads  to  a  lower  probability  of 
discontinuation overall and potentially to more considered and drawn out 
process of discontinuation.  
 
4.5.1: Policy Implications 
 
This  study  emphasizes  what  others  have  found  in  that  counselling  from 
health workers is extremely important in minimizing discontinuation rates. 
The results show that health worker encouragement has the largest effect in 
the first 6 months but discontinuations with side effects still occur at longer 
episode  durations.  Therefore  counselling  and  encouragement  from  health 
workers must be continued even once episode duration is long. Both pill and 
injection users should be given attention as both methods attract the same 
proportion of side effects however the average length of injection episodes is 
much longer suggesting that injection users are more likely to tolerate the 
side effects. Given that menstrual disruption is the  most likely side effect 
with  injectable  use  this  suggests  that  with  sufficient  motivation  and 
counselling  this  is  a  side  effect  which  does  not  have  to  lead  to 
discontinuation.  These  results  also  show  that  once  a  method  has  been 
adopted negative communication has little role in discontinuation so efforts 
should be focused on overcoming fear of side effects as a barrier to the initial 
adoption. As pointed out by Ali & Cleland (1999) the process of contraceptive 
discontinuation  is  complex  and  multi  dimensional  and  cannot  be  easily 
predicted based on the characteristics of the user of the episode.  As such  
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service providers should as far as possible treat each case as individual and 
have the flexibility to respond to the changing needs of users as they progress 
through each episode of use.  
 
4.5.2: Future study 
 
The wealth of data collected by the CCFCS leaves much scope for further 
study  in  this  area.  Including  the  men’s  data  into  the  study  would  be  an 
obvious next step to determine if anything in the husband’s characteristics is 
associated with discontinuation. It would also be illuminating to model the 
occurrence of side effects as the outcome variable to determine if there is 
anything  discernable  about  the  individual  which  makes  them  more 
susceptible to side effects, or more likely to report symptoms as side effects. 
Finally multi state models could be used to include multiple transitions and 
periods  of  non use.  In  this  way  the  individual  could  become  the  unit  of 
analysis  rather  than  the  episode  and  each  individual’s  propensity  to 
experience side effects and to discontinue could be examined across multiple 
episodes,  using  different  methods  and  including  periods  of  non use  and 
other reproductive behaviour across the whole study period.    
  164 
Chapter Five 
 
Future Intentions and Fear of Side Effects: Ghana 
DHS Data 
 
5.1: Introduction  
 
This  study  investigates  the  association  between  exposure  to  family 
planning information, through mass media and interpersonal channels, 
and the probability that a respondent will cite fear of side effects as her 
main reason for not intending to use a contraceptive method in the future. 
The literature proposes that exposure to mass media messages promoting 
family planning may reduce fear of side effects by providing trustworthy 
information  (Barber  &  Axinn,  2004).  Discussing  family  planning  with 
others  is  also  shown  to  be  associated  with  an  increased  probability  of 
current use (Bawah, 2002; Westoff & Bankole, 1997; Olaleye & Bankole, 
1994);  however  interpersonal  communication  could  also  be  working  to 
increase fear of side effects as negative personal experiences, rumours and 
misinformation can also be spread through a social network. If this is the 
case interpersonal communication about family planning may be acting 
both  to  facilitate  and  to  deter  method  use.  Therefore  estimates  of  the 
positive  association  between  interpersonal  communication  and  current 
use  of  a  contraceptive  method  at  the  aggregate  level  may  in  fact  be 
attenuated  by  the  negative  impact  of  such  communication  on  some 
individuals. This study will determine if this negative impact is observable 
through  a  positive  association  between  discussing  family  planning  and 
being afraid of side effects.  
 
The  data  analyzed  are  a  sub sample  of  women  aged  15 49  years  from 
those  asked  the  individual  women’s  questionnaire  of  the  2003  GDHS. 
Respondents included in the study are those who are not currently using 
any form of contraception and who state that they do not intend to do so 
in  the  future.  The  method  employed  is  multiple  logistic  regression  
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modelling,  used  to  determine  which  variables  explain  variation  in  the 
probability of fear of side effects being the main reason for not intending 
to use a contraceptive method in the future.  
 
5.1.1: Research Questions 
 
This study aims to use GDHS 2003 data to explore the fear of side effects 
as a reason for current non use of contraceptives by all women aged 15 49 
years. The research questions addressed are: 
 
•  What are the socio economic characteristics of women who say that 
fear  of  side  effects  is  their  main  reason  for  non use  of 
contraception? 
•  Does the probability of women citing fear of side effects as their 
main reason for not intending to use contraception vary according 
to their exposure to family planning information? 
•  If so, what is the magnitude and direction of the effect for different 
types of information source? 
 
5.1.2: Conceptual Framework 
 
Figure  5.1  shows  a  diagrammatic  representation  of  the  conceptual 
framework of this study. Each individual has certain background socio 
economic  and  demographic  characteristics,  which  together  with  past 
experience and information about family planning received from a variety 
of sources, feed into the decision making process. This decision making 
process results either in deciding to use a method of contraception or not 
to use a method. One of the reasons not to use may be fear of side effects 
and  this  can  be  strong  enough  to  result  in  the  intention  not  to  use  a 
method in the future for the same reason. According to the framework it is 
also possible for an individual to decide not to use for any other reason 
and  this  also  may  translate  into  intention  not  to  use  in  the  future.  
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Figure 5.1: Conceptual Framework Diagram 
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Figure  5.1  also  shows  that  where  a  method  is  adopted  it  may  then  be 
discontinued  due  to  actual  or  perceived  side  effects  and  a  fear  of  side 
effects and intention not to use is created in this way.  It is worth noting 
that for those not currently using and/or not intending to use in the future 
the  decision  making  process  may  be  very  passive  as  the  end  result  is 
inaction and the maintaining of the individuals current status quo with 
respect to contraceptive use. In fact it could be argued that in some cases 
there is no conscious decision making process at all and this stage of the 
framework  is  skipped  altogether.    However  the  implication  of  this 
framework is that those individuals would be unlikely to cite fear of side 
effects as their reason for not using a method as that does imply some sort 
of evaluation of information and thought process on the matter.  
 
5.1.3: Study Limitations  
 
One of the major limitations of this study is that it is not possible to place 
any of the events recorded into a temporal framework due to the cross 
sectional design of the survey. This is a common limitation suffered by all 
studies based on cross sectional surveys and it means that the results can 
be  interpreted  as  associations  only  rather  than  making  any  causal 
inference. For example, in this study it is equally possible for an individual 
to develop a fear of side effects based on what they have observed in their 
community and then subsequently have their first ever discussion about 
family planning. Therefore we cannot conclude that in this case discussing 
family  planning  causes  fear  of  side  effects  and  it  is  not  possible  to 
determine a causal sequence of events in this study.  
 
Another potential limitation of this study is the lack of inclusion of men or 
of husband’s characteristics.  As the sample contains unmarried women, 
husband’s  characteristics  could  not  be  included.  This  is  expanded  on 
further in section 5.3.1.3, but it was felt to be acceptable given that the 
question  on  which  the  response  variable  is  based  is  related  to  future 
intentions and therefore husband’s characteristics current to the time of 
the survey are less salient. Men undoubtedly do have an important role in  
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the spread of family planning information and in the experience of fear of 
side  effects.  However,  when  it  comes  to  reasons  for  non use  their 
influence really operates through the women’s perceptions, for example 
the woman is able to report if it is the husband’s disapproval which causes 
her not to intend to use contraception in the future. Similarly it is the 
women themselves who experience side effects and it is their perception of 
these issues which is the focus of this study.  
 
A final limiting factor of this study is the nature of the questions on which 
the response variable in this study is based. There is some uncertainty 
over the reliability of survey questions which ask respondents about their 
intentions  regarding  future  reproductive  behaviour.  In  general 
hypothetical questions where ‘respondents are asked to make predictions 
about their own future behaviour or reactions’ (Oppenheim, 1992: 126) 
should  be  avoided  as  although  they  represent  the  state  of  mind  of  the 
respondent at the time of the survey they may not always match to the 
future behaviour, especially where the question is asking about something 
the respondent has never experienced. In this case the response variable 
in the GDHS2003 is based on two such questions. First the respondent is 
asked ‘Do you think you will use a contraceptive method to delay or avoid 
pregnancy at any time in the future?’ and if the response is yes this is 
followed up with ‘What is the main reason that you think you will not use 
a  contraceptive  method  at  any  time  in  the  future?’  (Ghana  Statistical 
Service,  2004:  344 345).  Both  of  these  questions  are  asking  the 
respondents to predict their future behaviour and not only for one point in 
time in the future but for the entire ‘future’ which may be difficult for the 
respondent to answer accurately.  
 
In addition to this the question is field coded by the interviewer which 
could lead to some bias being introduced at the data collection stage. The 
instruction  given  to  interviewers  in  the  DHS  manual  regarding  field 
coding this question are presented in appendix 5A. To determine if the 
interviewer was influential to the results of this study the final model was 
refitted as a multi level model to see if there was any significant variation  
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in the response variable according to interviewer. In total there were 52 
different  interviewers  who  each  interviewed  between  1  and  102 
respondents in this data set. When the intercept of the model was allowed 
to  vary  randomly  according  to  interviewer  the  value  of  the  random 
intercept term was 0.279 with a standard error of 0.149. Based on a rough 
t test this term is not significantly improving the model. The parameter 
estimates for the rest of the model are very similar to those without the 
random effect added and so it was concluded that for the purpose of this 
study there is not a significant interviewer effect on the response variable 
and the multi level model was not pursued further.  
 
5.1.4: Structure of Chapter 
 
This chapter is presented in five sections, the first of which has already 
outlined  the  research  questions  and  the  conceptual  framework  of  the 
study  as  well  as  its’  limitations.    The  second  section  presents  relevant 
results from some of the previous studies done in this area and this is 
followed by a detailed description of the data set, the study variables and 
the statistical methods used. Section four presents the results, beginning 
with  the  preliminary  data  analysis,  and  then  looking  at  bivariate 
associations and finally the logistic regression. The fifth and final section 
of the chapter is a discussion of the findings of this study and some of the 
conclusions which can be drawn.  
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5.2: Previous Studies 
 
Non use of contraceptives among women who wish to delay or limit their 
child bearing is a serious problem with repercussion for the reproductive 
and general health of the population as well as for the national fertility 
rate. Singh et al. (2003) showed that in developing countries as a whole 
one third  of  all  unintended  pregnancies  are  among  women  using  a 
modern or traditional contraceptive method, and two thirds are among 
women  using  no  method  at  all.  The  majority  of  these  unintended 
pregnancies end in abortion and in developing countries most abortions 
are  unsafe  (Sedgh  et  al.,  2007a),  this  creates  a  serious  public  health 
problem and potentially raises the level of maternal mortality with severe 
impacts on families and the wider society. A comprehensive study based 
on  DHS  surveys  from  53  developing  countries  Sedgh  et  al.  (2007b) 
concluded that among women who cited concerns about side effects of 
contraception, the level of intention to use family planning was lower than 
the national average in every country in the study. This issue needs further 
attention as studies have shown that intention to use is a strong predictor 
of actual future behaviour (Curtis & Westoff, 1996).  
 
Many studies show that women commonly cite fear of side effects as a 
reason  for  not  using  contraception  (Mwageni  et  al,  1998;  Lutalo  et  al, 
2000; Schuler et al, 1994). In the study by Sedgh et al. (2007b) reasons for 
non use into are grouped three broad categories: 
 
1) Those related to program provision, including poor access, cost, lack of 
knowledge and method related reasons, one of which is health concerns or 
fear of side effects.  
2) Reasons indicating that the woman perceives she is at low risk of 
getting pregnant. 
3) Opposition to family planning. 
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Sedgh  et al. (2007b)  found that in 6 countries  in sub Saharan Africa13 
method related  concerns  were  the  reasons  for  not  intending  to  use 
contraception for more than a third of married women with unmet need. 
The study also went on to determine that among women with unmet need, 
those living in urban areas were more likely to cite a fear of side effects as 
a reason for not using family planning (Sedgh et al., 2007b). Additionally 
in  some  countries,  including  Ghana,  it  is  the  relatively  well educated 
among women with unmet need who are not using for this reason (Sedgh 
et al., 2007b). A study by Nair and Smith (1984) compared reasons for 
non use of contraception in 6 countries using data from the Contraceptive 
Prevalence Survey which was the precursor to the DHS. The study looked 
at currently married  non pregnant women  aged 15 44  years and asked 
them the main reason for not currently using a method. The study found 
that fear of side effects/health reasons was more frequently cited in the 
25 39 year age group and increased with number of living children.  
 
There appears to be a strong link between past use of contraception and 
current  non use  due  to  fear  of  side  effects,  suggesting  that  negative 
personal  experiences  are  influencing  fear  of  side  effects.    Sedgh  et  al. 
(2007) found that in 24 of the 34 countries they studied, women who had 
used contraception in the past were more likely than those who had not, to 
give  program related  reasons  for  non use.  This  suggests  that  past 
personal experience with a method may play some role in influencing fear 
of  side  effects  and  other  studies  have  found  similar  results.  Nair  and 
Smith (1984) also found that a significantly higher proportion of the ‘ever 
users’ compared with the ‘never users’ cite side effects/health reasons as 
their main reason for not using contraception.  
 
Other  authors  have  questioned  the  extent  to  which  side  effects  are 
experienced  and  a  study,  based  in  urban  Sudan  (Swar Eldahab,  1993), 
also included ‘ever use’ of contraceptives as a determinate in non use. The 
survey  based  study  found  that  over  40%  of  respondents  linked  their 
                                                 
13 Ghana, Kenya, Lesotho, Madagascar,Malawi and Tanzania  
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current non use of contraceptives to real or perceived side effects but only 
about one quarter of those had actual past experience of side effects. The 
study reached the conclusion that in this case ‘side effects of contraceptive 
use  are  more  often  assumed  than  actually  experienced’  (Swar Eldahab 
1993:370).  
 
Regardless of whether the side effects are real or perceived these studies 
imply that where individuals have had contact with service providers their 
needs  have  not  been  met  and  they  may  have  been  left  at  risk  of  an 
unintended pregnancy.  Sedgh et al. (2007: 37) suggest that these women 
have not ‘obtained services of sufficient quality to help them cope with the 
specifics  of  contraceptive  use.’  Insufficient  counseling,  inadequate 
methods  and  a  limited  range  of  methods  are  all  factors  related  to  the 
quality  of  service  provision  which  can  influence  a  woman’s  future 
contraceptive intentions.  
 
Diffusion of innovation theory states that communication is essential and 
primary to the decision making process and therefore, whether through 
mass  media  or  other  channels  can  affect  the  behaviour  of  individuals 
(Rogers, 1983). Studies’ focusing on the determinants of contraceptive use 
show  that  exposure  to  information  on  family  planning  through  mass 
media channels increases the likelihood of modern method use (Westoff & 
Bankole, 1997; Olaleye & Bankole, 1994). Exposure to mass media may 
therefore  affect  people’s  behaviour  in  a  number  of  different  ways  by 
increasing knowledge and correcting information (Barber & Axinn, 2004). 
It  could  be  inferred  from  these  findings  that  exposure  to  mass  media 
might lessen the fear of side effects by providing correct and trustworthy 
information, however, people may be affected in different ways according 
to their predisposition to use contraception and the association may not 
be so simple. 
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Many authors agree that mass media is effective at creating awareness and 
knowledge of innovations, but interpersonal communication is necessary 
for  actual  behaviour  change  (Hornik  &  McAnany,  2001;  Valente  et  al, 
1995;  Valente  et  al,  1996).  Interpersonal  communication  can  create  a 
climate for open discussion (in this case of the potential health effects of 
contraceptive  use)  and  prompt  people  to  consider  adopting  a  new 
behaviour (Hornik & McAnany, 2001). Studies have considered the effects 
of spousal communication on contraceptive behaviour and found that it is 
a  significant  predictor  of  contraceptive  use  (Olaleye  &  Bankole,  1994: 
Bawah,  2002).  In  contrast  to  mass  media  communication  it  is  not 
necessarily  reasonable  to  assume  that  inter personal  discussions  are 
communicating  positive  information  and  this  may  be  a  route  for  the 
transmission of myths and rumours. Therefore it is possible that exposure 
to information from interpersonal discussion may  actually increase the 
likelihood of fear of side effects in non users. 
 
Fear  of  side  effects  is  often  attributed  to  misinformation  and  rumours 
regarding the possible effects of modern methods (El Qaderi & Al Omari, 
2000 2001; IPPF, 2009). A focus group conducted as part of a study of 
contraceptive use in Rakai District in Uganda (Lutalo et al, 2000) found 
that while most participants understood the concept and goals of family 
planning,  ‘misconceptions  occurred  about  the  potential  health  risks  of 
contraceptives, particularly with respect to adverse effects on fertility or 
the  health  of  future  children’  (Lutalo  et  al,  2000:  224).  Participants 
emphasised the health risks to users and did not usually associate family 
planning with potential health benefits to mothers.  
 
Nair & Smith (1984) used discriminant analysis which showed that overall 
age, number of living children and ever use of family planning were the 
most powerful discriminators of reason for non use, however a high rate 
of correct classification was not achieved. Based on this result the author’s 
propose  that  women may  have  more  than  one  reason  for  non use  and 
instant evaluation at the time of the interview of the relative importance of 
these reasons might have been necessary. They also suggest that reasons  
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for non use may not be rational as the behaviour in question is inaction 
rather than action which may not have an associated rational decision 
making process (Nair & Smith, 1984).  However, Campbell et al. (2006) 
point  out  that  in  places  where  misinformation  about  side  effects  is 
common women who chose not to use for this reason are in fact making a 
rational decision.   
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5.3: Data and Methods 
 
5.3.1: Data  
 
The data used for this analysis is a sample taken from the 2003 Ghana 
Demographic Health Survey (GDHS). The Demographic Health Surveys 
(DHS) project mission is ‘collecting and analysing reliable demographic 
and  health  data  for  regional  and  national  family  planning  and  health 
programs’ (Measure DHS, not dated). The DHS is a worldwide research 
project initiated by US Agency for International Development (USAID) 
and has been operating since 1986 when it succeeded the World Fertility 
Survey. Surveys have been conducted in Ghana in 1988, 1993, 1998 and 
2003 being the most recent. One of the primary objectives of the 2003 
GDHS  was  ‘to  provide  current  and  reliable  data  on  family  planning 
behaviour’ (Ghana Statistical Service, 2004).  
 
The  2003  survey  used  a  two stage  sample  design  beginning  with  the 
selection  based  on  probability  proportional  to  size,  of  412  census 
enumeration areas (EAs). All households in these EAs were then listed 
and a systematic sample of households, 15, 16 or 20 depending on the 
region,  was  drawn  from  each.  The  resulting  sample  is  a  representative 
sample from which generalizations to the population can be made. Within 
each household all women aged 15 49 years and all men aged 15 59 years 
who were usually resident in the household or who had spent the night 
preceding the survey in the household were eligible for interview. Data 
was  collected  between  01\07\2003  and  01\10\2003  and  three 
questionnaires  were  used,  household,  individual  women  and  individual 
men. Interviews were completed in 6251 households, with 5691 women 
and 5015 men with response rates of 99%, 96% and 94% respectively. The 
individual women’s questionnaire is used for this analysis and the data 
were obtained electronically from ORC Macro through the Measure DHS 
website in standardized recode format.  
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5.3.1.1: Selection of Cases 
 
A  sub sample  was  drawn  for  analysis  so  that  only  those  who  might 
reasonably be prevented from using a method by their fear of side effects 
are included in the model.  The sample was drawn in the following stages: 
1)  1146 current contraceptive users identified as those who responded 
‘yes’ to the question ‘Are you currently doing something or using 
any  method  to  delay  or  avoid  getting  pregnant?’  were  excluded 
from the sample.  
2)  The remaining women were then asked ‘Do you think you will use a 
contraceptive method to delay or avoid pregnancy at any time in 
the future?’ Those 2759 women who responded in any way other 
than ‘does not intend to use’ to this question were also excluded 
from  the  sample.  The  sample  is  necessarily  restricted  up  to  this 
stage  of  selection  by  the  nature  of  the  data.  The  question  upon 
which the response variable in this study is based was only asked of 
the  1775  respondents  who  remain  in  the  sample  at  this  stage. 
Therefore it would not have been possible  to include any of the 
respondents excluded up to this point even if desired as they were 
not asked the required question.  
3)  The  response  of  interest  is  based  on  a  prospective  question  of 
future intentions so status at the time of the survey on variables 
such as currently pregnant or current sexually activity, which may 
change at any time in the future, should not affect future intentions 
with  regard  to  contraceptive  use.  Those  who  are  menopausal  or 
infecund  at  the  time  of  survey  are  not  exposed  to  the  risk  of 
pregnancy  and  this  is  a  status  unlikely  to  change  in  the  future. 
Therefore  their  future  intentions  towards  contraceptive  use  are 
likely to be heavily influenced by their current status. 434 women 
were excluded from the sample on this basis and were identified 
using  the  DHS  constructed  variable  for  exposure  to  the  risk  of 
pregnancy.  
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The  final  sample  at  this  stage  consists  of  1341  women  who  are  not 
menopausal or infecund, are not currently using a contraceptive method, 
and say they do not intend to use a contraceptive method at any time in 
the future. Figure 5.2 is a diagrammatic illustration of the sub sampling 
process.  
 
Figure 5.2: Diagram of Sample Sizes and the Sub sampling Process 
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5.3.1.2: Missing Data 
 
Figure 5.1 above shows the number of cases excluded from the sub sample 
due to missing data on two of the variables used to select the sub sample. 
In total 11 cases were unable to be selected into the sample on the basis of 
missing data. A further 11 cases were removed from the sample due to 
missing data on one or more of the variables to be used in the statistical 
modelling as shown in figure 5.3. It was felt acceptable to delete these 22 
cases on the basis that they constitute only 0.39% of the original sample or 
1.65% of the sub sample. The final sample is 1330 respondents who are 
not current contraceptive users, say they do not intend to use a method in 
the  future  and  give  a  main  reason  for  not  intending  to  use.  The  sub 
sample does not contain any missing data cells. 
 
Figure 5.3: Diagram of Missing Data Exclusion   
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5.3.1.3: Description of Sample  
 
As mentioned previously exclusions from the sample were not made on 
the basis of current exposure to the risk of pregnancy other than for those 
who  are  menopausal  or  infecund.  Therefore  the  selected  sub sample 
contains some individuals who were not exposed to the risk of pregnancy 
at the time of the survey but who are potentially going to be exposed to the 
risk  of  pregnancy  in  the  future.  This  includes  pregnant  women, 
amenorrheic women, those who have never had sex and those who are not 
sexually active at the time of survey. The frequency of these characteristics 
in the sample is shown in table 5.1. 
 
Table  5.1:  Factors  Effecting  Exposure  to  Pregnancy  at  the  Time  of 
Survey* 
  Frequency   Percent (N= 1330) 
Currently pregnant  93  7.0 
Never had intercourse  237  17.8 
Not  active  in  last  4 
weeks 
578  43.5 
Amenorrhea  183  13.8 
*respondents can be in more than one category at a time.  
 
Due to the current risk of exposure to pregnancy not being a pre requisite 
for  inclusion  in  this  study  503  unmarried  women  are  retained  in  the 
sample.  Of those, 378 are never married and 125 are formerly married. 
Although marriage patterns do have an important influence on fertility 
and contraceptive use through their association with exposure to sexual 
intercourse, in settings like Ghana, where exposure to sexual intercourse 
occurs outside of marriage, it is important to examine information that 
directly measures sexual behaviour rather than relying on marital status 
as a proxy for exposure (Blanc & Grey, 2000). In some societies in Ghana 
the concept of nuptuality is not clear cut and no social stigma is attached 
to  pre marital  conception  and  it  is  therefore  not  an  uncommon  event 
(Awusabo Asare, 1988). Exposure to risk of pregnancy and potential to be 
a contraceptive user is therefore not restricted to married women and it is 
not appropriate to use marital status as a proxy for exposure (Blanc & 
Grey, 2002). This point is examined for this sample in table 5.2 which  
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shows the cross tabulation of marital status by recent sexual activity in the 
sub sample drawn for analysis. 
   
Table 5.2: Cross Tabulation of Marital Status by Recent Sexual Activity  
Marital 
status 
Never had 
intercourse 
Active in 
last 4 
weeks 
Not active 
in last 4 
weeks 
Total 
Never 
married  
236  34  107  377 
Currently 
married  
1  464  363  828 
Formerly 
married 
0  17  108  125 
Total  237  515  578  1330 
 
Table 5.2 shows that 141 (37.4%) of those who are never married have 
engaged in sexual activity at some time. This is a significant proportion of 
women  who  have  been  exposed  to  the  risk  of  pregnancy  outside  of 
marriage and given that this sample consists entirely of non contraceptive 
users the exposure to the risk of pregnancy is even greater. Given this 
finding and to prevent any issues of colinearity in the statistical modelling 
recent sexual activity will be included as a potential predictor in the model 
and marital status will not be used.   
   
Including unmarried women in the analysis presents a limitation in that 
partners’ or couples’ characteristics such as husbands’ education, age or 
occupation cannot be included as study variables. All unmarried women 
have  missing  data  for  any  partners’  or  couples’  characteristics  and 
grouping  these  into  a  ‘not  applicable’  category  would  not  make 
substantive sense when interpreting the results of the analysis. Previous 
studies in Ghana looking at contraceptive use have found that partners’ 
characteristics  are  not  a  significant  predictor  of  contraceptive  use 
(Oheneba & Takyi, 1997; Tawiah, 1997). Based on this it is felt that the 
exclusion  of  partners’  characteristics  will  not  significantly  impact  the 
study  of  non use.  Inclusion  of  a  variable  determining  if  a  marriage  is 
polygamous  is  also  not  possible  and  considering  that  23%  of  married 
women  report  that  they  are  in  such  a  union  that  may  have  been 
informative to this study. Given the drastic reduction  in sample size if  
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unmarried  women  were  excluded  from  the  sample  it  is  felt  that  the 
benefits  from  including  unmarried  women  outweigh  the  limitations 
brought by their inclusion.  
 
5.3.2: Study Variables 
 
5.3.2.1: Response Variable  
 
The response variable is based on the following question which is asked of 
all  women  in  the  selected  sample  who  are  not  currently  using  a 
contraceptive method and do not intend to use a method in the future: 
 
What is the main reason that you think you will not use a 
contraceptive method at any time in the future? 
 
The respondents answer is coded into one of 19 possible categories which 
are shown below in table 5.3. 
 
Table 5.3: Main Reason for Not Intending to Use a Method  
   Frequency  Percent 
Not married  78  5.9 
Infrequent sex  76  5.7 
Menopausal, hysterectomy  20  1.5 
Subfecund/infecund  83  6.2 
Wants more children  164  12.3 
Respondent opposed to family planning  85  6.4 
Husband opposed to family planning  30  2.3 
Others opposed to family planning  2  .2 
Religious prohibition  71  5.3 
Knows no method  66  5.0 
Knows no source  21  1.6 
Health concerns  102  7.7 
Fear of side effects  380  28.6 
Lack of access  8  .6 
Costs too much  18  1.4 
Inconvenient to use  14  1.1 
Interferes with body’s normal processes  24  1.8 
Other  31  2.3 
Don’t Know  57  4.3 
Total  1330  100.0  
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Table  5.3  shows  that  despite  the  removal  of  menopausal  and  infecund 
women from the sample there are still 20 and 83 respondents respectively 
who give these as a main reason for not intending to use contraception. 
These respondents obviously self identify with these conditions but do not 
meet  the  DHS  criteria  for  inclusion  into  those  groups.  As  would  be 
expected in the menopausal category the respondents are concentrated in 
the two highest age groups and are all between 40 and 49 years old. In the 
infecund/subfecund category there are a few respondents at younger ages 
but  86%  of  respondents  are  aged  between  30  and  49  years.  As  the 
question being asked  concerns future intentions it  is also possible that 
these respondents, while not self identifying or meeting the DHS criteria 
for menopause or infecundity at the time of survey, believe that in the 
future this will be the reason they do not need a contraceptive method.  
 
This 19 category variable is recoded into a dichotomous variable where the 
outcome is coded as 1 if fear of side effects is the main reason for intention 
not  to  use  contraception  in  the  future  or  0  if  another  reason  is  main 
reason  for  intention  not  to  use  contraception  in  the  future.  The  new 
category  of  fear  of  side  effects  is  a  combination  of  the  three  previous 
categories of ‘fear of side effects’, ‘health concerns’ and ‘interferes with 
body’s normal processes’.  The distinction between these three categories 
is made at the time of interview by the interviewer who field codes the 
respondents answer into one of the available categories. Interviewers are 
given the following guidance to help with coding: 
 
‘SIDE  EFFECTS  are  undesirable  consequences  of  using  a 
method that do not adversely affect the health of the user. 
For example, side effects may be spotting or bleeding with 
the pill, while HEALTH CONCERNS may be that she heard 
that the pill may be linked to breast cancer.’ (ORC Macro, 
2006:110)  
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It  was  felt  that  this  rather  subtle  distinction  may  not  be  coded  in  a 
standardized  way  by  different  interviewers  and  so  to  avoid  any 
introduction  of  bias  the  categories  were  combined  together.  The  final 
response variable is as follows: 
 
1   Fear of side effects is the main reason for intention not to use 
contraception in the future = 506 (38 %) 
0   Another reason is the main reason for intention not to use    
      contraception in the future = 824 (62%) 
 
5.3.2.2: Explanatory Variables 
 
The  primary  explanatory  variables  in  this  study  are  measures  of 
communication regarding family planning. All of these variables are coded 
as  dichotomous  with  0  corresponding  to  negative  responses  and  1  to 
affirmative responses. Three variables are included that measure exposure 
to family planning information via interpersonal channels. The coding of 
the variables used in the analysis is shown in full in appendix 5B. They are 
defined as follows:  
 
•  Discussed family planning with someone other than partner in the 
last few months 
As couples’ characteristics are not included in this study a variable 
has  been  created  representing  whether  or  not  a  respondent  has 
discussed family planning with someone other than a partner. The 
variable  is  based  on  the  respondent’s  response  to  the  following 
questions ‘In the last few months, have you discussed the practice 
of family planning with your friends, neighbours or relatives? If the 
respondent  answers  ‘yes’,  a  follow  up  questions  is  asked  ‘with 
whom?’  and  then  the  respondent  is  prompted  by  ‘anyone  else?’ 
(Ghana Statistical Service, 2004) The result is 10 variables in the 
data set coded 0 for ‘no’ and 1 for ‘yes’ for whether the respondent 
has  discussed  family  planning  with  the  following  people: 
husband/partner,  mother,  father,  sister,  brother,  daughter,  son,  
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mother in law,  friends  or  others.  For  this  study  these  variables 
were combined together, excluding husband/partner, to create one 
dichotomous  variable  indicating  either,  yes,  the  respondent  has 
discussed family planning with someone other than their husband 
in the last few months or no, they have not. 
•  Respondent has heard a family planning message at a community 
meeting in the few months prior to survey 
•  Respondent has received a family planning message from a health 
worker in the few months prior to survey 
A further two variables are included as measures of exposure to mass 
media sources of family planning information:  
•  In  the  last  few  months  respondent  has  heard  messages  about 
family planning on the radio 
•  In the last few months respondent has seen messages about family 
planning on the television  
 
Background Variables Related to Family Planning 
 
The  following  variables  were  included  as  measures  of  general  attitude 
towards  family  planning  as  well  as  child  bearing  history  and  past 
experience with contraceptives: 
 
•  Children  ever  born.    A  discrete  continuous  variable  with  values 
ranging from 0 –12.  
•  Desire  for  more  children.  Categorical  variable  with  three  factor 
levels, wants, wants no more, undecided/other.  
•  Recent Sexual Activity. Categorical variable with three factor levels, 
‘active in last four weeks’, ‘not active in last four weeks’ and ‘never 
had intercourse’. 
•  Ever  use  of  a  contraceptive  method.  Binary  variable  coded  1  for 
‘yes’ 0 for ‘no’.  
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•  Approval  of  family  planning.  Coded  0  if  the  respondent 
disapproves of family planning and 1 if the respondent approves of 
family planning.  
 
Socio economic/Demographic Control Variables 
•  Age. A discrete continuous variable with values ranging from 15 –
49 years.  
•  Education.  Categorical  variable  with  three  factor  levels,  none, 
primary, secondary/higher. 
•  Ethnicity. Originally a categorical variable with nine factor levels 
this  variable  was  collapsed  into  five  factor  levels:  Akan,  Mole 
Dagbani,  Ewe,  Ga/Dangme  and  other  (other  combines  Guan, 
Grussi,  Gruma,  Hausa  and  the  original  other  categories).  The 
grouping was decided based on the reported distribution of each 
ethnic group in the population by the GDHS. Akan accounts for 
49% of the population with Mole Dagbani second largest at 17% 
and Ewe and Ga/Dangme with 13% and 8% respectively. Therefore 
these four groups represent 87% of the total population and it was 
deemed reasonable to combine all other categories representing a 
total of 13% of the population.  
•  Occupation. Originally a categorical variable with nine factor levels 
this variable was collapsed into three factor levels. Not working, 
agricultural self employed, and other employed. (Other employed 
combines  the  following  original  factor  levels, 
professional/technical/managerial, clerical,  sales, services, skilled 
manual, unskilled manual and ‘don’t know’.  The original categories 
of ‘agricultural employee’ and ‘household domestic’ were removed 
as  they  no  longer  contained  any  cases  after  the  sub sample  was 
drawn.) 
•  Region. Categorical variable with factor levels 1 10. 
•  Religion.  Originally  a  categorical  variable  with  nine  factor  levels 
this  variable  was  collapsed  into  five  factor  levels.  No  religion,  
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Roman  Catholic,  Protestant,  Moslem  and 
traditional/spiritualist/other.  (Protestant  combines  the  following 
categories:  Anglican,  Methodist,  Presbyterian  and  other 
Protestant.) 
•  Type of place of residence.  Dichotomous variable coded 1 for urban 
and 2 for rural.  
•  Wealth index. Categorical variable with five levels, poorest, poorer, 
middle, richer and richest. The wealth index is constructed by DHS 
based  on  all  household  assets  and  utility  services.  Principal 
component analysis is then used to apply weights to the indicator 
variables and the first of the factors produced is used as the wealth 
index.  Quintiles  are  then  constructed  based  on  the  frequency 
distribution of household population (Rutstein & Johnson, 2004). 
 
5.3.2: Methods 
 
5.3.2.1: Preliminary Data Analysis 
 
All preliminary analysis including selecting the sub sample and recoding 
variables as described previously was carried out using SPSS Version 16.0. 
The first stage in the preliminary  analysis  was to  explore the bivariate 
associations of the explanatory variables with the response using two way 
contingency tables. Most of the independent variables are categorical so 
two way contingency tables show the conditional probability of Y given 
the  factor  levels  of  X  for  each  independent  variable.  To  describe  the 
strength  of  any  associations  Pearson’s  Chi squared  tests  of  association 
were  carried  out  on  each  pair  of  variables.  The  Pearson  Chi squared 
statistic is shown in 5.1.  
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Ho is statistical independence between variables and the test compares the 
actual fixed cell values (nij) with the expected frequencies ( ij), which are 
the expectation of values of nij when Ho is true. If Ho is true differences 
should be small, χ2 takes a minimum value of zero when nij =  ij and the 
larger the difference the stronger the evidence against Ho.  
 
5.3.2.2: Statistical Modelling  
 
Fixed effects logistic regression was carried out using SPSS version 16.0. 
As described previously the response variable in this study is binary with 
two  possible  outcomes,  fear  of  side  effects  as  the  main  reason  for  not 
intending to use contraception in the future (success) or any other reason 
(failure).  The probability of success is θ and the probability of failure is 
the  compliment,  1 θ,  so:  Pr  (Y  =  1)  =  θ  and  Pr  (Y=0)  =  1 θ.  Multiple 
logistic  regression  is  used  with  a  logit  link  function  to  model  the 
probability that Y =1, the logit function is specified as: 
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) ( Log Logit                                                                      (5.2)  
 
This link function allows the prediction of the log of the odds in favour of a 
success (numerator event), relative to a failure (denominator event) for 
observation  i  as  a  function  of  a  vector  of  explanatory  variables.  The 
random  component  of  the  model  is  assumed  to  have  a  binomial 
distribution  (Agresti  &  Findlay,  1997).  The  logistic  regression  model  is 
specified as: 
 
k k X X X Logit β β β α θ + + + + = ...... ) ( 2 2 1 1           (5.3) 
 
The  regression  coefficient  β1  represents  the  change  in  the  log  odds 
associated  with  being  in  a  particular  category  of  X1  compared  to  the 
baseline  category  where  X1  =  0  while  holding  all  of  the  other  values 
constant.  Where  the  explanatory  variables  are  categorical,  dummy 
variables are created in order to be able to distinguish between the factor  
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levels of each variable. The model then estimates a separate regression 
coefficient for each factor level except the  baseline, to which the other 
levels  are  then  compared.    The  exponential  of  β1  the  odds  ratio  of  an 
individual in particular factor level citing fear of side effects as their main 
reason for intention not to use contraception compared to those in the 
baseline category. As the possible values of odds ratio are not symmetric, a 
negative association can only be represented by values between 0 and 1 
but a positive value can be from 1 to ∞, the strength of association is the 
same  when  two  values  are  the  inverse  of  each  other.    Predicted 
probabilities  can  also  be  calculated,  to  estimate  the  effects  of  certain 
combinations  of  values  of  explanatory  variables  or  of  the  interaction 
between two variables, while holding other variables in the model at the 
baseline, using the following equation: 
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=                            (5.4) 
For  categorical  variables  the  Wald  test  is  used  to  determine  the 
significance of individual parameters compared to the baseline category. 
The model selection for fixed effects was based on the principle of a nested 
hierarchy of models and used forward selection to comparing the deviance 
in the likelihood ratio test statistic between models. The likelihood ratio 
test  uses  the  deviance  in  the  L2  statistic  between  the  full  and  reduced 
models by testing that the extra parameters in the full model equal 0. The 
formula for the likelihood ratio statistic is: 
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−                  (5.5) 
 
H0 is that there is no difference between models and L0 represents the 
model where H0 is true with df equal to the number of extra parameters in 
L1,  a  p value  less  than  0.05  shows  that  the  inclusion  of  an  individual 
variable has significantly changed the model at the 5% level.  
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5.4: Results 
 
5.4.1: Preliminary Data Analysis 
 
 
5.4.1.1: Characteristics of Respondents 
 
 
Table 5.4 shows respondent’s characteristics in regard to the response and 
the interpersonal communication variables. This shows that overall 38% 
of  respondents  cite  fear  of  side  effects  as  their  main  reason  for  not 
intending to use a contraceptive method in the future. This figure differs 
from that quoted in the GDHS 2003 report due to the restricting of the 
sample and the merging of categories as outlined in section 5.3.1.  
 
Table 5.4: Characteristics of Respondents in the Sub sample   Response 
and Key Explanatory Variables 
  Frequency  Percent 
Response variable:  
Main reason for not intending to use a 
contraceptive method is fear of side effects 
506  38.0 
Main reason for not intending to use a 
contraceptive method is not fear of side effects 
824  62.0 
Interpersonal Communication Channels 
Discussed FP with others in the past few months 
Yes  242  18.2 
No  1088  81.8 
Heard a FP message at a community meeting in the past few months 
Yes  393  29.5 
No  937  70.5 
Heard a FP message from a health worker in the past few months 
Yes  539  40.5 
No  791  59.5 
Mass Media Communication Channels 
Heard a FP message on the radio in the last few months 
Yes  934  70.2 
No  396  29.8 
Seen an FP message on television in the last few months 
Yes  601  45.2 
No  729  54.8 
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In  terms  of  exposure  to  family  planning  information  through 
interpersonal  channels,  18%  of  respondents  had  discussed  family 
planning with someone, other than their husband, in the last few months. 
This is less than the corresponding figure for the original sample of all 
women in which 26.5% had discussed family planning with someone. This 
is to be expected considering the sample for this study is contraceptive 
non users not intending to use and it is intuitively reasonable that  these 
respondents may be less likely to discuss family planning than current 
users of contraception or those intending to use in the future. Despite this 
table 5.4 shows that respondents in this sample appear well exposed to 
family  planning  information  from  other  sources.  30%  and  41%  of 
respondents  have  heard  a  family  planning  message  from  a  community 
meeting  or  health  worker  respectively.  Regarding  family  planning 
information through mass media sources, messages have been heard on 
the radio by 70% of respondents making this by far the most frequently 
cited channel of mass media information, followed by television with 45% 
of respondents having heard a message.  
 
Table 5.5: Characteristics of Respondents in the Sub sample    Family 
Planning Related Variables 
  Frequency  Percent 
Family Planning Related Variables 
Desire for more children 
Wants  920  69.2 
Does not want  313  23.5 
Undecided/Other  97  7.3 
Recent sexual activity 
Active in last 4 weeks  515  38.7 
Not active in last 4 weeks  578  43.5 
Never had intercourse  237  17.8 
Ever use of a contraceptive method 
Never   920  69.2 
Only traditional  94  7.1 
Used modern  316  23.8 
Respondent approves of family planning 
Approves  809  60.8 
Disapproves  451  33.9 
Don’t know  70  5.3 
    * Other = never had sex and declared infecund     
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Table 5.5 shows the characteristics of the respondents with respect to the 
family planning related variables. The majority of respondents, 69%, want 
more  children  and  82%  are  sexually  active  with  approximately  half  of 
those  being  active  within  the  last  4  week  prior  to  survey.  Only  61% 
approve  of  family  planning  in  general  and  only  24%  have  ever  used  a 
modern method. Number of children ever born is treated as a continuous 
variable and so is not shown in table 5.5. The mean number of children 
ever born is 2.66 with a standard deviation of 2.75.  As would be expected 
the variable has a very strongly positively skewed distribution with 31.7% 
of respondents having no children and 24.2% having 5 or more.  
 
Table 5.6: Characteristics of Respondents in the Sub sample – 
Socioeconomic/Demographic Control Variables 
Variable  Percent 
(n) 
Variable  Percent 
(n) 
Education level  Region 
No education  37.1 (494)  Ashanti   20.5 (273) 
Primary   17.9 (238)  Greater Accra   14.4 (191) 
Secondary   45.0  (598)  Brong Ahafo   11.6 (154) 
Ethnicity  Northern   13.2 (176) 
Akan   43.4 (577)  Western   6.3 (84) 
Mole Dagbani   19.7 (262)  Eastern   10.5 (140) 
Ewe  10.6 (141)  Upper west   6.8 (91) 
Ga/Dangme   8.7 (116)  Volta  6.6 (88) 
Other   17.6 (234)  Upper east  2.9 (38) 
Occupation  Central   7.1 (95) 
Employed  44.1 (587)  Religion 
Agri self 
employed  
33.4 (444)  Protestant  56.1 (746) 
Not working   22.5 (299)  Roman Catholic   12.5 (166) 
Wealth Index  Moslem  21.7 (289) 
Poorest  23 (306)  Traditional/spiritualist/other  3.5 (46) 
Poorer  17.3 (230)  No religion   6.2 (83) 
Middle  17.7 (235)  Type of place of residence  
Richer  19.8 (263)  Rural   57.5 (765) 
Richest  22.3 (296)  Urban   42.5 (565) 
 
 
Table 5.6 shows the distribution of respondents according to background 
variables. The majority of respondents, 63%, have some education with 
71% of those having completed secondary school. Akan is the dominant 
ethnic group in the sample, as in the Ghanaian population as a whole, and  
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the majority of respondents are Protestant and live in rural areas.  Overall 
78%  of  respondents  are  working  either  in  agriculture  or  other 
employment. The distribution of respondents by region follows that for 
the entire survey as published in the GDHS 2003 report with the largest 
concentration  of  population  in  Ashanti  region  and  the  smallest  in  the 
upper  east  region.  The  sub sampling  process  has  also  preserved  the 
distribution  of  respondents  into  wealth  quintiles  relatively  well,  with 
slightly more respondents in the poorest and wealthiest quintiles in this 
sample. Age is treated as a continuous variable and the mean age of the 
respondents is 29.89 years with a standard deviation of 10. This is also 
very similar to the whole sample which has a mean age of 29.25 with a 
standard deviation of 9.6.  
     
5.4.1.2: Two way Contingency Tables and Chi Squared Tests for 
Association 
 
The  next  stage  in  the  preliminary  analysis  was  to  create  two  way 
contingency  tables  to  show  the  conditional  distribution  of  fear  of  side 
effects  by  all  other  variables.  Chi squared  tests  were  carried  out  to 
determine  if  there  is  an  association  between  each  of  the  background 
explanatory  variables  and  the  response  variable.  Table  5.7  shows  the 
percentage  distribution  of  those  who  cite  either,  fear  of  side  effects  or 
another  reason  as  their  main  reason  for  not  intending  to  use  a 
contraceptive  in  the  future,  by  exposure  to  family  planning 
communication.  
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Table 5.7: Main Reason for not intending to use Contraception in the 
Future by exposure to FP information         
Variable  Respondent cites ‘fear 
of side effects’ as main 
reason for not 
intending to use 
contraception in the 
future % (n) 
Respondent cites other 
reason as main reason for 
not intending to  
use contraception in the 
future % (n) 
Interpersonal Communication Channels 
Discussed FP with others in the past few months   
Yes   48.8 (118)  51.2 (124) 
No  35.7 (388)  64.3 (700) 
Heard a family planning message at a community 
 meeting in the past few months 
Yes   46.8 (184)  53.2 (209) 
No   34.4 (322)  65.6 (615) 
Heard a FP message from a health worker in the  
past few months  
Yes  45.3 (244)  54.7 (295) 
No   33.1 (262)  66.9 (529) 
Mass media Communication Channels 
Heard a FP message on the radio in the last few months  
Yes  42.6 (398)  57.4 (536) 
No   27.3 (108)  72.7 (288) 
Seen a FP message on television in the last few months 
Yes   45.6 (274)  54.4 (327) 
No   31.8 (232)  68.2 (497) 
 
 
Table 5.7 shows that in all cases the percentage of respondents who cite 
fear of side effects as their reason for not intending to use a method in the 
future is higher among those who have been exposed to a family planning 
message compared to among those who have not. Almost 50% of those 
who  have  discussed  family  planning  with  someone  other  than  their 
husband cite fear of side effects as their reason for not intending to use a 
method in the future. This suggests that there is evidence in this data to 
support the hypothesis that interpersonal communication may increase 
the  fear  of  side  effects  (by  spreading  myths  and  misinformation).  The 
alternate  hypothesis  that  mass  media  information  reduces  fear  of  side 
effects  is  not  supported  by  this  data.  To  formally  test  for  association 
between  the  variables  chi squared  tests  for  independence  were  carried 
out, the results are presented in table 5.8.  
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Table 5.8: Results of Chi squared Tests for Independence – Response 
Variable by Communications Variables 
Variable  Pearson Chi 
Square Value 
df  Asymp. Sig. 
(2 sided) 
Discussed FP with others in the 
past few months   
14.410  1  .000 
Heard a FP message at a 
community meeting in the past 
few months 
18.220  1  .000 
Heard a FP message from a 
health worker in the past few 
months 
20.065  1  .000 
Heard a FP message on the radio 
in the last few months 
27.762  1  .000 
Seen a FP message on television 
in the last few months 
26.485  1  .000 
 
Table 5.8 shows that in all cases the p values of the chi squared tests are 
below 0.01 so at the 1% significance level there is an association between 
hearing  a  family  planning  message  through  any  of  these  five 
communication channels and citing fear of side effects as the main reason 
for not intending to use a method in the future. 
 
Table  5.9  shows  the  conditional  distribution  of  fear  of  side  effects  by 
family  planning  related  variables.  The  table  shows  that  those  who  are 
more likely to cite fear of side effects as the main reason for not intending 
to use a method in the future do not want more children, are sexually 
active, and approve of family planning in general. There is clear evidence 
of a negative effect of past contraceptive use, with 34 % of those who have 
never used a method citing fear of side effects as the main reason for not 
intending to use a method in the future compared to 43% who have ever 
used a traditional method and 48% who have ever used a modern method. 
Not shown in table 5.9 is the difference in number of children ever born 
among those in the different response categories. The mean number of 
children ever born is slightly higher among those who cite fear of side 
effects as the main reason for not intending to use a method in the future 
at 2.73 compared to those who cite other reasons who have on average 
2.62 children.   
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Table 5.9: Main Reason for not intending to use Contraception in the 
Future by Family Planning Related Variables    
Variable  Respondent cites ‘fear of 
side effects’ as main 
reason for not intending to 
use contraception in the 
future % (n) 
Respondent cites 
other reason as main 
reason for not 
intending to  
use contraception in 
the future % (n) 
Desire for more children  
Wants  37.8 (348)  62.2 (572) 
Does not 
want 
45.0 (141)  55.0 (172) 
Undecided  17.5 (17)  82.5 (80) 
Recent sexual activity  
Active in last 
4 weeks 
44.7 (230)  55.3 (285) 
Not active in 
last 4 weeks 
34.1 (197)  65.9 (381) 
Never had 
intercourse 
33.3 (79)  66.7 (158) 
Ever use of a contraceptive method  
Never   34.0 (313)  66.0 (607) 
Only 
traditional 
42.6 (40)  57.4 (54) 
Used modern  48.4 (153)  51.6 (163) 
Respondent approves of family planning  
Approves  39.6 (171)  60.4 (489) 
Disapproves  37.9 (320)  62.1 (280) 
Don’t know  21.4 (15)  78.6 (55) 
 
All of the categorical variables are significantly associated at the 5% level 
with citing fear of side effects as the main reason for not intending to use a 
method in the future according to the results of the chi squared tests for 
associations which are shown in table 5.10.  
 
Table 5.10: Results of Chi squared Tests for Independence – Response 
Variable by Family Planning Related Variables 
Variable  Pearson Chi 
Square Value 
df  Asymp. Sig. 
(2 sided) 
Desire for more children  23.858  2  .000 
Recent sexual activity  15.643  2  .000 
Ever use of a contraceptive 
method 
21.553  2  .000 
Respondent approves of 
family planning 
8.986  2  .011 
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Table 5.11 shows fear of side effects by socio economic and demographic 
background  variables.  The  results  show  that  the  percentage  of 
respondents citing fear of side effects as the main reason for not intending 
to use a method in the future increases as both education level and wealth 
index increase. Those respondents who are Ga/Dangme, living in urban 
areas, are Protestant and employed are more likely than others to cite fear 
of side effects as the main reason for not intending to use a method in the 
future.  The  mean  age  of  respondents  who cite  reasons  other  than  side 
effects  as  their  main  reason  for  intending  not  to  use  a  contraceptive 
method in the future is 30 years, compared to a slightly younger 29.71 for 
those who do have a fear of side effects. Table 5.11 shows a significant 
regional effect with those regions  in the south of the country having a 
higher percentage of respondents citing fear of side effects as the main 
reason for not intending to use a method in the future compared to those 
in the north. In particular the Ashanti, Central and Volta regions have 
high percentages of women with fear of side effects.  
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Table 5.11: Main Reason for not Intending to use Contraception in the 
Future by Socio economic/Demographic Variables 
Variable  Respondent cites 
‘fear of side 
effects’ as main 
reason for not 
intending to use 
contraception in 
the future % (n) 
Respondent cites 
other reason as 
main reason for 
not intending to  
use 
contraception in 
the future % (n) 
Education level 
No education  27.5 (136)  72.5 (358) 
Primary   42.9 (102)  57.1 (136) 
Secondary/higher   44.8 (268)  55.2 (330) 
Ethnicity 
Akan   45.6 (263)  54.4 (314) 
Mole Dagbani   23.3 (61)  76.7 (201) 
Ewe  40.4 (57)  59.6 (84) 
Ga/Dangme  48.3 (56)  51.7 (60) 
Other  29.5 (69)  70.5 (165) 
Occupation 
Employed  45.1 (265)  54.9 (322) 
Agricultural self  employed   33.6 (149)  66.4 (295) 
Not working   30.8 (92)  69.2 (207) 
Wealth Index 
Poorest  24.5 (75)  75.5 (231) 
Poorer  34.3 (79)  65.7 (151) 
Middle  43.0 (101)  57.0 (134) 
Richer  43.7 (115)  56.3 (148) 
Richest  45.9 (136)  54.1 (160) 
Region 
Ashanti   57.1 (156)  42.9 (117) 
Greater Accra   40.3 (77)  59.7 (114) 
Brong Ahafo   23.4 (36)  76.6 (118) 
Northern   17.6 (31)  82.4 (145) 
Western   42.9 (36)  57.1 (48) 
Eastern   43.6 (61)  56.4 (79) 
Upper west   24.2 (22)  75.8 (69) 
Volta  45.5 (40)  54.5 (48) 
Upper east  10.5 (4)  89.5 (34) 
Central   45.3 (43)  54.7 (52) 
Religion 
Protestant  44.6 (333)  55.4 (413) 
Roman Catholic   38.6 (64)  61.4 (102) 
Moslem  27.0 (78)  73.0 (211) 
Traditional/spiritualist/other  17.4 (8)  82.6 (38) 
No religion   27.7 (23)  72.3 (60) 
Type of place of residence 
Rural   34.5 (323)  65.5 (501) 
Urban   42.8 (242)  57.2 (264)  
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Figure  5.4  shows  a  map  of  Ghana  representing  this  result  and  shows 
clearly  that  the  regions  in  the  south  have  a  higher  percentage  of 
respondents citing fear of side effects as the main reason for not intending 
to use a method in the future.  
 
Figure 5.4: Map Showing Percent of Respondents who Cite Fear of Side 
Effects as their Main Reason for not Intending to use a Contraceptive 
Method in the Future by Region   
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Table  5.12  shows  the  results  of  the  chi squared  tests  for  association 
between the response and the socio economic explanatory variables. The 
table shows that all of these variables have a significant association at the 
1% level with reason for not intending to use a method in the future. 
 
Table 5.12: Results of Chi squared Tests for Independence – Response 
Variable by Background Variables 
Variable   Pearson Chi Square 
Value 
df  Asymp. Sig. (2 
sided) 
Education level  37.141  2  .000 
Ethnicity  50.886  4  .000 
Occupation  23.060  2  .000 
Religion  40.847  4  .000 
Region  114.311  9  .000 
Type of place of 
residence 
9.549  1  .002 
Wealth index  38.985  4  .000 
 
 
5.4.2: Binary Logistic Regression Results 
 
The logistic regression models were selected using forward selection based 
on  the  likelihood  ratio  test  as  described  in  section  5.3.2.2.  The  model 
selection process was carried out in three stages. First the family planning 
communication  variables  were  considered  and  a  model  containing  the 
significant  communication  variables  was  selected.  Next,  the  family 
planning  related  variables  were  added  to  this  model  and  those  that 
significantly improved the fit of the model were retained. Finally the same 
process was repeated this time including all of the socio economic and 
demographic  background  variables.  Once  a  final  model  was  fitted 
interaction between variables were tested to see if they improved the fit of 
the model but no interaction were included in the final model. Table 5.13 
shows the estimated coefficients for model one which contains only the 
significant family planning communication variables.   
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Table  5.13:  Logistic  Regression  Coefficients  for  Model  1  with  Main 
Reason for Not Intending to Use a Method in the Future as the Response 
Variable and Family Planning Communication Variables  
Variable  β  SE (β)   p  exp 
(β) 
Heard a family planning message from health worker in the last 
few months 
No (RC)  0      1.00 
Yes  .353  .120  .003  1.423 
Heard a family planning message on the radio in the last few 
months  
No (RC)  0      1.00 
Yes   .417  .149  .005  1.517 
Seen a family planning message on the television in the last few 
months  
No (RC)  0      1.00 
Yes  .337  .130  .009  1.401 
Constant    1.095    .117  .000  .335 
 
Not  shown  in  table  5.13  are  the  variables  which  were  not  significant 
predictors of intention not to use a contraceptive method in the future. 
This includes hearing a family planning message at a community meeting 
and  discussing  family  planning  with  someone  other  than  the  husband. 
Table  5.13  shows  that  for  each  of  the  three  remaining  family  planning 
communication variables the odds of citing fear of side effects as the main 
reason  for  intention  not  to  use  a  contraceptive  method  in  the  future 
increase by between 40% and 52% for those who have been exposed to 
messages compared to those who have not.  
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Table 5.14 shows the model coefficients for model two, to which the family 
planning related variables have been added.  
 
Table  5.14:    Logistic  Regression  Coefficients  for  Model  2  with  Main 
Reason for Not Intending to Use a Method in the Future as the Response 
Variable, Family Planning Communication Variables and Family Planning 
Related Variables  
Variable  β  SE (β)   p  exp 
(β) 
Heard a family planning message from health worker in the last 
few months 
No (RC)  0      1.00 
Yes  .340  .125  .006  1.405 
Heard a family planning message on the radio in the last few 
months  
No (RC)  0      1.00 
Yes   .384  .153  .012  1.468 
Seen a family planning message on the television in the last few 
months  
No (RC)  0      1.00 
Yes  .310  .138  .024  1.363 
Desire for more children  
Wants (RC)  0      1.00 
Does not want  .159  .141  .260  1.173 
Undecided/Other   1.242    .284  .000  .289 
Recent sexual activity  
Active in last 4 weeks (RC)  0      1.00 
Not active in last 4 weeks  .251  .184  .173  1.285 
Never had intercourse   .177    .181  .329  .838 
Ever use of a contraceptive method  
Never (RC)  0      1.00 
Only traditional  .283  .235  .227  1.328 
Used modern  .396  .147  .007  1.485 
Constant    1.159  .175  .000  .314 
 
Table 5.14 shows that the effect of the family planning communication 
variables  is  moderated  slightly  by  the  inclusion  of  the  family  planning 
related variables but all three remain significant. Number of children ever 
born  and  general  approval  of  family  planning  are  not  included  in  the 
model  as  their  inclusion  did  not  improve  the  overall  fit  of  the  model.  
Recent  sexual  activity  is  included  in  the  model  on  the  basis  of  the 
likelihood  ratio  test;  however  the  Wald  tests  shows  that  neither  of  the 
categories  is  significantly  different  to  the  baseline  category.  Those 
respondents  who  are  undecided  about  wanting  more  children  have  
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significantly lower odds of citing fear of side effects as the main reason for 
intention not to use a contraceptive method in the future than those who 
want  more  children.  Table  5.14  also  shows  that  respondents  who  have 
used a modern method in the past are 48% more likely to cite fear of side 
effects as the main reason for intention not to use a contraceptive method 
in the future than those who have never used. This figure is 33% for those 
who  have  used  traditional  methods  only  in  the  past  but  this  is  not 
significantly different from those who have never used a method.  
 
Table  5.15  shows  the  final  model  with  all  of  the  explanatory  variables 
added.    The  Hosmer  and  Lemeshow  Test  shows  this  model  to  be  an 
acceptable fit to the data with a chi squared value of 15.29 on 8df and a p 
value of 0.54. The Nagelkerke R Square is .204 suggesting that there is 
still  a  significant  amount  of  variance  in  this  data  unexplained  by  the 
model. A plot of the change in deviance against the predicted probabilities 
of this model shows that the model fits reasonably well for cases where 
fear of side effects is not the reason for intention not to use in the future 
but those who do cite fear of side effects as main reason for intention not 
to use a method in the future but have small predicted probabilities are 
poorly represented in the model. The plot is included in appendix 5C. 
 
In this model being exposed to a family planning message from radio or 
television is no longer a significant predictor of main reason for intention 
not to use a contraceptive method in the future. The only communication 
variable remaining is receiving a message from a health worker  which 
increases  the  odds  of  citing  fear  of  side  effects  as  the  main  reason  for 
intention not to use a contraceptive method in the future by 68%. For the 
purposes  of  model  interpretation  predicted  probabilities  have  been 
predicted  for  the  probability  of  citing  fear  of  side  effects  as  the  main 
reason  for  intention  not  to  use  a  contraceptive  method  in  the  future 
according to selected characteristics while holding all other variables at 
their baseline values.  
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Table  5.15:  Logistic  Regression  Coefficients  for  Model  3  with  Main 
Reason for Not Intending to Use a Method in the Future as the Response 
Variable,  Family  Planning  Communication  Variables,  Family  Planning 
Related Variables  and Background Variables 
Variable  β  SE (β)   p  exp 
(β) 
Heard a family planning message from health worker in the last 
few months 
No (RC)  0      1.00 
Yes  .521  .136  .000  1.684 
Heard a family planning message on the radio in the last few 
months  
No (RC)  0      1.00 
Yes   .033  .158  .835  1.033 
Seen a family planning message on the television in the last few 
months  
No (RC)  0      1.00 
Yes  .282  .167  .091  1.326 
Desire for more children  
Wants (RC)  0      1.00 
Does not want  .411  .176  .020  1.509 
Undecided/Other   1.083  .297  .000  .338 
Recent sexual activity  
Never had intercourse (RC)  0      1.00 
Active in last 4 weeks  .622  .233  .008  1.863 
Not active in last 4 weeks  .122  .220  .581  1.129 
Ever use of a contraceptive method  
Never (RC)  0      1.00 
Only traditional  .171  .251  .496  1.187 
Used modern  .382  .158  .016  1.465 
Age     .043  .010  .000  .958 
Occupation  
Not working (RC)  0      1.00 
Agricultural self employed   .535  .218  .014  1.708 
Employed  .615  .191  .001  1.850 
Region  
Western (RC)  0      1.00 
Central   .002  .317  .995  1.002 
Greater Accra     .099  .283  .726  .906 
Volta  .137  .326  .674  1.147 
Eastern    .064  .293  .828  .938 
Ashanti   .675  .267  .011  1.964 
Brong Ahafo   .941  .303  .002  .390 
Northern    1.083  .313  .001  .339 
Upper west    .733  .347  .034  .480 
Upper east   1.655  .585  .005  .191 
Constant   .370  .317  .243  .691 
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Figure 5.5 shows the predicted probabilities of citing fear of side effects as 
the main reason for intention not to use a contraceptive method in the 
future  according  to  whether  or  not  the  respondent  has  heard  a  family 
planning message from a health worker, with age at the mean (30 years) 
and all other variables at the baseline values. The figure shows that there 
is a significantly higher probability of citing fear of side effects as the main 
reason for intention not to use a contraceptive method in the future if a 
respondent has heard a message from a health worker. 
 
Figure 5.5: Predicted Probabilities of Fear of Side Effects as Main 
Reason for not Intending to Use a Contraceptive Method in the Future by 
Hearing a Family Planning Message from a Health Worker14  
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14 When calculating the predicted probabilities age is set to the mean value, 30 years, and 
all other variables are held at their baseline values.    
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Figure 5.6 shows the predicted probabilities of citing fear of side effects as 
the main reason for intention not to use a contraceptive method in the 
future according to region, with age at the mean (30 years) and all other 
variables at the baseline values. The figure shows that generally there is a 
significantly  lower  probability  of  citing  fear  of  side  effects  as  the  main 
reason for intention not to use a contraceptive method in the future, in 
regions  in  the  north  of  Ghana  compared  to  regions  in  the  south.  The 
Ashanti  region  stands  out  as  having  an  extremely  high  probability  of  
respondents citing fear of side effects as the main reason for intention not 
to  use  a  contraceptive  method  in  the  future  at  over  0.25,  suggesting  a 
particular issue with fear of side effects in this region.  
 
Figure 5.6: Predicted Probabilities of Fear of Side Effects as Main 
Reason for not Intending to Use a Contraceptive Method in the Future by 
Region15  
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15 When calculating the predicted probabilities age is set to the mean value, 30 years, and 
all other variables are held at their baseline values.    
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Figure 5.7 shows the predicted probabilities of citing fear of side effects as 
the main reason for intention not to use a contraceptive method in the 
future by age, with all other variables at the baseline values. The figure 
shows  a  clear  pattern  that  there  is  a  significantly  lower  probability  of 
citing fear of side effects as the main reason for intention not to use a 
contraceptive method in the future, as age increases.  
 
Figure 5.7: Predicted Probability of Fear of Side Effects as Main Reason 
for not Intending to Use a Contraceptive Method in the Future by Age16  
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16 When calculating the predicted probabilities age is varied while all other variables are 
held at their baseline values.    
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Table 5.16 shows the predicted probabilities for the remaining variables in 
the model with age at the mean value and all other variables at baseline.  
 
Table  5.16:  Predicted  Probabilities  of  Fear  of  Side  Effects  as  Main 
Reason for not Intending to Use a Contraceptive Method in the Future by 
Explanatory Variables17  
Variable  Predicted Probability 
Desire for more children 
Wants  0.16 
Does not want  0.22 
Undecided/Other  0.06 
Recent sexual activity 
Never had intercourse   0.16 
Active in last 4 weeks  0.26 
Not active in last 4 weeks  0.18 
Ever use of a contraceptive method 
Never   0.16 
Only traditional  0.18 
Used modern  0.22 
Occupation 
Not working   0.16 
Agricultural self employed   0.25 
Employed  0.26 
 
Table  5.16  shows  that  the  predicted  probabilities  of  citing  fear  of  side 
effects as the main reason for intention not to use a contraceptive method 
in the future are highest for those who do not want other children, who 
are  currently  sexually  active,  are  employed  and    have  used  a  modern 
method in the past.   
 
 
                                                 
17 When calculating the predicted probabilities age is set to the mean value, 30 years, and 
all other variables are held at their baseline values.     
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5.5: Discussion and Conclusions 
 
5.5.1 Discussion 
 
The results show that exposure to family planning messages in the mass 
media does not have any significant effect on the likelihood of fear of side 
effects being the main reason for not intending to use a method in the 
future. This is contrary to what might be expected given the framework of 
the  study  but  is  not  in  contradiction  with  any  previous  studies.    In 
addition to this the results of the focus group study presented in chapter 
three of this thesis also found that mass media communication was not 
mentioned as an important source of information on contraceptive use.  
The  focus  group  participants  identified  interpersonal  sources  of 
information,  in  particular  information  from  health  workers,  as  being 
influential  to their  knowledge  of  side  effects.  In  concurrence  with  this 
finding  the only family planning communication variable in this study 
which does have a significant effect is receiving a message from a health 
worker which increases the odds of fear of side effects being the main 
reason  for  not  intending  to  use  a  method  in  the  future.  Again  this  is 
contrary to what might be expected but there are a number of possible 
explanations for this. 
 
Firstly, this result raises a question over the content of the information 
being given by health workers.  The framework for this study assumes 
that  information  from  health  workers  is  positive  and  encourages 
contraceptive use in all cases but that may not necessarily be accurate in 
instances  where  a  provider  has  a  particular  bias  against  certain  sub 
groups,  such  as  adolescents  or  the  unmarried,  or  against  providing 
certain methods.  
 
Secondly, there is an intuitive link between provider communication and 
fear of side effects in the sense that in order to have ‘fear of side effects’ an 
individual  must  have  some  knowledge  of  side  effects.  Some  of  this 
knowledge  may  come  from  past  experience,  some  from  others  in  the  
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social  network  and  some  from  service  providers.  While  some  of  the 
information gathered by an individual may be based on negative stories 
or  misinformation  it  is  also  reasonable  that  basic  factual  information 
about the potential side effects of methods gathered from a health worker 
may contribute to fear of side effects. Thought about in these terms it 
seems  natural  that  there  would  be  an  association  between  increased 
likelihood of fear of side effects and information from a health worker. 
Additionally those individuals whose fear of side effects is decreased by 
the  information  received  from  a  health  worker  have  likely  gone  on  to 
either use a method, or say they do intend to use a method in the future, 
in which case they are not longer in the sample for this study.  
 
A result of this study which was expected, given the existing literature, is 
that the past use of modern methods increases the likelihood of fear of 
side effects being the main reason for not intending to use a method in 
the future. This is in agreement with results found by Sedgh et al. (2007: 
37) who suggest that this reflects poor quality services and these women 
have not ‘obtained services of sufficient quality to help them cope with the 
specifics of contraceptive use.’ This may also be related to the source of 
contraceptive supplies and rather than indicating low quality care it may 
indicate a lack of counseling altogether when contraceptives are obtained 
from a commercial source. This is also an issue raised by the women in 
the  focus  group  study  who  raised  the  idea  that  when  side  effects  are 
experienced it is often the case that individuals have not seen a health 
professional when they obtained their method.  
 
Although this result suggests that a great number of past users of modern 
methods have had problematic experiences with their method this is not 
actually the case. The majority of past users who have not experienced 
any problems will either be continuing to use currently or intending to 
use again in the future and hence will not be in this sub sample at all. 
Therefore, while past  negative experiences  are undoubtedly sometimes 
the cause of current fear of side effects and intentions not to use a method 
again  in  the  future,  the  magnitude  of  the  problem  on  the  whole  is  
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overemphasized by the design of this analysis. Additionally the results 
show a strong regional effect with fear of side effects as main reason for 
not intending to use being most prevalent in the south. This may reflect 
regional  differences  in  the  family  planning  supply  environment  and 
quality of care. This result could also show evidence of a diffusion effect in 
the  spread  of  negative  information  about  potential  side  effects  and 
highlights  that  particular  attention  needs  to  be  paid  to  this  issue  in 
southern Ghana and in the Ashanti region especially.  
 
Contrary  to  the  study  by  Nair  and  Smith  (1984)  urban  and  rural 
residence,  level  of  education  and  number  of  living  children  were  not 
found  to  be  significant  predictors  of  reason  for  not  intending  to  use 
contraception  in  the  future.  However  the  patterns  seen  in  the  socio 
economic and family planning related variable which are significant in 
this study do suggest an interesting interpretation. The results show that 
the probability of citing fear of side effects as the main reason for not 
intending to use a method of contraception in the future is lowest for 
those  individuals  who  are  not  employed,  undecided  about  or  wanting 
children in the future, not currently sexually active and older. In addition, 
they are likely to be the least well informed on family planning through 
the mass media or  interpersonal communication channels and are the 
least  likely  to  have  second  hand  experience  of  the  outcomes  of 
contraceptive use by virtue of living in the regions of the country where 
the contraceptive prevalence is the lowest.  Taken as a whole this profile is 
the exact opposite of the profile we would expect to fit a current user of a 
modern contraceptive method.  Therefore where the probability of citing 
fear  of  side  effects  as  the  main  reason  for  not  intending  to  use 
contraception in the future is high, the profile of those individuals is on 
average most similar to the profile of current users of modern methods.   
 
This suggests that fear of side effects is the last in a series of barriers to 
the adoption of a modern method and occurs most often when individuals 
are at the end of the decision making process and have already overcome 
other, perhaps more substantial, barriers such as lack of knowledge or  
  211 
lack of access.  These individuals are sufficiently motivated to avoid or 
delay pregnancy that they have engaged in the decision making processes 
and  either  directly  sought  or  indirectly  gained  knowledge  of  modern 
contraceptive methods.  Along with this they have also gained knowledge 
of the potential for negative side effects resulting from the use of modern 
methods and their motivation to use is not yet quite sufficient for them to 
overcome this final barrier. This could imply that those individuals who 
are most likely to cite fear of side effects as their main reason for not 
intending to use a contraceptive method in the future could be the most 
open  to  changing  their  intentions  and  their  future  contraceptive 
behaviour with increased counselling and encouragement on managing  
or tolerating potential side effects.   
 
The previous interpretation of the results of this study would contradict 
Cleland’s (2001) ideas that fear of side effects is simply an acceptable way 
of expressing general disapproval of family planning. This interpretation 
of  the  results  would also  be  at  odds  with  the  conclusions  of  Nair  and 
Smith  (1984)  regarding  the  lack  of  engagement  in  a  rational  decision 
making  process  by  individuals  with  fear  of  side  effects;  although  this 
study does find similar results to theirs, in the sense that a high level of 
variation in the outcome variable remains unexplained by this model. The 
variables included as predictors in this analysis are done so on the basis 
of  their  relevance  in  previous  studies  to  contraceptive  non users. 
However perhaps given the results of this study, those who do not intend 
to use in the future due to fear of side effects should be treated as having a 
socio economic profile more comparable to current users than  current 
non users and further study is needed to determine which characteristics 
are  most  pertinent  to  predicting  reasons  for  not  intending  to  use  a 
method.   
 
5.5.2 Conclusion 
 
In conclusion this study presents results which show that individuals who 
cite  fear  of  side  effects  as  their  main  reason  for  not  intending  to  use  
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contraception in the future are more likely to be employed, live in the 
south of Ghana, be older on average, not want any more children but be 
currently sexually active (and hence at risk of unwanted pregnancy) and 
have  heard  family  planning  information  from  a  health  worker.  This 
profile  suggests  that these  individuals  may  be  more  similar  to  current 
users  than  to  those  who  do  not  intended  to  use  contraception  in  the 
future for other reasons. One way of interpreting these results is that this 
group are more likely than any other, with the right encouragement and 
information, to change their future intentions and  should therefore be 
targeted  by  service  providers  and  IEC  activities.    Looking  back  at  the 
conceptual framework for this study, presented in figure 3.1, it may be 
possible with the correct inputs through the communication channels to 
make the relationship between contraceptive use and fear of side effects a 
two way flow; meaning that those who have the intention not to use a 
contraceptive in the future due to fear of side effects can change their 
intentions and become contraceptive users. Additionally those who are 
past users but do not intend to use in the future due to fear of side effects, 
possibly related to past personal experience, can also become users again 
with access to proper counselling and a range of different methods.  
 
The association between hearing a family planning message from a health 
worker and being more likely to be afraid of side effects may represent 
intentional information gathering behaviour on the part of the individual, 
which indicates that they have at least some level of interest in family 
planning and some potential motivation to avoid pregnancy. They have 
found  out  enough  detailed  information,  from  health  workers  and 
presumably other sources, in order to develop a fear of the potential side 
effects, but with a more positive information and encouragement may be 
able  to  overcome  this  fear  and  change  their  future  intentions  for 
contraceptive use .  
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Chapter Six 
 
Summary and Conclusion 
 
This  final  chapter  of  the  thesis  will  summarize  the  results  of  all three 
papers and bring together the findings to make some overall conclusions. 
The original aims as set out in the introduction will be addressed and the 
use of different data and methodologies will also be commented on and 
the  success  of  the  strategy  evaluated.  This  chapter  will  also  include 
sections on policy recommendations and suggestions for further study. 
 
6.1: Summary of Results 
 
Paper one:  
•  Contraceptive side  effects are a frequent topic of  discussion but 
most of the information being discussed is based on real events 
and expected side effects. As such this type of information passed 
around the informal social network cannot be dismissed as rumour 
or myth.  
•  Communication  from  health  workers  is  seen  to  be  the  most 
influential  source  of  information.  Second  to  this  is  information 
from women who are known to be current users; however many 
women are reluctant to disclose their status as users because they 
may face pressure to stop using if they become ill for any reason 
other than their contraceptive use.  
•  In most cases women were able to give rational explanations for 
the more extreme stories of side effects they hear. For example, it 
is often thought that side effects result from user error or that the 
symptoms being attributed to side effects are actually caused by a 
coincidental illness or disease. Fear of side effects persists despite 
these  rationalizations  however  where  the  motivation  to  avoid 
pregnancy  is  high  potential  users  can  overcome  their  fears, 
through proper counselling.     
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Paper two: 
•  The  most  frequently  reported  side  effect  is  menstrual  changes 
which account for ¼ of all the months of side  effects reported. 
Injectables and the pill are most often associated with experiencing 
side effects and they each attract around the same frequency of 
side effects once the length of episodes is taken into account.  
•  Experiencing side effects is shown to be a significant predicator of 
discontinuation and in all cases the probability of discontinuation 
is  higher  where  side  effects  are  experienced.  The  relationship 
between side effects and discontinuation varies over time and the 
probability  of  discontinuing  when  a  side  effect  is  experienced, 
relative to when it is not, increases as the duration of the episode 
increases.  
•  The  only  family  planning  communication  variable  which 
significantly  predicts  discontinuation  is  being  encouraged  by  a 
health worker at some point during the episode. The probability of 
discontinuing is 10% less if encouragement from a health worker is 
received in episodes 0 6 months long compared to if it is not. The 
strength of the effect of encouragement by a health worker also 
varies  over  time  and  the  difference  in  probability  of 
discontinuation  amongst  those  who  have  been  encouraged  and 
those  who  have  not  decreases  as  the  duration  of  the  episode 
increases.  
 
Paper three: 
•  The  only  family  planning  communication  variable  which  has  a 
significant effect on predicting reason for not intending to use a 
method in the future is communication from a health worker.  
•  Those who have heard a family planning message from a health 
worker in the few months prior to the survey are more likely to cite 
fear of side effects as their reason for intention not to use in the 
future than those who have not.   
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•  The socio economic profile of those who cite fear of side effects as 
their main reason for not intending to use in the future is more 
similar to current users than those who intend not to use for other 
reasons. Those citing fear of side effects as their main reason for 
not intending to use in the future are on average employed, living 
in  the  south  of  Ghana,  sexually  active  but  not  wanting  more 
children and are past users of modern methods.   
 
6.2: Conclusion 
 
The two main questions which this thesis sought to answer were: 
 
•  In  what  way  does  fear  of  side  effects  influence  contraceptive 
behaviour  and  function  as  a  barrier  to  the  use  of  modern  or 
hormonal methods among women in Ghana?  
•  Is the fear of side effects and subsequent contraceptive behaviour 
influenced  by  exposure  to  different  sources  of  family  planning 
information?  
 
The results of the three studies show that in each case fear of side effects, 
or  the  actual  experience  of  side  effects  does  significantly  influence 
contraceptive behaviour. Fear of side effects act as a barrier by preventing 
the adoption of a contraceptive method and influencing future intentions 
regarding contraceptive use, while the experience of side effects increases 
discontinuation of methods and so interrupts the continuity of use. Both 
of  these  scenarios  influence  the  overall  contraceptive  prevalence  by 
reducing the number of current users in the population at any given time.  
 
The fear of side effects seems to be exaggerated compared to the actual 
experience of side effects, which while undoubtedly causing discomfort 
and health problems for some are not a problem for the majority of users. 
This  is  due  to  negative  information  circulating  through  the  informal 
social network and providing women with many negative examples on 
which to base their opinions. Generally speaking, a new user who takes a  
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method, has no side effects and is happy with the method is not a topic of 
conversation. Therefore negative information, which is based on one or 
two cases, is amplified as by being retold multiple times within the social 
network. The fact that this information usually originates from the actual 
experience  of  a  contraceptive  user  means  the  information  circulating 
cannot be dismissed at myth or rumour.  
 
Those negative experiences being discussed do not necessarily reflect the 
experience of a typical user but rather cases of incorrect use or of other 
illnesses  being  blamed  on  method  use.    The  misuse  of  methods  is  a 
problem when inadequate counselling and instructions are given or in the 
case of the pill when a service provider is not consulted at all but rather 
the pills are brought from a drug store or pharmacy.  The availability of 
the pill without prescription may increase its use by those who find this 
the most convenient point of access, but a consequence of this may be an 
increase in fear of side effects due to occasional extreme effects  being 
discussed within the informal network.  
 
Past experience of using a modern method is also a contributing factor to 
fear of side effects and intention not to use a method. This may reflect 
poor quality of care and a lack of follow up care at the time of the previous 
episode of use. This is problematic because it does not only result in the 
discontinuation at that time but it has lasting effects on those individuals’ 
intentions for their future contraceptive behaviour. Not only is this, but 
the negative effect is also passed on, via discussions of the experience 
within  the  social  network,  to  influence  the  contraceptive  behaviour  of 
more than original user.  
 
Positive information is most likely to be conveyed by current users who 
are potentially very influential in overcoming fear of side effects.  Current 
users are considered by others to be a reliable source of information and 
they should be encouraged to participate in education campaigns. The 
results  from  all  three  papers  also  highlight  the  importance  of  family 
planning communication from health workers and counselling on what to  
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expect and how to cope with side effects. Other sources of information on 
family planning or sources or encouragement or discouragement do not 
have  any  significant  effects  on  contraceptive  behaviours  in  this  study. 
Encouragement from a health worker during an episode of use decreases 
the  probability  of  discontinuation  of  the  episode,  however  hearing  a 
family planning message from a health worker increases the probability 
that someone not intending to use a method in the future will cite fear of 
side effects as the main reason.  
 
The  association  between  the  probability  of  intention  not  to  use  in  the 
future due to fear of side effects and hearing information from a health 
worker may be reflecting information seeking behaviour on the part of  
the individual. In order to develop fear of side effects individuals have 
been exposed to a certain amount of information which has made them 
aware of the potential problems methods can have. The fact that these 
women  have  engaged  in  information  seeking  behaviour  and  an  active 
decision making process means that serious barriers to use, such as lack 
of knowledge or disapproval, have already been overcome. Although they 
do not intend to use in the future at the time of the survey, with sufficient 
motivation  to  avoid  pregnancy  and  some  encouragement  they  may  be 
able to also overcome the barrier of fear of side effects.  
 
Some women are still ambivalent about their fertility intentions and their 
desired family size, for example in transitional populations where desired 
family size is decreasing but there are still many people in the community 
with  large  families.  Ghana  is  characteristic  of  this  kind  of  population 
where the CPR is relatively high and the TFR relatively low in comparison 
to other countries with a similar level of socio economic development. 
This  is  especially  true  in  southern  Ghana  where  the  level  of  social 
development is higher than in the north. Desired family size is changing 
individual’s  fertility  intentions  but  small  families  are  not  yet  a  fully 
established  social  norm.  Where  women  are  ambivalent  about  their 
fertility intentions fear of side effects can be enough of a deterrent for 
preventing  them  from  adopting  a  method.  However,  once  they  have  
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become highly motivated to limit or space their births fear of side effects 
is not longer sufficient to stop them from adopting a modern method.   
 
It seems from the above conclusions that there may be a tipping point 
between motivation and lack of understanding. With some motivation to 
avoid  pregnancy  women  will  seek  information  and  improve  their 
understanding  of  contraceptive  use.  When  they  are  then  exposed  to 
negative information and the possibility of side effects their motivation 
may  not  be  strong  enough  to  proceed  to  the  final  step  of  adopting  a 
method.  However  this  study  shows  that  with  sufficient  motivation  to 
avoid pregnancy and adequate counseling the fear of side effects can be 
overcome and the actual experience of side effects can be tolerated.  
 
The three different types of data have each contributed a new perspective 
on this issue and have come together successfully to provide both depth 
and  breadth  of  knowledge  on  this  issue.  Rather  than  being  combined 
within one study the different methodologies are able to stand alone and 
their  individual  strengths  can  be  fully  exploited.  The  combination  of 
methods,  each  with  their  own  strengths  and  weaknesses,  compliment 
each other as one method compensates for the weaknesses of another.  
 
6.3: Policy recommendations  
 
•  Current users should be encouraged to act as peer educators and 
share their positive experiences with potential users within their 
communities. Current users can be involved in IEC activities or 
other forms of peer to peer counselling. This should be done with 
care  to  protect  each  individual  from  any  social  consequences  of 
disclosing  their  contraceptive  status.  Increased  education  to 
improve  the  general  acceptability  in  the  community  of  modern 
method use will facilitate the use of peer educator and encourage 
women to adopt this role. 
•  Counselling  from  health  workers  is  extremely  important  in 
minimizing discontinuation rates and so effort should be expended  
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in  insuring  service  providers  are  well  trained  and  are  providing 
appropriate  and  adequate  counselling.  Additionally  how  side 
effects are dealt with when they do occur should be examined to 
avoid negative experiences. Side effects should not be dismissed or 
minimized,  in  particular  menstrual  changes  which  are  often 
experienced. 
•  Information acquired through informal communication should not 
be  dismissed  by  health  workers  but  rather  some  way  must  be 
found to communicate the relative uncommonness of these events 
and  that  there  is  not  necessarily  any  link  between  one  persons 
experience and another.  
•  In addition a very important but neglected and unregulated source 
of  contraceptives  is  pharmacies.  Widespread  availability  of 
methods undoubtedly increases the CPR; however an unintended 
effect of this is an increase in fear of side effects due to a lack of 
adequate counseling. More attention to the training of pharmacists 
to provide counseling on side effects may help to decrease misuse 
and hence the negative flow of information.   
•  Currently  particular  attention  needs  to  be  paid  to  this  issue  in 
southern Ghana and in the Ashanti region especially. However fear 
of side effects may increase as the CPR increases and women are 
exposed to more information and more examples of the potential 
negatives  of  using  a  modern  method.  This  means  that  in  other 
regions of Ghana as the CPR rises in the future so may the fear of 
side  effects  rise  and  service  providers  should  be  aware  of  this 
potential.  
•  Those who do not intend to use a method in the future because of 
fear  of  side  effects  are  more  alike  current  users  than  those  not 
intending to use for other reasons. Therefore they may be more 
likely  than  any  other  with  the  right  encouragement  and 
information, to change their future intentions and should therefore 
be targeted by service providers and IEC activities.   
•  The  models  show  that  each  individual  may  have  an  inherent 
capacity to tolerate side effects or not.  As such service providers  
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should as far as possible treat each case as individual and have the 
flexibility  to  respond  to  the  changing  needs  of  users  as  they 
progress through each episode of use.  
 
6.4: Suggestions for Further Study 
 
An obvious extension to this study would be to study the role of men in 
the  creation  of  fear  of  side  effects.  Husband’s  characteristics  could  be 
included  in  models  of  female’s  contraceptive  behaviour  or  models 
specified based solely on men’s data where the husband reports on his 
wife’s contraceptive use.  Qualitative research on this topic involving men 
would also be illuminating as their level of knowledge regarding these 
issues is unknown within the literature.  
 
This study concluded that it is not possible to predict fear of side effects 
based on socio economic characteristics and it would be interesting to see 
if this is also true for the actual experience of side effects. It would also be 
informative  to  model  the  occurrence  of  side  effects  as  the  outcome 
variable to determine if there is anything discernable about the individual 
which  makes  them  more  susceptible  to  side  effects,  or  more  likely  to 
report symptoms as side effects. 
 
One  of  the  real  strengths  of  this  study  has  been  the  availability  of  a 
longitudinal data from Ghana set appropriate for this study. Longitudinal 
studies in sub Saharan African settings are rare due to the expense and 
difficultly involved with their collection. The Cape Coast data is very rich 
and complex and there is the potential for more studies which could be 
done. The results of this study show that there is significant women level 
variation in propensity to discontinue so looking at the factors causing 
that  variation  may  help  programmes  to  better  target  their  limited 
resources. Event history analysis techniques such as multi state models 
could be used to include multiple transitions and periods of non use. In 
this way the individual could become the unit of analysis rather than the 
episode and each individual’s propensity to experience side effects and to  
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discontinue could be examined across multiple episodes, using different 
methods  and  including  periods  of  non use  and  other  reproductive 
behaviour across the whole study period.   
 
 
 
 
  
  222 
  Appendices  
 
Appendix 3A  
Focus Group Question Schedule 
 
1. Introduction 
 
Thank you all for coming today and taking part in this study. My name is 
(NAME)  and  I  will  be  leading  this  discussion  and  this  is  (NAME  OF 
ASSISTANT) who will be helping me. She will not be participating in the 
discussion but will just be listening and taking some notes. Before we begin I 
am going to tell you all about the study and exactly what is going to happen 
so that you can make sure that you want to carry on and you will know what 
to expect.  
 
INFORMED CONSENT PROCEDURE (see appendix 3C).  
 
We are really interested to hear what you think about these issues so please 
do not think that there is any right or wrong answers and feel free to say what 
you really feel. We want you to feel comfortable and just chat like you would 
if you were talking to friends. I have a list of the topics we want to cover but 
you will also be able to add anything else you think is important that I have 
not asked about. Finally we are interested in everyone’s opinions so please try 
to let everyone have a chance to speak. So, if everyone is ready we will turn 
on the tape now and begin. 
 
2. Opening questions (Ice Breaker)   
 
Can we please go around the group and introduce ourselves. Please tell us: 
Your name  
How old you are 
Are you married or not  
Who else is living with you in your household? 
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3. Discussion of family planning 
 
So, you have all heard about family planning but from where did you first 
learn about it? 
Where do you get information about family planning now? 
(IF NEEDED) Do you discuss family planning with other people? 
Who do you discuss family planning with? 
In what sorts of situation do you discuss family planning? 
If you wanted advice about family planning who would you talk to?  
Who  do  you  think  would  give  you  the  most  reliable  advice  about  family 
planning? 
Is there anyone you would not talk to about family planning? Why not? 
What sorts of things do people say to each other when they are discussing 
family planning?  
When people are discussing family planning do they tell each other about 
good experiences they have had? And bad experiences?  
 
4. Side effects 
 
So,  we  just  mentioned  that  sometimes  when  they  are  discussing  family 
planning people tell each other about bad experiences they have had. I would 
like to know more about this.  
You have mentioned side effects can you give some examples of what that 
might be? 
Are side effects related to using a particular method of contraception? 
How do you know about side effects? 
Who gets side effects? 
What can a person do if they have side effects? 
 
5. ‘Fear of side effects’  
When people say they are afraid of side effects what do you think they mean?  
For example: 
Are they afraid of being sick? Or of dying? 
Are they afraid they will not be able to get help?  
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Are they afraid of something happening now? 
Or in the future? 
Do you think all of the stories about side effects are true? 
Do you think people spread rumours about using contraception? For what 
reason? 
Do people believe them? 
Do  you  think  fear  of  side  effects  influence  peoples  attitude  to  family 
planning? 
Do  you  think  fear  of  side  effects  might  influence  whether  people  use 
contraceptives or not? 
Would it influence what type of method people used?  
Would it make a difference where they heard about side effects? Or from 
whom?  
Do you think there is anything that could be done to make people less afraid 
of side effects? 
 
6. Closing questions 
 
So,  I  think  we  have  covered  everything  now.  Before  we  finish  is  there 
anything else you would like to add?  
 
Okay so we are going to end the discussion and turn off the tape now. Thank 
you very much for participating and I hope that you enjoyed it. 
 
 
  Probes 
Can you explain that further? 
Can you say more? 
Could you give an example? 
Please say more. 
I don’t understand. 
Please describe what you mean.  
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Appendix 3B  
Study Information and Screening Questions 
 
Hello, my name is (NAME) and I am conducting a study here in (NAME 
OF VILLAGE). The Study is about family planning and contraceptive use 
and we are looking at how people get information about family planning 
and  how  they  share  information  with  others.  Specifically  we  are 
interested  in what people think about the side effects of contraceptive 
methods and how they learned what they know about this issue. Is it okay 
for  me  to  ask  you  a  few  questions  to  see  if  you  would  be  suitable  to 
participate in the study? 
 
Screening Questions 
 
Do you live in (NAME OF VILLAGE)?    YES    NO 
 
How old are you?          _______________ 
 
Have you ever heard about family planning and contraceptive use? 
 
YES    NO 
 
I would like to ask you to participate in the study I just told you about. 
You would need to come to (LOCATION OF FOCUS GROUPS) and have a 
discussion  with  around  6  other  women  from  this  village  about  family 
planning and how you share information. It would take about 2 hours and 
you would receive a small gift to thank you for taking the time.  
  
Are you interested in taking part?       YES    NO 
 
If NO, Thank them for their time. 
 
If YES, Provide them with details of an appropriate group and take their 
contact details if appropriate  
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Appendix 3C  
Verbal Informed Consent Procedure  
 
Study information 
This study is being conducted by Claire Bailey who is a research student 
studying for a PhD at the University of Southampton in the UK. The study 
is part of the PhD Thesis and will help Claire to complete her studies. 
Claire is working here in Ghana with the help of staff at the University of 
Cape Coast but her research is independent and she is not associated with 
any  government  or  non governmental  organization.  Claire’s  study  and 
this research is being funded by a UK government department called the 
Economic  and  Social  Research  Council.  The  results  of  the  study  will 
hopefully  be  published  in  a  journal  so  that  other  researchers  can 
understand the research but there will not be any direct intervention here 
in the village based on the results of the study. 
 
Neither Claire nor the other members of the research team are doctors or 
nurses or otherwise medically trained. We will not be able to help you 
with specific medical problems or provide medical advice or advice about 
family planning. If you have a specific problem we may be able to give you 
information about where you can go for help but that is all.  
 
The  study  is  all  about  contraceptive  use  among  women  in  Ghana  and 
specifically  it  is  interested  in  the  issue  of  people  being  afraid  to  use 
contraception  because  of  possible  side  effects.  We  would  like  to  know 
more about this issue from you and would like you to discuss this within 
the group. You will be asked to talk about how you get information about 
family planning and who you talk about it with. We will also discuss what 
you know about side effects and how you think that affects whether or not 
people  use  contraceptives.  We  are  interested  in  your  thoughts  and 
opinions. We would also be happy for you to discuss your own personal 
experiences but you do not have to if you don’t feel comfortable.  
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Whether or not you participate is totally up to you and you should not let 
anyone else decide this for you. If you decide to start the study but then 
later change your mind you can stop whenever you want and leave if you 
want and that will be no problem. Also if you want to continue with the 
study  but  do  not  feel  comfortable  talking  about  a  particular  topic  or 
answering a question you may say so and not answer that part but still 
carry on with the rest of the discussion. If you have any questions or are 
worried about anything at any time please say something so we can make 
sure you are comfortable.  
 
We  will  be  tape  recording  the  conversation  so  that  later  on  we  can 
remember exactly what we talked about. No one except the research team 
will ever listen to the tape. We will call each other by our names when we 
are  here  and  during  the  discussion  but  when  we  write  up  what  is 
discussed on the tapes we will not use your names at all and then the 
tapes will be erased. No one will be able to tell who you are or what you 
said by looking at the results of the study.  Only the research team and the 
other members of the group will hear what you say today. The research 
team have agreed not to tell anyone who said what during the discussion 
and we would like to ask you to please do the same. It is okay for you to 
tell people generally what you have talked about but please don’t mention 
any names or say exactly what each person said.  
 
Would you like to ask any questions? 
 
Okay so just to make sure that everyone is happy to carry on I’m going to 
ask you a few questions. 
 
MODERATOR: Please write the name of each participant in the space 
provided and then make a mark in the box if that respondent verbally 
answers yes to the following questions: 
 
1)  Do  you  understand  what  I  have  said  about  the  research  and  the 
purpose of the research?  
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2) Do you understand what you are being asked to do? 
 
3) Is it okay for you to talk about this topic? 
 
4) Do you feel like you have had a chance to ask any questions?  
 
5) Is it okay with you for us to tape record the conversation? 
 
6) Do you understand that you can leave the study at any time with out 
any problem? 
 
7) Do you understand that you can refuse to answer any question and still 
stay in the study? 
 
8) Do you understand that we will not use your name after the discussion 
and we will keep what you say private? 
 
9) Is it okay that we ask you to keep the discussion private? 
 
10) Do you agree to take part in this study? 
 
Participants 
name: 
Q 1  Q 2  Q 3  Q 4  Q5  Q6  Q7  Q8  Q9  Q10 
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Appendix 3D 
School of Social Science Research Ethics Committee 
Application   
 
School of Social Sciences 
                July 2006 
ETHICS COMMITTEE APPLICATION FORM  
 
 
Please note: 
•  You must not begin your study until ethical approval has 
been obtained.  
•  You must complete a risk assessment form prior to 
commencing your study.  
 
1.  Name(s):  Claire Elizabeth Bailey 
 
2.  Current Position MPhil/PhD student     
 
3.  Contact Details: 
Division/School  Division of Social Statistics 
      School of Social Sciences  
 
Email   ceb504@soton.ac.uk 
 
Phone 02380 593317 internal ext.23317 
 
 
4.  Is  the  proposed  study  being  conducted  as  part  of  an  education 
qualification (e.g., PhD) 
 
  Yes      No   
 
  
5.  If Yes, state name of supervisor (the supervisor should complete 
the declaration at the end of this form) 
 
   Dr Zoë Matthews 
 
 
6.  Title of Project:     
   
Fear  of  Side  Effects  as  a  Barrier  to  Contraceptive  Use  in  Ghana:  Paper  3  – 
Qualitative Data 
 
 
7.  What are the proposed start and end dates of the study? 
 
  Start: 16
th July 2007 End: 8
th October 2007  
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8.  Briefly describe the rationale, study aims and the relevant research 
questions 
   
Rationale 
 
Ghana  was  the  first  country  in  Sub-Saharan  Africa  to  implement  an  official 
population policy in 1969 in response to the recognition by the government of 
high fertility and high population growth rate and their potentially detrimental 
consequences. This policy  had only  a modest impact due to lack of political 
commitment and was revised in 1994 to take account of emerging issues such as 
the HIV/AIDS epidemic
1. The Vision 2020 Plan of Action was adopted of which 
the central aims are to eradicate poverty, accelerate economic development and 
enhance quality of life for all citizens. One goal of Vision 2020 is to have a 
contraceptive prevalence rate of modern methods of 50% by 2020. Knowledge of 
contraceptive methods in Ghana is almost universal with 98% of all women aged 
15-49  reporting  knowledge  of  at  least  one  method.  However  the  overall 
contraceptive  prevalence  rate  remains  relatively  low  at  20.7%  for  all  women 
aged 15-49 in 2003.  
 
Many studies have used large scale survey data to determine the socio-economic 
and  cultural  characteristics  which  may  act  as  determinates  of  individuals 
contraceptive  behaviour  and  in  doing  so  have  identified  several  barriers  to 
contraceptive use. One of the issues that is consistently raised in such studies in 
Sub-Saharan Africa is that of the non-use of contraceptive methods due to fear of 
side  effects.  According  to  the  2003  Ghana  Demographic  and  Health  Survey 
(GDHS), fear of side effects was the most cited method-related reason for non-
use among all women and is particularly cited by women aged less than 30. Fear 
of side effects has increased in importance as a reason for non-use between 1998 
and 2003, from 18% to 26%. 
 
While quantitative studies have highlighted this issue as a barrier to the use of 
modern methods, hormonal methods in particular, it remains an ill defined and 
poorly  understood  concept.  It  is  unclear  from  these  quantitative  measures  if 
respondents are referring to fear that a side effect of a contraceptive method will 
make a respondent unwell, fear that they will be unable to get medical care for a 
potential  side  effect  or  a  perceived  fear  of  side  effects  stemming  from 
misinformation and rumours. Each of these definitions would need very different 
policy or programmatic intervention if the fear of side effects were to be lessened 
as a barrier to contraceptive use; therefore a better understanding of this issue is 
required.  
 
 
 
                                                 
1 Ghana Statistical Service (GSS), Noguchi Memorial Institute for Medical Research 
(NMIMR) and ORC Macro (2004) Ghana Demographic and Health Survey 2003 GSS, 
NMIMR  and  ORC  Macro:  Calverton,  Maryland  USA  online  from  Measure  DHS  at 
http://www.measuredhs.com/pubs/pdftoc.cfm?ID=463 cited 09/06/05  
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Aims 
 
The key explanatory element in this study is the spread of information about 
family  planning  through  the  mass  media  and  inter-personally  through  social 
networks. When studying mass media effects it can generally be assumed that 
mass media messages are promoting family planning and may reduce fear of side 
effects by providing trustworthy information. However this assumption does not 
hold  for  interpersonal  discussion  with  relatives,  friends  and  neighbours  as 
negative  as  well  as  positive  experiences  may  be  shared  and  rumours  and 
misinformation can also be spread through a social network. Discussing family 
planning with others may be an important influence on reproductive behaviour as 
studies suggest that diffusion of innovation theory  states that while the mass 
media  is  effective  at  creating  awareness  and  knowledge  of  innovations, 
interpersonal communication is necessary for actual behaviour change.
2 
 
The aim of this paper is to use a qualitative methodology to explore in greater 
depth the way individuals perceive information about family planning and the 
way such information is received and passed on to others in the specific context 
of fear of side effects. The study aims to better define what is meant by the term 
fear  of  side  effect  in  this  particular  social  context  and  to  determine  on  what 
information and from what sources is this fear constructed. The study ultimately 
aims  to  explore  how  individuals  feel  that  different  types  and  sources  of 
information influence attitude, opinion and behaviour in relation to contraceptive 
use. Concurrently the nature of the methodology provides an insight into group 
dynamics and informal social interaction.  
 
Research Question 
 
The research questions for this section of the study are: 
 
•  How do women in Ghana define the term ‘fear of side effects’? 
•  How is information about contraceptive use passed from person to person 
through a social network? 
•  Does information received about contraceptive use from family, friends 
or neighbours influence attitudes towards contraceptive use, specifically 
fear of side effects? 
•  If  so  are  particular  people  or  types  of  information  more  or  less 
influential? 
•  Does fear of side effects influence contraceptive behaviour and act as a 
barrier to the use of modern or hormonal methods? 
  
 
 
 
 
                                                 
2 Hornik, R & McAnany, E. (2001) Theories and Evidence: Mass Media Effects and 
Fertility  Change  Communication  Theory  11  (4):  454-471  online  from  EBSCO  at 
http://ejournals.ebsco.com/direct.asp?ArticleID=QK962UBR85GRWVRA07GM>  cited 
02/07/05 
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9.  Briefly describe the design of the study 
 
This study forms one paper of a three paper PhD in which the issues of  inter-
personal discussion and fear of side effects are explored using three different 
methodologies and three different sources of data. Based on the same rationale 
each paper is essentially asking the same question of all three data sources but in 
each paper different aspects of the issue are being brought into focus by the 
differing methodologies.  The first paper uses the Ghana 2003 Demographic and 
Health  Survey  data  and  multi-level  logistic  regression  analysis  to  take  a 
nationally  representative  look  at  the  association  between  exposure  to  family 
planning information, through mass media and interpersonal channels, and the 
probability that a respondent will cite fear of side effects as their main reason for 
not  intending  to  use  a  contraceptive  method  in  the future.  The  second  paper 
overcomes  the  inherent  limitations  of  a  cross-sectional  survey  by  using  a 
longitudinal data set collected in the Cape Coast region of Southern Ghana. This 
paper will explore the relationship between knowledge of bad health effects from 
using modern contraceptive methods and the probability of subsequent adoption 
of such method. It is the third paper for which ethical approval is currently being 
sought  and the aims and research questions related to this study  are detailed 
above. 
 
The qualitative data collection will be carried  out in two village locations in 
Central Region and Western Region, Ghana. In order to spatially tie the different 
elements of the research together the locations have been chosen from the six 
locations used as data collection areas in the longitudinal study on which another 
paper in the thesis is based.  The two villages have been chosen primarily for 
practical purposes, based on their location and proximity to each other and to the 
University of Cape Coast which is the base location for the fieldwork. These two 
villages also share a common local language which reduces the need for multiple 
translations. The study locations will remain flexible until arrival in the field 
when they will be formally decided in light of actual field conditions. 
 
The methodology used for primary data collection is focus group discussions 
(FGDs). Upon arrival in the field a team of two research assistants will be hired 
and trained to act as moderator and assistant moderator for the FGDs as well as 
contributing to the specific wording of the materials to be used in the research. 
The research assistants will be female students or staff members of the Faculty of 
Social Sciences of the University of Cape Coast and will be recruited with the 
assistance of the Dean of the Faculty.  The research assistants will be fluent in 
both English and the local languages (Twi and/or Fante).  
 
12 focus groups will be conducted with 6-8 participants per group and organized 
in a multiple-layer design specified as follows: 
 
  Aged 30 or under  Aged over 30 
Village 1  3 groups  3 groups 
Village 2  3 groups  3 groups 
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The groups are split by age based on the previous findings of the 2003 Ghana 
Demographic Health Survey which suggested differentiation on the issue of side 
effects among respondents in these two aged groups
3.  
 
A preliminary copy of the focus group schedule is attached as appendix A. This 
schedule  is  subject  to  changes  in  wording  in  consultation  with  the  research 
assistants who will be  moderating the  focus  groups in order to use language 
appropriate to the local context and with which the moderator feels comfortable. 
The  schedule  may  also  be  translated  into  a  local  language  by  the  research 
assistants, although current advice suggests that this may not be necessary as the 
local languages do not have a strong written tradition and the research assistants 
may prefer to work with written English. This applies to all written material to be 
used in this research.   
 
10.  Who are the participants? 
 
The participants in this study are women in the age range 18-49 residing in one 
of  the  two  study  locations.  They  may  be  users  or  non-users  of  modern 
contraception but they will at some time in their lives have discussed family 
planning  or  contraception  with  someone  else.  Homogeneity  of  the  groups  is 
important in order to create a comfortable and permissive environment for the 
participants and aid in the analysis of the data across groups. By the design of the 
focus groups participants will be homogenous on the grounds of gender, age, and 
village of residence.  
 
11.  How will they be identified, approached and recruited to the study? 
(please attach a copy of the information sheet if you are using one) 
   
Participants  may  be  identified  in  a  number  of  ways  but  the  following  three 
strategies identified by Krueger and Casey (2000) are deemed to have the most 
potential for this study: 
 
•  Obtain lists of people  with the chosen observable characteristics from 
community organizations or village administration and sample potential 
participants from those lists. 
•  Piggyback  focus  groups.  Identify  local  meetings  or  events  at  a  place 
where participants come for recreation, shopping or some other purpose 
and then stop potential participants to ask screening questions then invite 
them to participate in a focus group.  
•  Snowball  sampling.  Once  some  participants  have  been  identified  use 
them to recruit/identify further potential participants.  
 
The  actual  identification  of  participants  will  be  finally  decided  taking  into 
consideration the field context and the local knowledge of the research assistants 
but at this stage it is felt that piggy back focus groups have the most practical 
                                                 
3 Ghana Statistical Service (GSS), Noguchi Memorial Institute for Medical Research 
(NMIMR) and ORC Macro (2004) Ghana Demographic and Health Survey 2003 GSS, 
NMIMR and ORC Macro: Calverton, Maryland USA online from Measure DHS at 
http://www.measuredhs.com/pubs/pdftoc.cfm?ID=463 cited 09/06/05  
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potential for this study. This strategy for identifying participants mentions the 
possibility of conducting the groups very close to the original meeting or event 
both in time and place but this does not have to be the case and participants can 
also be recruited for a focus group conducted at some other time.  
 
Once identified on the basis of observable charichteristics participants will be 
approached by a research assistant and given a short verbal introduction to the 
study  they  will  then  be  asked  a  few  screening  questions  to  determine  their 
suitability  and  into  which  group  they  should  be  placed.    If  the  participant 
expresses interest in taking part they will be invited to a group and given the 
required  details.    The  introductory  information  and  screening  questions  are 
attached as appendix B. 
 
 
12.  How will you obtain the consent of participants?  
  (Please attach a copy of the consent form if you are using one) 
 
The process of gaining informed consent is central to the research process. Legal 
definitions  of  consent  comprise  three  elements,  capacity,  the  ability  to  make 
rational  decisions,  voluntariness,  decision-making  free  of  coercion,  and 
information,  being  fully  and  effectively  advised  of  the  implications  of 
participation.
4  The basic principle of informed consent is that participants are 
given enough information to allow them to make decisions about the potential 
risks  and  benefits  of  participation.
5  The  process  of  informed  consent  usually 
involves a written information sheet and a form to be signed by the participant 
formally giving consent. However this process does not take into account the 
socio-cultural  setting  of  this  study  in  which  a  proportion  of  the  potential 
participants can reasonably be expected to have low literacy skill and a limited 
educational  background.    According  to  UNESCO  statistics  the  adult  female 
literacy rate in Ghana for 200-04 was 65.9%, which suggests that given a random 
sample one could expect one third of potential participants to be illiterate.
6 Van 
Den  Hoonaard
1  points  out  that  informed  consent  must  be  tailored  to  the 
circumstances of the potential participants and take into account participant’s 
skills including level of reading recognition and comprehension. Further to this 
Oliver  (2003)  notes  that  a  way  should  be  found  to  explain the  basics  of  the 
research  to  the  participants  in  a  manner  which  they  understand  which  may 
involve overcoming limitations of language and limited education. 
7 
 
 
 
 
                                                 
4 Van Den Hoonaard, Will C. (Ed.) (2002) Walking the Tightrope: Ethical Issues for 
Qualitative Researchers  University of Toronto Press: London 
5 Gregory Ian (2003) Ethic in Research Continuum: London 
6  UNESCO  (2005)  EFA  Global  monitoring  Report  2005  online  from  UNESCO  at 
http://portal.unesco.org/education/en/ev.php-
URL_ID=35313&URL_DO=DO_TOPIC&URL_SECTION=201.html cited 23/05/07 
7 Oliver P. (2003) ‘The Students Guide to Research Ethics’ Open University Press: 
Maidenhead Berkshire  
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In  its  guidelines  for  research  involving  people  in  developing  countries  the 
Wellcome Trust state the following: 
‘The  process  [of  obtaining  consent]  is  more  important 
than the signing of a consent form, which should only be 
regarded as evidence that a consent process has been 
carried out. Written consent may not always be the most 
appropriate form of recording consent, for example where 
participants  are  visually  impaired  or  illiterate.  In  such 
cases,  it  is  recommended  that  alternative  forms  of 
recording consent be used. These could include making 
a note of verbal consent in a participant’s personalised 
record or making an audio or video tape.’8 
In  this  study  the  basics  of  the  research  and  the  issues  of  anonymity, 
confidentially, withdrawal from the study, and audio recording will be verbally 
explained  to  participants  by  the  focus  group  moderator  before  the  discussion 
begins. The moderator will have a check list of items to mention and will be 
required to gain a verbal response from each participant at each item which will 
then be noted by the moderator.  The explanation and the check list are included 
as appendix C but these may be subject to change in consultation with the local 
research assistants in order to ensure the terminology and phrasing is acceptable 
in  the  local  context.    Although  not  all  of  the  participants  will  have  limited 
literacy it is felt by the researcher that introducing different procedures based on 
education level is unnecessarily highlighting a difference to the members of each 
focus  group.  This  could  severely  impede  the  discussion  in  the  group  by 
introduction  a  structure  of  hierarchy  or  status  based  on  education  level  and 
making the less educated members of the group feel inferior or inadequate.   
 
 
13.  Is there any reason to believe participants may not be able to give 
full 
  informed consent? If yes, what steps do you propose to take to  
  safeguard their interests? 
 
Other than the issues of literacy and education level previously mentioned there 
is no reason to believe participants will not be able to give full informed consent. 
 
 
 
                                                 
8  Wellcome  Trust  (Undated)  Research  Involving  People  in  developing  Countries: 
Position Statement and Guidance Notes for Applicants online at  
http://www.wellcome.ac.uk/doc_wtd015295.html#P96_10119 cited 20/05/07 
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14.  If participants are under the responsibility or care of others (such 
as  parents/carers,  teachers  or  medical  staff)  what  plans  do  you 
have to obtain permission to approach the participants to take part 
in the study? 
   
N/A 
   
15.  Briefly  describe  what  participation  in  the  study  will  involve  for 
study  participants.  Please  attach  copies  of  any  questionnaires 
and/or interview schedules to be used 
 
Each participant will take part in a focus group discussion about how people 
receive  and  pass  on  information  about  contraception,  the  content  of  this 
information,  and  in  what  way  this  information  influences  attitudes  and 
behaviour. The discussion will be with a small group of 6 to 8 peers and will take 
approximately  2  hours  altogether.  (The  focus  group  schedule  is  attached  as 
appendix  A).  Each  participant  will  receive  a  small  gift,  probably  a  food  or 
household item such as soap or sugar, in compensation for their time. This is not 
intended as an incentive to attend the focus group as its primary function is not 
recruitment or stimulus to attend a session but rather as a token of appreciation.
9 
 
 
16.  How will it be made clear to participants that they may withdraw 
consent 
  to participate at any time without penalty? 
   
It will be made clear to participants during the informed consent procedure that 
their participation is entirely voluntary and they may withdraw from the study at 
any time. It will also be made clear that participants are not obliged to discuss 
particular  topics  that  they  are  not  comfortable  with  and  they  may  refuse  to 
answer specific questions without having to withdraw themselves entirely from 
the study.  
 
Gifts given to participants in compensation for their time will be given when 
they  arrive  at  the  study  location  rather  then  after  the  discussion  is  over  to 
reinforce the idea that they may leave at any time and that the compensation is 
not dependant on a participant staying until the end of the discussion if they do 
not wish.  
 
17.  Detail any possible distress, discomfort, inconvenience  or other 
adverse effects the participants may experience, including after the 
study, and how this will be dealt with. 
 
The nature of the topic raises some issues which have the potential to cause 
distress  for  the  participants.  Issues  may  be  raised  such  as  recalling  stressful 
events  such  as  episodes  of  poor  health  due  to  adverse  side  effects  or  family 
conflict over the use of contraception which could cause a participant to become 
upset at the time of the discussion.  In the  context of a focus  group it  is the 
responsibility  of  the  moderator  to  structure  the  discussion,  encourage  active 
                                                 
9 Krueger, Richard A. & Casey, Mary Anne (2000) Focus Groups: A Practical Guide for 
Applied Research Sage Publications Ltd.: London   
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participation and prevent heated debates or personal attacks.
10  The moderator 
will also be looking out for signs of distress or discomfort in participants and 
will ensure that they are happy to carry on. 
 
It is also possible that participants may be happy to get a chance to talk about 
their life and feel that someone is concerned for them and is listening to their 
story  which  may  mitigate  any  personal  distress  felt  at  the  time.  As  a  result 
overall the participants may feel more valued and have an enhanced sense of 
their own self worth.
11 
 
It is possible that a participant may disclose personal information in the course of 
the discussion which on reflection they may rather not have shared which could 
cause then to be distressed. All participants will be asked to keep the contents of 
the discussion confidential during the informed consent process and this will be 
re-iterated to them at the end of the discussion. Of course participants’ actions 
after the group cannot be guaranteed so there is also possible disclosure to other 
members of the community which all members will be made aware of.  
  
There is also the issue that the members of each group will likely know each 
other in some respect and will possible have to face each other again in daily life.  
There are arguments within the literature about the effect of conducting focus 
groups  with  participants  who  know  each  other  and  there  is  a  possibility  that 
participants may be more reluctant to disclose personal information in a group of 
people they know and are likely to see again. However, in village settings such 
as  those  in  this  study  it  is  virtually  impossible  to  put  together  groups  of 
participants who do not already know each other to some degree.  It is felt that 
the topic of contraception and contraceptive use is not sufficiently sensitive as to 
present  a  problem  in  this  regard  and  participants  will  be  made  aware  in  the 
informed consent process that they may refuse to answers specific questions or 
disclose certain personal information if they wish. One of the benefits of using 
focus  groups discussions is that participants are free to talk in  general  terms 
about the community as a whole if they so wish rather than being forced to 
reveal to personal information.  The researcher will also strive not to have family 
members participate in the same groups if possible.  
 
18.  How will participant anonymity and confidentiality be maintained? 
 
Anonymity 
 
The anonymity of focus group respondents will be preserved in a number of 
ways. As the purpose of focus groups is to compare and contrast opinion across a 
range of groups rather than individuals within each group it is not necessary to 
                                                 
10 May, T. (2001) Social Research – Issues, Methods and Process (3
rd edition) Open 
University Press: Buckingham 
11 Oliver P. (2003) ‘The Students Guide to Research Ethics’ Open University Press\: 
Maidenhead Berkshire 
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maintain  references  to  individual  identity  beyond  the  data  collection  stage.
12 
When the interview tapes are transcribed names of individuals will not be used 
and  where  it  is  desirable  to  distinguish  between  individuals  numbers  will  be 
assigned by the researcher. Any personal and identifying information disclosed 
by participants in the opening questions of the group, which are designed to get 
people  talking  and  are  not  of  substantive  interest  to  the  analysis  will  not  be 
transcribed. Where participants make reference to third parties during the course 
of conversation any identifying information related to those third parties, such as 
names  or  addresses,  will  be  replaced  at  the  time  of  transcription  with  false 
identity data in such a way that the meaning of the conversation is preserved. 
Only  anonymous  transcripts  of  the  data  will  be  used  for  analysis  and  any 
resulting publications. 
 
Confidentiality 
 
Only the researcher and/or members of the research team will be present at the 
time  of  the  focus  groups  or  interviews.  Only  the  research  team,  along  with 
translator/transcribers  in  the  event  that  they  are not  members  of  the  research 
team, will have any access to the original recordings.   All participants will be 
asked not to discuss the specific contents of their focus group discussion with 
other people after it has taken place. 
 
 
19.  How will data be stored securely during and after the study? 
 
During the study: 
Recordings from the mini-disc recorder will be uploaded at the earliest possible 
opportunity  to  the  researcher’s  laptop  which  is  password  protected  and  only 
accessible by the researcher. In the event that these files need to be transferred to 
other computers for the purposes of transcription, files will be transferred by the 
researcher personally on a password protected USB device. Once the necessary 
transcription has taken place any copies of files, either audio or text will then be 
deleted leaving only the primary researchers lap-top and USB back-up copies. 
Any hardcopy paperwork related to the focus groups or focus group participants 
will be kept by the researcher in as secure a place as possible i.e. within locked 
personal or office accommodation. 
 
After the study: 
Recordings will be erased from the minidisk recorder and electronic audio files 
and  transcripts  will  be  stored  on  both  the  researchers’  personal  laptop  and 
University file storage area which are both password protected. In the event that 
other forms of backup are required these will be either on a password protected 
USB device or on CD’s which will be kept locked in a filing cabinet for which 
the researcher is the sole key holder. Any hardcopy material will also be kept in 
this filling cabinet or if no longer needed will be shredded and disposed of as 
sensitive waste.  
 
 
                                                 
12 Krueger, Richard A. & Casey, Mary Anne (2000) Focus Groups: A Practical Guide 
for Applied Research Sage Publications Ltd.: London   
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20.  Describe any plans you have for feeding back the findings of the 
study to participants 
   
There are currently no plans in place for feeding back the findings of the study to 
the participants. It is expected that either a final version of the resulting paper or 
a summary of such will be sent to the research team after the completion of the 
PhD.  This  document  may  also  be  distributed  to  participants  who  specifically 
request it at the time of the focus group. It is felt at this time that it is unlikely 
that will occur as the participants will be made aware that the only outcome of 
the study will be in English and will be a written document. The researcher is 
aware  that  this  will  limit  the  accessibility  of  the  findings  to  the  participants. 
Should individuals request a written document the form of this will be explained 
to  them  and  their  contact  details  will  be  obtained  and  keep  secure  until  a 
summary of findings can be made available. 
 
21.  What are the main ethical issues raised by your research and how 
do you intend to manage these? 
 
The main ethical issues of this research are informed consent, anonymity and 
confidentiality;  strategies  for  the  management  of  these  have  previously  been 
mentioned. Other issues arise due to the sensitive nature of the topic and its 
context in a developing country. The fact that the study is about contraceptive 
use will be made clear to potential participants from the very beginning and so 
they  will  be  able  to  judge  for  themselves  if  they  consider  this  a  particularly 
sensitive area and if they would be comfortable talking about this is a group 
context. The researcher will ensure that participants remain free from coercion 
and  are  fully  informed  about  the  nature  of  the  study  before  they  give  their 
informed  consent.  The  fact  that  the  research  is  taking  place  in  a  developing 
country  context  creates  an  inherent  power  imbalance  and  significant  cultural 
differences between researcher and participant.  This will be managed by having 
the actual research conducted by local research assistants who will be asked to 
consult  on  all  aspects  of  the  research  prior  to  data  collection  to  ensure  it  is 
appropriate to the local context.  Any possible bias in the analysis of results 
arising from the researchers’ cultural background will be kept to a minimum 
through the constant awareness of the researcher of this danger and transparency 
in the process of analysis.  
 
 
22.  Please outline any other information you feel may be relevant to 
this  
   submission 
   
  N/A 
 
 
 
Please include your research proposal with this form 
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Appendix A – Focus group Question Schedule 
 
1. Introduction 
 
Thank  you  all  for  coming  today  and  taking  part  in  this  study.  My  name  is 
(NAME)  and  I  will  be  leading  this  discussion  and  this  is  (NAME  OF 
ASSISTANT)  who  will  be  helping  me.  She  will  not  be  participating  in  the 
discussion but will just be listening and taking some notes. Before we begin I am 
going to tell you all about the study and exactly what is going to happen so that 
you can make sure that you want to carry on and you will know what to expect.  
 
INFORMED CONSENT PROCEDURE (see appendix C).  
 
We are really interested to hear what you think about these issues so please do 
not think that there is any right or wrong answers and feel free to say what you 
really feel. We want you to feel comfortable and just chat like you would if you 
were talking to friends. I have a list of the topics we want to cover but you will 
also be able to add anything else you think is important that I have not asked 
about.  Finally  we  are  interested  in  everyone  opinions  so  please  try  to  let 
everyone have a chance to speak. So, if everyone is ready we will turn on the 
tape now and begin. 
 
2. Opening questions (Ice Breaker)  
 
Can we please go around the group and introduce ourselves. Please tell us: 
•  Your name  
•  How old you are 
•  Are you married or not  
•  Who else is living with you in your household? 
 
3. Discussion of family planning 
 
So, you have all heard about family planning but from where did you first learn 
about it? 
Where do you get information about family planning now? 
(IF NEEDED) Do you discuss family planning with other people? 
Who do you discuss family planning with? 
In what sorts of situation do you discuss family planning? 
If you wanted advice about family planning who would you talk to?  
Who  do  you  think  would  give  you  the  most  reliable  advice  about  family 
planning? 
Is there anyone you would not talk to about family planning? Why not? 
What sorts of things do people say to each other when they are discussing family 
planning?  
When people are discussing family planning do they tell each other about good 
experiences they have had? And bad experiences?  
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4. Side effects 
 
So, we just mentioned that sometimes when they are discussing family planning 
people tell each other about bad experiences they have had. I would like to know 
more about this.  
You have mentioned side effects can you give some examples of what that might 
be? 
Are side effects related to using a particular method of contraception? 
How do you know about side effects? 
Who gets side effects? 
What can a person do if they have side effects? 
 
5. ‘Fear of side effects’  
When people say they are afraid of side effects what do you think they mean?  
For example: 
Are they afraid of being sick? Or of dying? 
Are they afraid they will not be able to get help? 
Are they afraid of something happening now? 
Or in the future? 
Do you think all of the stories about side effects are true? 
Do  you  think  people  spread  rumours  about  using  contraception?  For  what 
reason? 
Do people believe them? 
Do you think fear of side effects influence peoples attitude to family planning? 
Do you think fear of side effects might influence if people use contraceptives or 
not? 
Would it influence what type of method people used?  
Would it make a difference where they heard about side effects? Or from who?  
Do you think there is anything that could be done to make people less afraid of 
side effects? 
 
6. Closing questions 
 
So, I think we have covered everything now. Before we finish is there anything 
else you would like to add?  
 
Okay so we are going to end the discussion and turn off the tape now. Thank you 
very much for participating and I hope that you enjoyed it. 
 
 
Probes 
Can you explain that further? 
Can you say more? 
Could you give an example? 
Please say more. 
I don’t understand. 
Please describe what you mean.  
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Appendix B – Study information and screening questions 
 
Hello, my name is (NAME) and I am conducting a study here in (NAME OF 
VILLAGE). The Study is about family planning and contraceptive use and we 
are looking at how people get information about family planning and how they 
share information with others. Specifically we are interested in what people think 
about the side effects of contraceptive methods and how they learned what they 
know about this issue. Is it okay for me to ask you a few questions to see if you 
would be suitable to participate in the study? 
 
Screening Questions 
 
1)  Do you live in (NAME OF VILLAGE)?    YES    NO 
 
2)  How old are you?          _______________ 
 
3)  Have you ever heard about family planning and contraceptive use? 
 
YES    NO 
 
 
4)  Have you ever discussed family planning with another person (other than 
your husband if you are married)? 
YES    NO 
 
 
I would like to ask you to participate in the study I just told you about. You 
would  need  to  come  to  (LOCATION  OF  FOCUS  GROUPS)  and  have  a 
discussion with around 6 other women from this village about family planning 
and how  you share information.  It would take  about 2 hours and  you  would 
receive a small gift to thank you for taking the time.  
  
Are you interested in taking part?        YES    NO 
 
If NO, Thank them for their time. 
 
If YES, Provide them with details of an appropriate group and take their contact 
details if appropriate.  
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Appendix C – Informed consent 
 
Study information 
This  study  is  being  conducted  by  Claire  Bailey  who  is  a  research  student 
studying for a PhD at the University of Southampton in the UK. The study is part 
of the PhD Thesis and will help Claire to complete her studies. Claire is working 
here in Ghana with the help of staff at the University of Cape Coast but her 
research is independent and she is not associated with any government or non-
governmental organization. Claire’s study and this research is being funded by a 
UK government department called the Economic and Social Research Council. 
The results of the study will hopefully be published in a journal so that other 
researchers  can  understand  the  research  but  there  will  not  be  any  direct 
intervention here in the village based on the results of the study. 
 
Neither Claire nor the other members of the research team are doctors or nurses 
or otherwise medically trained. We will not be able to help you with specific 
medical problems or provide medical advice or advice about family planning. If 
you  have  a  specific  problem  we  may  be  able  to  give  you  information  about 
where you can go for help but that is all.  
 
The study is all about contraceptive use among women in Ghana and specifically 
it is interested in the issue of people being afraid to use contraception because of 
possible side effects. We would like to know more about this issue from you and 
would like you to discuss this within the group. You will be asked to talk about 
how you get information about family planning and who you talk about it with. 
We will also discuss what you know about side effects and how you think that 
affects  whether  or  not  people  use  contraceptives.  We  are  interested  in  your 
thoughts and opinions. We would also be happy for you to discuss your own 
personal experiences but you do not have to if you don’t feel comfortable.  
 
Whether or not you participate is totally up to you and you should not let anyone 
else decide this for you. If you decide to start the study but then later change 
your mind you can stop whenever you want and leave if you want and that will 
be  no  problem.  Also  if  you  want  to  continue  with  the  study  but  do  not  feel 
comfortable talking about a particular topic or answering a question you may say 
so and not answer that part but still carry on with the rest of the discussion. If 
you have any questions or are worried about anything at any time please say 
something so we can make sure you are comfortable.  
 
We will be tape recording the conversation so that later on we can remember 
exactly what we talked about. No-one except the research team will ever listen to 
the tape. We will call each other by our names when we are here and during the 
discussion but when we write up what is written on the tapes we will not use 
your names at all and then the tapes will be erased. No-one will be able to tell 
who you are or what you said by looking at the results of the study.  Only the 
research team and the other members of the group will hear what you say today. 
The  research  team  have  agreed  not  to  tell  anyone  who  said  what  during  the 
discussion and we would like to ask you to please do the same. It is okay for you 
to tell people generally what you have talked about but please don’t mention any 
names or say exactly what each person said.   
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Would you like to ask any questions? 
 
Okay so just to make sure that everyone is happy to carry on I’m going to ask 
you a few questions. 
 
MODERATOR: Please write the name of each participant in the space provided 
and then make a mark in the box if that respondent verbally answers yes to the 
following questions: 
 
1) Do you understand what I have said about the research and the purpose of the 
research? 
 
2) Do you understand what you are being asked to do? 
 
3) Is it okay for you to talk about this topic? 
 
4) Do you feel like you have had a chance to ask any questions?  
 
5) Is it okay with you for us to tape record the conversation? 
 
6) Do you understand that you can leave the study at any time with out any 
problem? 
 
7) Do you understand that you can refuse to answer any question and still stay in 
the study? 
 
8) Do you understand that we will not use your name after the discussion and we 
will keep what you say private? 
 
9) Is it okay that we ask you to keep the discussion private? 
 
10) Do you agree to take part in this study? 
 
 
Participants 
name: 
Q 1  Q 2  Q 3  Q 4  Q5  Q6  Q7  Q8  Q9  Q10 
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Appendix 3E 
Letter of Research Ethics Approval from School of Social 
Science Research Ethics Committee, University of 
Southampton  
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Appendix 4A  
Calendar data preparation   contraceptive use status  
 
In the calendar data contraceptive use is recorded by month in four different 
variables:  cs1,  cs2,  cs3  and  cs4.  Contraceptive  users  can  be  recorded  as 
simultaneously using up to four methods. In order to create one variable to 
measure contraceptive use dynamics over time these multiple entries must 
be combined.   
Multiple entries occur in two circumstances: 
1   Where method use is recorded in such a way that methods which are 
often  naturally  combined  to  make  a  contraceptive  strategy  are 
recorded  as  separate  methods  being  used  simultaneously.  For 
example where rhythm method/periodic abstinence may be recorded 
simultaneously  with  withdrawal  or  condom  use.  On  occasion  the 
methods  used  together  may  not  form  a  natural  combination,  for 
example using the pill and rhythm method simultaneously and those 
cases might be described as redundant use. The strategy for dealing 
with this is based on the efficacy of the method with the most effective 
method taking priority,  as follows: 
•  Where one method is modern and one (or more) is traditional 
the modern method is recorded e.g. if rhythm and condom are 
both  reported  over  the  same  period  of  continuous  use  then 
condom is used 
•  Where one method is reported in a consistent episode lasting 3 
or  more  months  and  a  subsequent  method  is  reported 
simultaneous  to  only  one  month  of  the  episode  then  the 
continuously used method is reported for that month and the 
episode  is  not  considered  interrupted,  e.g.  if  a  continuous 
episode of rhythm method lasting 9 months has one of those 
months  also  coded  as  condom  then  that  month  is  coded 
rhythm.  
•  Where  both  methods  are  modern  the  following  hierarchy  is 
followed: 
i.  Injection  (note:  injection  was  favoured  over  all  others 
where recording injection preserved a spell of injectable 
use and/or preserved the minimum 3 month injectable 
spell length) 
ii.  Pill 
iii.  Condom 
iv.  IUD 
v.  Foam/jelly/diaphragm 
NOTE: there were  no  conflicting cases with  sterilization and 
Norplant 
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•  Where  more  than  one  traditional  method  is  used  the  following 
hierarchy is used: 
vi.  Rhythm  
vii.  Withdrawal 
viii.  Herbs 
ix.  Other 
NOTE:  Where  following  this  hierarchy  would  result  in  one 
month  of  use  of  a  method  interrupting  a  continuous  spell  of 
another method then the continuous spell was preserved.  
 
2  –  The  second  occasion  where  two  (or  more)  methods  are  recorded  per 
month is at the transition periods between episodes of use/non use. In this 
case the methods were not used simultaneously but rather were both used 
alone within a single unit of time. In these cases that month was coded as the 
method  for which  the  episode  is beginning.  For  example,  if  a respondent 
switched from pill to injection and at the month of the switch both methods 
were recorded then that month would be considered injection. Where there 
was one month of non use recorded simultaneous to the new method then 
the new method was used for that month so the switch appears without a 
break between methods.    
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Appendix 4B 
Example of Data File Structure 
 
Both examples show one individual woman who contributes three different 
episodes of use to the dataset. The first episode is a 7 month long episode of 
pill use which ends in a discontinuation. The second episode is a 10 month 
long episode also of pill use and also ending in a discontinuation. The third 
episode is a 3 month long episode of injectable use which ends by being right 
censored due in this case to the end of the observation period (or in other 
case potentially due to the individual being lost to follow up).  
 
The woman month file structure shows that this individual contributes the 
first  20  cases  (months)  and  the  first  3  episodes  to  the  data  set.    The 
individual experiences four months of side effects in total with one of those 
months being in the last month of the first episode of pill use. Hence this 
whole  episode  is  coded  1  for  variable  se2  (side  effect  experienced  in  last 
episode of month). This episode will be considered as discontinued due to 
side effects provided that the episode was not followed within 9 months by a 
pregnancy and the individual was still at risk of pregnancy (i.e. they were not 
abstaining and/or their husband was not away) at the end of the episode. 
Side effects were also experienced in the subsequent episode of pill use and 
the variable se will have been coded 1 for all months of the episode to reflect 
this. However this episode will not be considered to have been discontinued 
due to side effects given that they did not  occur in the last month of the 
episode.  
 
The episode based file example shows that in this format time is recorded as 
the total length of the episode and realtime is recorded as the month the 
episode  started.    The  time  varying  variables  cannot  be  included  in  the 
episode based file and se and se2 capture the occurrence of a side effect in 
any month of the episode or in the final month of the episode respectively. 
The  episode  based  example  shows  that  variables  that  are  fixed  across  
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episode, such as age or method, can still vary across women. Other variables, 
such  as  ethnicity  or  community  (not  shown  here),  are  also  fixed  across 
woman.  
Example of Woman Month file 
Case 
ID 
Woman 
ID 
Episode 
ID 
time  Real 
time 
duration  method  event  se 
vary 
se2  age 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
3 
3 
3 
1 
2 
3 
4 
5 
6 
7 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
1 
2 
3 
24 
25 
26 
27 
28 
29 
30 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
69 
70 
71 
0 6 
0 6 
0 6 
0 6 
0 6 
0 6 
7 12 
0 6 
0 6 
0 6 
0 6 
0 6 
0 6 
7 12 
7 12 
7 12 
7 12 
0 6 
0 6 
0 6 
pill 
pill 
pill 
pill 
pill 
pill 
pill 
pill 
pill 
pill 
pill 
pill 
pill 
pill 
pill 
pill 
pill 
inject 
inject 
inject 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
1 
0 
0 
1 
0 
0 
0 
0 
0 
1 
1 
0 
0 
0 
0 
0 
0 
1 
1 
1 
1 
1 
1 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
16 24 
25 34 
25 34 
25 34 
 
Example of Episode Based File 
Woman 
ID 
Episode 
ID 
episode  time  realtime  method  event  se  se2  age 
1  1  3  7  24  pill  1  1  1  16 24 
1  2  3  10  38  pill  1  1  0  16 24 
1  3  3  3  69  inject  0  0  0  25 34 
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Appendix 4C  
Study Variable Code Book  
EF  variable appears in episode based file only 
WM  variable appears in women month file only 
BOTH  variable appears in both files with the same coding 
Time 
varying 
in the WM file the variable can take a different value for each month of 
the episode 
Fixed  for 
episode 
in the WM file the variable takes the same value for each month of the 
episode, in the EF the value appears once per episode and can vary 
within woman 
Fixed  for 
woman 
in  the  WM  file  the  variable  takes  the  same  value  for  each  month 
contributed by the same woman, in the EF the value appears once per 
episode and is fixed for each episode contributed by the same woman 
 
Variable 
Name 
File   Variable Description  Category Coding 
caseID  WM  unique  women month 
identifier – Time varying 
continuous 1   8937 
episodeID  BOTH  unique  episode  identifier    
fixed for episode 
continuous 1   732 
womenID  BOTH  unique  women  identifier    
fixed for episode 
continuous 1   476 
episode   BOTH  total  number  of  episodes 
per  women     fixed  for 
episode  
continuous 1   6  
time  WM  length of episode in months 
– Time varying 
Continuous 2   60 
realtime  WM  real  time  month  episode 
begins – Time varying 
Continuous 13   73 
time2  EF  Total  length  of  episode  – 
fixed for episode 
Continuous 2   60 
realtime2  EF  Real time month of the first 
month of episode   fixed for 
episode 
Continuous 13   72 
event  EF  Occurrence  of  a 
discontinuation  (or  not)    
fixed for episode 
1 = event (discontinuation or switch) 
0 = no event 
sevary  WM  Monthly side effects data    
time varying 
1 = dizziness 
2 = weight gain 
3 = weight loss 
4 = headache 
5 = bleeding 
6 = irregular periods 
7 = painful periods 
8 = cramps 
9 = heart 
10 = martial 
11 = loss of pleasure 
12 = loss of sexual function 
13 = weakness 
14 = other  
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Variable 
Name 
File   Variable Description  Category Coding 
se  BOTH  Any  type  of  side  effect 
experienced  in  ANY  month 
of  episode       fixed  for 
episode 
0 = no 
1 = yes 
se2  BOTH  Any type of side effect in the 
LAST  month  of  episode    
fixed for episode  
0 = no 
1 = yes 
method  BOTH  Contraceptive  method    
fixed for episode  
1 = pill 
2 = injectable 
3 = foam/diaphragm/jelly 
4 = condom 
5 = IUD 
8 = rhythm 
9 = withdrawal 
10 = herbs 
11 = Norplant 
12 = post partum abstinence 
15 = other 
method2  BOTH  Contraceptive  method  – 
four  categories     fixed  for 
episode 
1 = pill 
2 = injectable 
3 = condom 
4 = other 
method3  BOTH  Contraceptive  method  – 
modern/traditional     fixed 
for episode 
1= modern method 
2 = traditional method 
panel  EF  closest prior panel interview 
to the first month of episode 
  fixed for episode 
1   7 
everpill  BOTH  women has used pill before 
prior  to  round  1  or  in 
previous  episode  within 
calendar   fixed for episode 
0 = no 
1 = yes 
everinj  BOTH  women  has  used  injection 
before prior to round 1 or in 
previous  episode  within 
calendar   fixed for episode 
0 = no 
1 = yes 
end  BOTH  event  that  ends  episode    
fixed for episode 
0 = right censored 
1 = discontinuation 
2 = switch 
abstainvary  WM  Respondent  abstaining  – 
Time varying 
0 = no 
1 = yes 
abstain  BOTH  Respondent  abstaining  at 
the  time  of  discontinuation 
  fixed for episode 
0 = no 
1 = yes 
awayvary  WM  husband  away  –  Time 
varying 
0 = no 
1 = yes 
away  BOTH  husband away at the time of 
discontinuation     fixed  for 
episode 
0  =  no  (or  episode  is  censored  or 
ends in a switch) 
1 = yes 
preg  BOTH  woman is pregnant within 9 
months  of  discontinuation 
of  episode     fixed  for 
episode 
0  =  no  (or  episode  is  censored, 
calendar  period  ends  before  9 
months or episode ends in a switch) 
1 = yes  
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Variable 
Name 
File   Variable Description  Category Coding 
HWvary  WM  encouragement  given  by  a 
health  worker   month 
varying 
0 = no 
1 = yes 
HW  BOTH  encouragement  given  by  a 
health worker in any one or 
more months of the episode 
  fixed for episode 
0 = no 
1 = yes 
age  BOTH  age  of  respondent  at  first 
month of episode    fixed for 
episode 
1 = 16 24 
2 = 25 34 
3 = 35 49 
event  WM  Occurrence  of  a 
discontinuation  (or  not)    
month varying 
1 = event (discontinuation or switch) 
0 = no event 
ethnicity  BOTH  respondents  ethnicity    
fixed for woman 
1 = Fante 
2 = Ga   Adangbe 
3 = other/Denkyira/ Ahanta/ Ewe 
village  BOTH  respondents  village     fixed 
for woman 
1 6 
religion  BOTH  respondents religion   fixed 
for woman 
1 = Catholic 
2 = Protestant 
3 = Moslem 
4 = Pentecostal 
5 = other/none/traditional/syncretic 
educ  BOTH  respondents highest level of 
education       fixed  for 
woman 
0= none 
1=primary 
2 = middle/junior secondary 
3 = secondary/ higher 
ceb  BOTH  children  ever  born    at  the 
start  of  the  episode     fixed 
for episode 
0 = none 
1 = 1 or 2 
2 = 3 or 4 
3 = 5 or more 
fecund  BOTH  When  you  want  to  become 
pregnant,  do  you  become 
pregnant  quickly  or  does  it 
take a long time?   asked at 
round 1   fixed for woman 
0 = quickly 
1 = takes a long time 
2  =  cannot  become  pregnant/don’t 
know 
ideal  BOTH  ideal number of children    
asked at round 1   fixed for 
woman 
1 = o, 1 or 2 
2 = 3 or 4 
3 = 5 or more 
4  =  non numerical  answer*/don’t 
know 
repintention  BOTH  woman’s  reproductive 
intention  (with  current 
husband)   asked at closest 
round   fixed for episode 
1 = wants (a)nother child 
2 = wants no more (none) 
3  =  cannot  get 
pregnant/undecided/don’t know 
 
 
discussfp  BOTH  respondent  has  discussed 
family  planning  with 
husband     asked  at  closest 
round   fixed for episode 
0 = no 
1 = yes 
99 = don’t know  
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Variable 
Name 
File   Variable Description  Category Coding 
encouraged  BOTH  Have  you  ever  talked  to 
anyone who encouraged you 
to use any method to space 
births or avoid pregnancy?   
asked  at  closest  round    
fixed for episode 
0 = no 
1 = yes 
99 = don’t know 
discouraged  BOTH  Have  you  ever  talked  to 
anyone  who  discouraged 
you  to  use  any  method  to 
space  births  or  avoid 
pregnancy?     asked  at 
closest  round     fixed  for 
episode 
0 = no 
1 = yes 
99 = don’t know 
* Up to God/ all eggs in body/other 
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Appendix 4D 
Final Model (fixed effect plus random intercept at level 2) 
Residual Checks 
 
Check  of  the  assumption  of  constant  variance  among  the  individual  level 
(level 2) residuals 
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Check of the normality assumption of individual level (level 2) residuals 
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Appendix 5A 
DHS Interviewers Manual   Field Coding Instructions for 
Questions on Reason for Non use of Contraceptives 
 
The  following  is  an  extract  from  the  DHS  interviewers  manual  which 
provides the instructions for interviewers on how to field code responses to 
the questions related to reason for not intending to use contraception in the 
future: 
 
“Q. 707: REASON FOR NOT USING A METHOD 
 
Check the woman’s response in Q. 702. If she says that she wants to have 
a/another child (code ‘1’ is circled), mark the box on the left and ask the 
question under that box. If she wants no (more) children (code ‘2’ circled), 
mark the box on the right and ask the question under that box. 
 
There are many reasons that a person may not be using contraception, so 
listen to your respondent carefully. Record as many reasons as the woman 
mentions. The following are some guides to use in deciding which code(s) to 
mark: 
 
Code INFREQUENT SEX if the respondent says she is not sexually active 
enough to be using a method. NOT HAVING SEX would be the appropriate 
code if she says she is not sexually active at all. 
 
MENOPAUSAL means she is no longer menstruating and therefore cannot 
get pregnant, and HYSTERECTOMY is an operation to remove her uterus. 
If  the  respondent  says  she  is  not  using  because  she  has  not  resumed 
menstruation since her last birth, record POSTPARTUM AMENORRHEIC. 
Code SUBFECUND/INFECUND if she thinks she cannot get pregnant for 
reasons other than she is menopausal, has had a hysterectomy, or her period 
has not returned since her last birth.  
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FATALISTIC  means  that  the  respondent  feels  that  the  pregnancy  is 
predetermined by fate and she has no control over pregnancy. 
 
RESPONDENT  OPPOSED  means  that  the  respondent  herself  does  not 
approve of family planning. If her husband or partner is opposed to family 
planning, circle the code for HUSBAND/PARTNER OPPOSED. If she says 
she is not using because someone other than her husband or partner tells her 
they are opposed to her using family planning, code OTHERS OPPOSED. 
RELIGIOUS PROHIBITION means that she feels her religion does not allow 
the use of family planning. 
 
SIDE EFFECTS are undesirable consequences of using a method that do not 
adversely  affect  the  health  of  the  user.  For  example,  side  effects  may  be 
spotting or bleeding with the pill, while HEALTH CONCERNS may be that 
she heard that the pill may be linked to breast cancer. 
INCONVENIENT would be if she considers the contraceptive methods to be 
too troublesome to use, such as being messy. This is inconvenient to use, but 
not inconvenient to get the method, since LACK OF ACCESS/TOO FAR is a 
separate category. 
 
If the woman’s main reason is not listed as a response, write her response on 
the OTHER line and circle ‘X.’ If the woman does not know at all why she is 
not using contraception, record DON’T KNOW.” 
ORC Macro (2006:105) 
 
 “Q. 711: REASON FOR NOT INTENDING TO USE 
 
This question is asked of women who are not currently using a method and 
do not intend to use a method in the future. There are many reasons that a 
person  may not use  contraception,  so  listen  to your respondent  carefully. 
Record  what  the  respondent  considers  to  be  her  main  reason  for  not 
intending to use contraception.  
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Only record NOT MARRIED if the respondent offers this as her reason for 
not intending to use a method. If the woman’s main reason is not listed as a 
response, write her response in the OTHER category and circle ‘96.’ If the 
woman  does  not  know  at  all  why  she  will  not  use  contraception,  record 
DON’T KNOW.” 
ORC Macro (2006: 106)  
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Appendix 5B 
Variable codebook 
 
Variable 
name 
Variable 
description 
Variable 
type 
Categories  (RC  = 
reference category) 
mainreason  Main  reason  for  not 
intending  to  use  a 
contraceptive method 
is fear of side effects 
Binary  Yes = 1 
No = 0 
fpdiscuss  Discussed  FP  with 
others in the past few 
months 
Binary  Yes = 1 
No = 0 (RC) 
fpcomm  Heard  a  FP  message 
at  a  community 
meeting  in  the  past 
few months 
Binary  Yes = 1 
No = 0 (RC) 
fphealth  Heard  a  FP  message 
from a health worker 
in  the  past  few 
months 
Binary  Yes = 1 
No = 0 (RC) 
mmedia  Heard  a  FP  message 
from  a  mass  media 
source in the past few 
months 
Binary  Yes = 1 
No = 0 (RC) 
ceb  Number  of  children 
ever born 
Continuous   0 13 
desire  Desire  for  more 
children 
Categorical  Wants = 1 (RC) 
Does not want = 2 
Undecided/Other= 3 
activity  Recent sexual activity  Categorical  Never had intercourse = 0 
Active in last 4 weeks = 1 
(RC) 
Not active in last 4 weeks = 2  
ever  Ever  use  of  a 
contraceptive method 
Categorical  Never  = 0 (RC) 
Only traditional = 1 
Used modern = 2 
approve  Respondent approves 
of family planning 
Categorical  Disapproves = 0 
Approves = 1 (RC) 
Don’t know = 8 
pregnant  Currently pregnant  Categorical  No/unsure = 0 (RC) 
Yes = 1 
amen  Currently 
amenorrheic 
Categorical  No = 0 (RC) 
Yes = 1 
age  Age of respondent in 
completed years 
Continuous   15 49 
educ  Respondents 
education level 
Categorical  No education = 0 (RC) 
Primary = 1 
Secondary = 2   
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Variable 
name 
Variable 
description 
Variable 
type 
Categories  (RC  = 
reference category) 
ethnic  Ethnicity  Categorical  Akan = 1 (RC) 
Mole Dagbani = 2 
Ewe = 3 
Ga/Dangme = 4 
Other = 5 
occu  Occupation  Categorical  Not working = 0 
Agri self employed = 1 
Employed = 2 (RC) 
region  Region  Categorical  Western = 1 
Central = 2 
Greater Accra = 3 
Volta = 4 
Eastern = 5 
Ashanti = 6 (RC) 
Brong Ahafo = 7 
Northern  = 8 
Upper west = 9 
Upper east = 10 
religion  Respondents religion  Categorical  Roman Catholic =  1 
Christian = 2 (RC) 
Moslem = 3 
Traditional/spiritualist/other 
= 4 
No religion = 0 
urbrur  Type  of  place  of 
residence  
Categorical  Urban = 1 
Rural = 2 (RC) 
wealth  Wealth Index  Categorical  Poorest = 1 (RC) 
Poorer = 2 
Middle = 3 
Richer = 4 
Richest = 5 
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Appendix 5C 
Plot of change in deviance against predicted probabilities  
 
Plot  of  change  in  deviance  against  predicted  probabilities  for  Model  3  – 
Communication  Variables,  Family  Planning  Related  Variables  and 
Background Variables 
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